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ABSTRACT
The objective of study was to determine the effects of exogenous cortisol
administration on leptin concentrations relative to 1) appetitic center development of the
hypothalamus by gene expression in dairy bull calves and 2) altered voluntary feed intake
in beef calves. In experiment 1, Holstein bull calves (n = 27) were weighed and randomly
assigned to treatments within four hours of parturition (day 0). Each calf was
intravenously infused with either a low cortisol (LC; n = 9, 3.5 ug/kg of body weight
(BW)), high cortisol (HC; n = 9, 7.0 ug/kg of BW), or a sham infusion control (CON; n =
9, similar volume of saline). Each calf was administered a second infusion (half dose) of
its respective treatment 24 h postpartum. All calves were housed similarly and fed milk
replacer (28% CP, 20% fat) three times daily. Blood collections were performed via
jugular venipuncture before infusion and daily from days 0-5 of age. At 5 days of age,
calves were euthanized via overdose of sodium pentobarbital (Beuthanasia-D Special;
Schering-Plough Animal Health, Union, NJ). Cerebral-spinal fluid (CSF) from the third
ventricle of the brain, hypothalamic, and adipose tissue (AT; omental, perirenal, and
mesenteric) were collected. Blood and CSF samples were analyzed for leptin
concentrations via a validated RIA (Multispecies leptin RIA, Linco Research, St. Charles,
MO, USA). Adipose tissue samples were analyzed via western blotting for leptin and
glucocorticoid receptor (GR) and normalized to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) expression. Hypothalamus samples were analyzed via qRTPCR for genes of interest associated with neuronal growth factors and normalized to the
average of two housekeeping genes. In experiment 2, calves (n = 32 males; n = 30
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females) from Angus and Angus crossbred cows were weighed and randomly assigned to
treatments as previously described in experiment 1. Blood collections were performed via
jugular venipuncture before infusion and daily from days 0-17 of age. Calves were
weaned via abrupt separation from dams at ~7 months of age and BW was collected
biweekly from day 0 until the end of the study. Animals entered an automated feeding
behavior data acquisition system (GROWSAFE Systems, Airdrie, Alberta, Canada) at
367 ± 4 days of age and 385 ± 4 days for heifers and steers respectively and daily feed
intake (FI) calculated. Animals were randomly allotted to one of two pens (per sex) with
three nodes per pen and allowed a two week adjustment period to a commercial total
mixed ration (1.27 Mcal NEm/kg and 15.8% CP; all on DM basis) for heifers and a
finishing ration (1.30 Mcal NEm/kg, 0.45 Mcal NEg/kg and 13.8% CP; all on DM basis)
for steers. Heifer body condition scores (BCS) were collected at the beginning and end of
the trial. Heifers underwent the feeding trial for 70 days and steers until they obtained a
back fat (BF) thickness at the 12th rib of 1.15 cm (~110-140 days). Blood samples were
analyzed similar to experiment 1. All data was analyzed via repeated measures using
appropriate models of SAS (SAS Institute Inc., Cary, NC). Perinatal dairy bull calves had
decreased (P < 0.013) serum and CSF leptin concentrations of HC and LC calves
compared to CON whilaye day 0 was decreased (P < 0.001) compared to all other days of
age. Leptin protein expression was decreased (P < 0.044) in perirenal and omental AT of
LC calves compared to CON. Hypothalamic expression of BDNF, FGF1 and FGF2 were
decreased (P<0.006) in HC and LC compared to CON. In postnatal beef calves, a
treatment by day interaction (P = 0.0028) was reported in which decreased (P < 0.001)
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serum leptin concentrations were observed in HC and LC calves compared to CON from
days 2-17 of age. Calf BW at birth and adjusted 205d weaning weight did not differ (P >
0.05) between treatments. During the feeding trial: BW gain, BCS change, number of
feed events were increased (P = 0.001) in LC compared to HC and CON heifers, while
steers BF thickness did not differ between treatments (P > 0.05). However, LC observed
greater daily FI (P = 0.047), tended to have greater final BW (P = 0.080), and
numerically required fewer days on feed to achieve finishing weight compared to HC and
CON steers. In summary, exogenous cortisol administered to calves at birth reduced
leptin concentrations and altered appetitic control center development of the brain in
perinatal dairy bull calves and improved FI of beef steers during a feeding trial.
Key words: exogenous glucocorticoid, leptin, appetitic center development, feed intake,
cattle
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CHAPTER I
REVIEW OF LITERATURE
INTRODUCTION
Profitability in beef cattle production may be influenced by voluntary feed intake
and the neuronal circuitry that regulate it. Leptin promotes development of appetite
control centers of the brain during early postnatal development. Conversely, decreased
leptin concentrations during this time have been associated with increased feed intake in
ruminants. Glucocorticoids have been reported to decrease leptin concentrations and may
serve as a tool to alter endocrine status and associated brain development in beef
production.
PROGRAMMING
Origin and historical importance
In humans, the first observations in which conditions of offspring at birth were
linked to gestational conditions came from the Dutch Hunger winter of 1944 to 1945.
During this time, the population of the Netherlands underwent a period of famine in
which rations were limited and people received 400 to 800 calories a day, including
pregnant women. Stein et al. (1975) made observations in which nutrient restriction
during early pregnancy was associated with increased number of stillbirths and increased
postnatal mortality. Interestingly, only women exposed to nutrient restriction from mid to
late pregnancy observed depressed birth weights of offspring (Roseboom et al., 2006;
Schulz, 2010) as well as decreased crown to heel length and head circumference (Stein et
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al., 2004). However, this was the first instance in which the low birth weight of offspring
was speculated to have been caused by maternal nutrition rather than being premature.
The Dutch Hunger study brought about the idea that an adverse fetal environment,
low birth weights, and adult disease were potentially correlated. Following the famine,
offspring of women who experienced early gestation nutrient restriction had children
with normal birth weights; however, these children experienced greater instances of
obesity in adulthood (Roseboom et al., 2006; Schulz, 2010) and were glucose intolerant
(Ravelli et al., 1998). However, timing for programming due to altered fetal environment
may differ amongst organ systems. Maternal intake restriction during the Dutch famine
did not affect the basal blood pressure but induced glucose intolerance in offspring
(Ravelli et al., 1998; Roseboom et al., 1999). A greater impairment of glucose tolerance
was observed in offspring born to mothers that underwent restriction during late gestation
compared to mother’s nutrient restricted during mid or early gestation (Ravelli et al.,
1998). Additionally, glucose tolerance increased as weight, length or head circumference
at birth increased (Ravelli et al., 1998).
In animals, the first observations of gestational conditions and offspring
performance were made by Wallace (1948). Briefly, ewes fed the same plane of nutrition
throughout gestation observed greater weight gain over time as measured by live-weight
growth curves of the ewes. However, twin-bearing ewes observed greater weight at
corresponding stages of pregnancy than singleton bearing ewes. While ewes did gain
body weight, the primary contribution of weight gain was due to the gravid uterus.
Additionally, weight gain was greatest during the last trimester of pregnancy and greatest
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in twin-bearing versus singleton-bearing ewes. Since then, numerous epidemiological
studies have evaluated the association between fetal growth and offspring performance
relative to increased risk of cardiovascular disease, obesity, hypertension, insulin
resistance, type II diabetes, immune dysfunction, stunted growth (Barker, 2004;
McMillen and Robinson, 2005; Barker, 2007).
Thrifty genotype and phenotype hypothesis
Associations between gestational environment and adult health played a role in
the development of the thrifty genotype hypothesis by Neel (1962) in which “thrifty”
genes or probable epigenetic modification of genes were selected during a period of
scarce food. This was so that individuals with those genes or genetic modifications
experienced improved fat storage capacity, though experienced increased risk of insulin
resistance later in life when there is adequate to abundant food available. Following
evidence from epidemiological studies, adaption of the thrifty genotype hypothesis came
in the form of the thrifty phenotype hypothesis by Hales and Barker (1992). The thrifty
phenotype hypothesis suggests that poor fetal environment induces an adaptive response
in the fetus to alter growth of key body organs at the cost of growth for other organs, that
will alter postnatal metabolism and other physiological responses (Hales and Barker,
2001). However, when addressing fetal adaptation as a result of the intrauterine
environment, the concept of programming was introduced.
Maternal milieu
In livestock species especially, the uterine environment may induce adaptive
changes in subsequent offspring based on overall capacity, influenced by if the species is
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litter-bearing or not, as well as frame size of the animal. In addition to the physical
restrictions of the dam, altered uterine environment may play a role in transgenerational
inheritance models. For example, any adaptations to the uterine environment during
gestation may occur in the first generation and persist to offspring of the next generation.
For example, Long et al. (2013b) observed altered blood profiles of granddaughters to
ewes administered glucocorticoids during gestation; material which will be discussed in
detail later on in the review. Thus, when considering any adaptations in fetal physiology,
invesrigations must take into consideration the role and action of the maternal
environment in utero. As these adaptations may predispose subsequent offspring to
altered physiology that may or may not be desirable in specific environments.
Epigenetic hypothesis
Epigenetics describes the study of heritable changes in gene expression that are
not caused by changes in the underlying DNA sequence (Riggs et al., 1996). The
epigenome is comprised of compounds that surround the DNA and are involved in the
modification of the genome. This influences the ability of cells to recognize and
remember histone modifications (Cavalli and Paro, 1998; Grewal and Klar, 1996), also
referred to as the epigenetic code. Two mechanisms have been proposed for the
generation of an epigenetic code. First, methyl groups added to DNA at cytosine bases
followed by post-translational modification of histone proteins via the addition of methyl
or acetyl groups (Waterland et al., 2007). Alterations to the first proposed mechanism
would limiting methyl donor groups to interfere with overall histone methylation
(McMullen et al., 2012). As methylation and histone modification determine expression
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of genes and allows a variety of phenotypes to be expressed from a single genotype. The
second proposed mechanism involves transcriptional activity of specific genes during
times of DNA methylation which will alter the amount of DNA available for methylation
downstream (Waterland et al., 2007). This could be accomplished by altering the activity
of the enzymes responsible for DNA methylation and histone modifications (McMullen
et al., 2012).
Epigenetic regulation is sensitive to alteration during embryogenesis, fetal
development, puberty and old age (Weaver et al., 2004; Dolinoy et al., 2007). During
fetal development, embryonic and fetal derived tissues are de-methylated and remethylated (Morgan et al., 2005) which make them susceptible to environmental
insult/stimuli. Modified gene expression during periods of development could result in
altered organ structure, cell number, apoptotic remodeling, and metabolic differentiation
(Waterland and Garza, 1999; Waterland and Jirtke, 2004).
Developmental programming
Incorrectly, developmental programming and ‘fetal programming’ are commonly
used interchangeably. However, fetal programming encompasses only gestation and
prenatal life. Developmental programming describes the phenomenon in which a
stimulus or insult introduced during a critical period of time and results in permanent
consequences such as structural, physiological, and metabolic changes that effect
development and production (Godfrey, 2002; Nathanielsz et al., 2007). Therefore, as
growth and development occur, the fetus is susceptible to changes in the internal or
external environment as well as any genetic predispositions. Programming encompasses
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the plasticity in which an organism responds to environmental or nutritional signals
during early life that could lead to potential adverse consequences (Gicquel et al., 2008).
Thus, the concept of developmental programming encompasses not only prenatal
development, but the impact of early postnatal development on long-term effects in
offspring as well.
Metabolic and nutritional programming
Following parturition, offspring must meet their own nutritional requirements
opposed to in utero in which the dam and placenta provided everything the fetus needed.
Following birth, animals may undergo metabolic and nutritional programming. Metabolic
imprinting has been used to describe the biological phenomena surrounding the
relationship between intrauterine nutritional experiences and subsequent health outcomes
(Waterland and Garza, 2000). Metabolic programming encompasses adaptive responses
of an organism to specific nutritional conditions in early postnatal life. Waterland and
Garze (2000) described metabolic imprinting as being characterized by 1) a susceptibility
limited to a critical ontogenic window early in development 2) a persistent effect lasting
through adulthood 3) a specific and measurable outcome which may differ quantifibly
among individuals 4) a dose-response or threshold relation between a specific exposure
and outcome. This pairs with nutritional programming as it is related to altered organ and
tissue structure and tissue remodeling (Langley-Evans et al., 2006). This includes
anything that could disrupt development and result in smaller organ size, altered cell
number, or altered cell type as observed in rodents (McArdle et al., 2006). Early studies
in livestock observed that protein intake during gestation in pigs did not affect litter size
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and birth weight (Mahan and Mangan, 1975; Gatford et al., 2004). However, this may
alter performance later in life. Low birth weight piglets from otherwise normal litters gain
less and have increased adipose mass compared to normal birth weight piglets (Kuhn et
al., 2003). Development of the fetus occurs in a defined chronological manner, in which,
once adaptation occurs as a response to external stimuli, it is generally irreversible
(McMullen et al., 2012). However, there is a period of plasticity in which the fetus is
experiencing rapid cell proliferation and may be more susceptible to environmental
stimuli (McCance and Widdowson, 1974).
Relevance to beef production
Currently, these concepts introduced in the mid to late 1900’s relate to the
livestock industry today, as market animals impacted by programming effects may
observe reduced growth, altered carcass composition, and reduced meat yield and quality.
Fetal growth and development is an important component for beef cattle production, as a
large issue in the livestock industry is reduced production due to decreased growth rate,
reduced feed efficiency and ADG, and increased neonatal morbidity and mortality
(Uetake, 2013) and decreased birth weights (Kais et al., 2010). Increased instances of
poor carcass composition that contain higher amounts of adipose tissue, reduced
myofibril numbers, and increased connective tissue that results in inferior meat quality, as
well as other diseases and disorders (Reynolds et al., 2006; Wu et al., 2006; Kais et al.,
2010; Uetake, 2013) are of concern as well.
PERIODS OF DEVELOPMENT
General
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Severity, duration, and the stage of development in which an insult or stimulus is
applied are all factors contributing to potential programming effects. Adaptive change
may occur when the fetal environment is deprived of nutrients concomitant to critical
period associated with the growth of key body organs which may lead to adverse effects
postnatally (Godfrey and Barker, 2000; Gicquel et al., 2008). Thus, developmental
programming is a broad subject encompassing prenatal and early postnatal effects on
subsequent offspring performance in adulthood. Previous debate has been observed in the
literature as to whether developmental plasticity or developmental programming during
critical periods of development are the true source and/or accurate descriptions of what
mechanistic adaptations are occurring during this time. However, McMillen and
Robinson (2005) describe an overlay between the two specific critical periods during
development. There are critical windows of developmental plasticity and programming
mechanisms that may be implemented during those periods of times to induce adaptations
in the offspring. Relative to the study of livestock species, two critical periods are
primarily evaluated: 1) fetal growth and development of integrated systems responses and
2) postnatal growth and development of integrated systems responses. The programming
mechanism potentially implemented during this critical period window suggested by
McMillen and Robinson (2005) alters adaptive cardiovascular, metabolic, neuroendocrine
responses via hormonal stimulation.
FETAL DEVELOPMENT
Developmental hierarchy

8

Fetal growth is defined as kg of fetal weight gain over the course of gestation.
While most fetal growth occurs during late gestation (Winters et al., 1942; Lyne, 1960;
Ferrell et al., 1976; Prior and Laster, 1979), overall fetal growth observes a flattened,
sigmoidal pattern. In which early gestation observes exponential growth followed by a
rapid linear phase that begins to plateau until parturition (Greenwood and Bell, 2003a;
Greenwood and Bell, 2003b). During gestation, the fetus prioritizes development of
specific organs and associated systems over others. Initially, the central nervous system
(CNS) and associated organs are partitioned nutrients for establishment and development.
This system is prioritized throughout all of gestation until term irrespective of nutrient
availability from the maternal circulation (Zhu et al., 2006; Du et al., 2010). Generally,
the development of vital organs will precede development of structural components, such
as muscle, fat, and bone (Palsson, 1995). For animals intended for market, tissues such as
muscle and adipose, while the most economically important, are low priority compared to
vital organs and nervous tissues (Zhu et al., 2006; Du et al., 2010). This prioritization
structure leaves muscle and adipose tissue development susceptible to altered nutrient
availability in utero (Zhu et al., 2006; Du et al., 2010). A generalized timeline of fetal
development throughout gestation in cattle is shown in Figure 1.1.
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Figure 1.1. Generalized timeline of bovine embryonic and fetal growth during gestation
Central nervous system
Development of primitive system s during the early embryonic stages will occur
regardless of nutrient availability in utero. During the embryonic period of development
following fertilization, the three germ layers (derived from the gastrula) are developed
which each give rise to different cells, tissues, and organs via gastrulation. The inner
layer, or endoderm, forms the internal glands and organs such as the lungs, intestines,
thyroid, pancreas, urinary system, and part of the digestive system. The middle layer, or
mesoderm, gives rise to vasculature, muscles, bone, cartilage, and the heart. Finally, the
outermost layer, or the ectoderm, leads to the development of the epidermis, nervous
10

system, and connective tissues. Following gastrulation is the development of the
structures that will give rise to the nervous system. Following neurulation is
organogenesis in which the cardiovascular system (derived from the mesoderm) is the
first functional organ developing in the embryo. This is imperative to getting nutrients
and growth factors to the developing tissues and cells of the embryo as the embryonic
stage of development occurs up to approximately 45 days of gestational age followed by
the fetal stage that lasts until term in cattle.
The CNS begins early in embryonic development, but is not finalized until early
postnatal life. The following developmental observations were performed by an intensive
study by Ferreira et al. (2018) in Bos Indicus bovine embryos and fetuses. Briefly, a
bovine embryo has developed a neural tube derived from the neural plate with both
cranial and caudal neuropores and somites (bilateral paired blocks of paraxial mesoderm)
by 17 days of gestational age. Then by 24 days, the neural tube has developed into the
five encephalic vesicles known as the telencephalon, diencephalon, mesencephalon,
metencephalon, and myelencephalon as well as the beginnings of the spinal cord. At 45
days of gestational age, fetal development begins and coincides with the presence of
circulating blood cells. By day 65, the five encephalic vesicles are differentiated as well
as establishment of the primitive spinal cord and separation of the meningeal layers
(membraneous cover of the brain and spinal cord) into dura mater, erachnoid mater, and
pia mater. The subarachnoid space contains cerebrospinal fluid (CSF). At 90 days, the
primary CNS regions have differentiated and main structures, such as the hypothalamus
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and third ventricle of the diencephalon, can be determined based off of morphology. The
primitive spinal cord has finalized development by 110 days of gestational age as well.
Fetal pancreatic development
The development of the endocrine system can be influenced by nutrient
availability in utero. Insufficient maternal nutrition may induce metabolic insults during
gestation that impair fetal development of endocrine organs, such as the pancreas, and
may be a contributing factor to the occurrence of metabolic syndrome or diabetes in
postnatal animals. The pancreas produces insulin which plays a role in body homeostasis
as it regulates glucose in the body, but alteration during fetal development may induce
permanent changes to the fetus in adult life. Especially considering that disorders
associated with suboptimal fetal growth are caused by altered development of key
endocrine axes, which may impede physiological mechanisms (Gicquel et al., 2008).
Pancreatic development is imperative to endocrine function and may be impaired due to
reduced fetal growth. Intrauterine growth retardation during gestation has been associated
with pancreatic growth disturbance and impaired function of subsequent offspring that
may reduce insulin concentrations in adult life.
In livestock species, the endocrine pancreas develops over a long period of fetal
and early postnatal life (Bonner-Weir, 1980). However, periods of maternal nutrient
restriction have been observed to influence pancreas weight in offspring. Previous reports
of maternal nutrient restriction on pancreatic growth reported no differences in bovine
(Long et al., 2009) or ovine (Vonnahme et al., 2003) offspring. More recently, decreased
pancreas weights have been observed in fetuses of late gestation nutrient restricted Angus
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cows (d 110 to d 190 of gestation; McCarty et al., 2019). In nutrient restricted ewes, fetal
pancreas weight at 90 days of gestation was decreased, but pancreas weight did not differ
at birth between treatments (Gao et al., 2009).
Interestingly, similar reports of decreased fetal pancreas weight have been described in
ewes fed obesogenic diets 60 days prior to conception (Zhang et al., 2011). The
observation of altered organ weights in offspring due to the maternal environment reflect
the idea that prenatal induced changes during gestation may influence postnatal
circulating concentrations of hormones (Fowden and Forhead, 2004). In this instance,
pancreatic growth disturbance and impaired function may reduce insulin concentrations.
LeMaster et al. (2017) reported maternal plasma insulin concentrations were decreased
when nutrient restriction occurred during late gestation in beef cows. McCarty et al.
(2020) observed decreased insulin concentrations in Angus cows and their associated
fetuses, but increased in whole fetal pancreas on day 190 of gestation when dams were
nutrient restricted during late gestation (day 110 to 190 of gestation).
Reduced insulin secretion may be associated with reduced transport of nutrients
coming from maternal circulation to the developing fetus. When placental and uterine
blood flow was reduced in overfed pregnant ewes, a concomitant decrease in fetal insulin
concentration was observed (Wallace et al., 2002). Reduced insulin could also be relative
to younger dams experiencing nutrient restriction. Younger cows have previously been
observed to be more susceptible to nutrient restriction compared to older cows (Bellows
and Short, 1978; LeMaster et al., 2017). Immature and growing heifers do not have the
developed maternal ability to repartition nutrients to the developing fetus, thus, mature
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females have been reported to tolerate nutrient restriction better than immature females
(Bellows and Short, 1978; Wallace et al., 2002). During periods of nutrient restriction,
there is an increased likelihood of negative long-term effects on subsequent offspring
born to immature dams.
Fetal muscle and adipose tissue development
In cattle, fetal muscle development initially occurs within the first 2 months postconception, though very few muscle fibers are formed during this time, thus, nutrient
restriction during early gestation isn’t as detrimental (Russell and Oteruelo, 1981). Most
muscle cell formation occurs between 2 to 8 months of gestation in which any insults
during this time would result in detrimental effects to muscle fiber number, thus,
irreversible effects on meat composition in the future (Russell and Oteruelo, 1981; Zhu et
al., 2006, Du et al., 2010). To review, muscle development during gestation has been
broken into embryonic and fetal stages (Du et al., 2010), in which primary and secondary
myogenesis occurs during the embryonic and fetal stages, respectively. Skeletal muscle
development is initiated when multipotent mesenchymal stem cells (finite pool)
differentiate into myocytes (Dodson et al., 2010; Du et al., 2010; Yan et al., 2012).
Mesenchymal stem cells are stimulated via signaling from neighboring tissues to promote
myoblast formation (Kollias and McDermott, 2008; Du et al., 2010). During mygenesis,
additional myogenic regulatory factors promote differentiation and proliferation of
myoblasts into multinucleated myotubules (Keren et al., 2006; Kollias and McDermott,
2008; Du et al., 2010). Signaling cascades associated with myogenesis are Wingless and
Int (Wnt) and Sonic hedgehog that serve to regulate the expression of paired box 3 and 7

14

(Pax3, Pax7). Pax3 and Pax7 activation then stimulate the release of myogenic regulatory
factors such as myogenic factor 5 (Myf5), myogenic differentiation 1 (MyoD), and
myogenin (MyoG) (Buckingham, 2001; Kassar-Duchossoy et al., 2005; Du et al., 2010).
Primary myogenesis, or initial muscle formation, is observed when myocytes
proliferate into primary muscle fibers (Du et al., 2010). These primary fibers serve as the
scaffolding for other muscle fiber development. Remaining mesenchymal stem cells that
do not differentiate into myocytes will either differentiate into adipocytes for
intramuscular fat accumulation sites, or fibroblasts for structural connective tissue
(Dodson et al., 2010; Du et al., 2010; Yan et al., 2012). Secondary myogenesis
contributes to the majority of myofibers that make up skeletal muscle. As this process
ends prior to parturition, it results in a fixed total number of muscle fibers (Strickland,
1978; Karuatatne et al., 2005; Du et al., 2010). The last trimester of gestation is sensitive
to periods of nutrient restriction in livestock species as reduced myofiber number has
been observed in both sheep (Zhu et al., 2006) and pigs (Dwyer et al., 1994). Calves born
to cows that underwent mid to late gestation nutrient restriction were lighter at birth
(Ramirez et al., 2020). Additionally, calves of severely restricted (50% of requirements)
cows observed compensatory growth from weaning to harvest but no difference on
adipocyte diameter or Longissimus muscle area compared to calves born to control fed
dams (Ramirez et al., 2020). To summarize, mature skeletal muscle is made up of
myocytes, adipocytes, and fibroblasts in which the proportion of the previously
mentioned components determines composition, potential yield, and meat quality.
However, prenatal muscle development is established via myofiber hyperplasia and
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hypertrophy, whereas postnatal muscle accretion relies on hypertrophy of pre-existing
fibers (Du et al., 2010).
As previously mentioned, mesenchymal stem cells that do not differentiate into
myocytes will either differentiate into adipocytes or fibroblasts (Dodson et al., 2010; Du
et al., 2010; Yan et al., 2012). Fetal adipose development begins during the second
trimester when mesenchymal stem cells differentiate into adipocyctes. To do so,
differentiation into adipocytes occurs through stimulation of transcription factors for
CCAAT enhancer binding proteins (CEBP) and peroxisome proliferator activated
receptor gamma (PPARγ; Clarke et al., 1997b; Wu et al., 1999). Binding of the alpha
subunit of CEBP to the PPARγ promoter region promotes positive feedback which
further stimulates the release of CEBPA (Clarke et al., 1997b; Wu et al., 1999).
Activation of PPARγ stimulates the release of genes associated with triglyceride uptake
and storage, necessary for adipocyte development (Frohnert et al., 1999; Rosen and
MacDougald, 2006). At birth, greater amounts of brown adipose tissue (BAT) are present
as it contains a higher amount of mitochondria and plays a role in thermogenesis of the
animal to improve survivability. It also contains a unique uncoupling protein-1 (UCP1)
that enables rapid generation of heat and is commonly found surrounding major internal
organs. Brown and white adipocytes have been observed in human and ruminant fetuses
at term (Lean, 1989; Casteilla et al., 1987; Yuen et al., 2003). Both ruminants and
humans are born with fully developed BAT that is stimulated by the cold to activate
UCP1 and become thermogenically active (Clarke et al., 1997c). Moreover, an inverse
relationship has been suggested between BAT distribution and total fat mass (Bispham et
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al., 2005). Originally, it was believed that the total mass of adipose tissue was determined
by the number of adipocytes developed during gestation and their respective size during
postnatal growth (Spalding et al., 2008). However, recent evidence suggests that this is
not completely true as adipocyte number can increase postnatally (Helper, Vishvanath,
and Gupta, 2017). Additionally, fetal adiposity is strongly influenced by maternal nutrient
restriction (Bispham et al., 2003; Whorwood et al., 2001).
Maternal nutrient supply models during gestation
Many models revolve around maternal nutrient supply or how nutritional schemes
or supplementation practices impact fetal development and subsequent offspring growth.
The effect of maternal nutrient models are relative to the type of insult or stimulus.and
the time at which the insult or stimulus is implemented. In models of maternal over
nutrition or undernutrition, growth and development in ruminant species are primarily
studied as a result of energy, protein, and fat restriction (Satterfield et al., 2013; Yan et
al., 2013). The restriction of these factors contributes to the overall nutrient supply
available to the fetus. Additionally, nutrient restriction may negatively impact postnatal
offspring growth if it occurs during critical periods of development during gestation
(Barker and Clark, 1997). Maternal nutrient restriction during pregnancy has been
observed to reduce overall growth in bovine (Long et al., 2009), ovine (Vonnahme et al.,
2003; Ford et al., 2007; Zhang et al., 2011), swine (Schoknecht et al., 1994), and equine
(Pugh, 1993) fetuses. The effects of nutrient restriction in cows during gestation
published prior to 2020 are summarized in Table 1.1. Furthermore, induction of fetal
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IUGR using nutrient restriction models have been previously demonstrated in sheep
(Vonnahme et al., 2003) and cattle (Long et al., 2009).
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Table 1.1. Effects of maternal nutrient restriction during gestation and their impact on fetal growth published up to 2020 in cattle
Restriction
Restriction
BW(kg) or BCS of
Author
(d of
Effect
Type
dams precalving
gestation)
Hafez et al., 1968
45 to term
Intake
Heifers 441 vs 625
↓ calf birth weight
Tudor, 1972
150 to term
Intake
Cows
↓ birth weight and gestation length
Corah et al., 1974
180 to term
Intake
Heifers ΔBW of + 36.1 ↓ birth weight
vs -5.8
Bellows and Short, 1978 190 to term
Intake
Heifers 329 vs 378
↓ birth weight
Heifers 346 vs 361
↓ birth weight
Cows 422 vs 473
No effect
Kroker and Cummins,
190 to term
Intake
Heifers ΔBW 42.5 vs - ↓ birth weight
1979
12 vs -46
Prior et al 1979
42 to term
Intake
Heifers 355 vs 421 vs
No effect at 90, 125, 150, 180, 210, 240, and 255
469
d of gestation
Waldhalm et al., 1979
120 to term
Protein
Cows 371 vs 410
↓ gestation length
Tudor and O'Rourke
180 to term
Intake
Δ BW during trt + 63.8 ↓ birth weight and gestation length
1980
or -36.8
Doornbos et al., 1984
220 to term
Intake
Heifers and cows 450
No effect
vs 456
Anthony et al., 1986
205 to term
Protein
Heifers 473 vs 498
No effect
Boyd et al., 1987
230 to term
Intake
Cows 503 vs 527
↓ birth weight
Carstens et al., 1987

190 to term

Protein

Heifers ΔBW 97 vs 180 No effect

Warrington et al., 1988

90 to term

Intake

↓ calf birth weight, ↓ gestation length

Houghton et al., 1990

190 to term

Intake

Heifers ΔBW of -3.75
vs -92
Cows 643 vs 575

Miner et al 1990
Rasby et al., 1990

220 to term
145 to 259

Intake
Intake

Cows ΔBw 1.9 to 46.4
Cows 419 vs 511

No effect
No effect
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No effect

Shell et al., 1995
Martin et al., 1997
Cooper, 1998
Perry et al., 1999
Zhu et al., 2007

100 to term
140 to term
0 to 140
42 to 198
30 to 125

Intake
Protein
Intake
Protein
Intake

Cows 514 vs 571
Heifers 475 vs 357
Heifers
Heifers (Not reported)
Cows

Long et al., 2009
Long et al., 2010a

30 to 125
32 to 83

Intake
Intake

Meyer et al., 2010

30 to 125

Intake

Cows
Heifers 360 vs 420; 4.9
vs 5.2
Cows

Long et al., 2012

45 to 185

Intake

Cows

Meyer et al., 2014

45 to 185

Intake

Cows

Camacho et al., 2014a

30 to 140

Intake

Cows

Camacho et al., 2014b

30 to 85

Intake

Cows

Prezotto et al., 2016

30 to 85

Intake

Cows

Camacho et al., 2018

30 to 85

Intake

Cows

McCarty et al., 2020

30 to 110

Intake

Cows
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No effect
No effect
No effect
No effect
↓ fetal weight, ↓ placentome weight, and
↑cotyledon vascularity 125 d of gestation
No effect 250 d of gestation
↓ cotyledon weight, ↓ placentome surface area
No effect birth weight or postnatal growth at
term
No effect at term on fetal BW or EBW
↑fetal reticular mass by d 245 of gestation
No effect on BW or organ weight of offspring >
433 d of age (harvest), ↓ yield grade at harvest, ↑
adipocyte diameter in subcutaneous, mesenteric
and omental adipose tissue at harvest
No effect at term
↑maternal ipsilateral uterine artery blood flow d
198 of gestation
No effect at d 85 on fetal BW or EBW, ↓ fetal
BW, liver mass, and ruminal mass at d 140 of
gestation
No effect at d 245 on fetal BW or EBW
↓ fetal jejunal O2 consumption and ↓ maternal
hepatic weight on d 85 of gestation
↑ number and weight of cotyledons d 85 of
gestation, ↑ number of cotyledons d 140 of
gestation; No effect fetal BW
No effect on fetal pancreas weight at d 190 of
gestation

McCarty et al., 2020

110 to 190

Intake

Cows
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↓ beta cell number at d 190 of gestation
↓ fetal pancreas weight, ↓ maternal and fetal
insulin concentrations, and ↓ beta cell number
at d 190 of gestation

While maternal nutrition studies have been performed over early, mid, and late
gestation in cattle, experiments performed nutrient restriction during early gestation have
observed impaired fetal growth and adaptations that may result in metabolic syndrome
(Symonds et al., 2009). As lipid synthesis (39 MJ/kg) has a greater energy requirement
compared to carbohydrate or protein (15–25 MJ/kg), fetus adipose growth and
development is more sensitive to environmental conditions in which oxygen and
metabolic substrates may be limited (Stevens et al., 1990; Budge et al., 2000).
Specifically, early gestation maternal nutrition affects adipose tissue development by
increasing adipocyte precursor cells and other nutrient adaptions (Symonds et al., 2009).
Decreased myofibril number and increased myofibril cross-sectional area in beef cattle
were observed as a result of maternal nutrient restriction during gestation (Funston et al.,
2010). Similarly, nutrient restricted cattle during early gestation from days 30 to 85 of
gestation observed decreased myofiber diameter (Gonzalez et al., 2013). Early gestation
nutrient restriction tends to reduce myofibril number in offspring (Robinson et al., 2013),
while Long et al. (2010) observed that restricting beef heifers by 55% of NRC
recommendations during early gestation did not influence birth weight or postpartum
growth, however, muscle tissue was altered, as indicated by increased muscle fiber area,
increased concentrations of DNA, in the adult animal. Increased adipose tissue depots as
a result of late gestation nutrient restriction have been observed across a number of
species (Symonds et al., 2003). Conversely, models of overnutrition during gestation
(1.5 times maintenance energy requirements) have been observed to increase mRNA
abundance of markers relative to fibrogenesis and adipogenesis in fetal skeletal muscle in
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Nellore cattle irrespective of the time at which the insult occurred (Duarte et al., 2014).
Additionally, Greenwood et al. (2005) observed that animals that experienced stress in
utero had reduced skeletal growth. George et al (2012) observed that intake restricted
ewes during days 28 to 78 of gestation gave birth to female offspring with increased
insulin secretion and altered glucose metabolism, consistent with efficient energy
acquisition and storage.
In late gestation, maternal capacity restricts growth of the fetus as well as the
number of offspring (Davies et al., 2005). Increased blood pressure in offspring has been
induced in late gestation via glucocorticoid administration, diabetes, and placental
dysfunction (Amri et al., 1999; Alexander, 2003; Nehiri et al., 2008). It has been known
for a long time in livestock that maternal undernutrition will result in reduced fetal
growth during gestation (Wallace, 1946), however, it is dependent upon the time period
in which the insult occurs. Some experiments have reported exceptions to this generality.
Studies that have reported no effect due to nutrient restriction, did not observe differences
in cow weight at the end of the treatment period, indicating that the nutrient restriction
was not severe enough to cause differences in fetal growth (Bellows and Short, 1978;
Doornbos et al., 1984; Shell et al., 1990). Heifers tend to respond to nutritional
restriction with decreased calf birth weight more consistently then cows (Bellows and
Short, 1978). Not only can maternal nutrient restriction reduce calf birth weight, it can
also shorten gestation length (Hafez et al., 1968, Warrington et al., 1988; Long et al.,
2010). Protein restriction in isocaloric diets fed during the last 4 months of gestation

23

decreased gestation length by 8 days (Waldhalm et al., 1979), but did not affect calf birth
weight.
As previously mentioned, most livestock species will undergo a period of nutrient
restriction at some point during gestation due to lack of availability of high quality forage
to handle increasing nutrient demands of the dam. As gestation progresses, energy
requirements of the dam are greater to accommodate both the maintenance requirements
of the dam as well as the growing fetus. Particularly the final third of gestation during
which the fetus undergoes rapid, exponential growth prior in cattle. From mid to late
gestation, nutrient restriction may occur due to the increased nutritional demands of the
fetus. As well as the fact that most cows are bred during periods of poor quality forage
(Wu et al., 2006) and are maintained on low quality forage without additional
supplementation to meet their energy requirements (NRC, 1996). Experiments
incorporating maternal nutrient restriction models in cattle during this period of fetal
growth and development have reported increased perinatal mortality, impaired fetal
growth, reduced birth weights, reduced postnatal growth, and increased risk of disease
(Kroker and Cummins, 1979; Barker, 1997; Barker, 2004; Barker, 2007; Nathanielsz et
al., 2007). Taylor et al. (2018) reported that fetuses collected at day 190 of gestation had
decreased empty carcass weights in nutrient restricted cows, irrespective of when the
restriction occurred during gestation (early or mid).Whereas, late gestation undernutrition
is associated with fetal growth retardation while low protein is associated asymmetrical
fetal growth in cattle (Maresca et al., 2018). By late gestation, not only is the fetus
undergoing exponential growth prior to parturition and is limited by the nutrients
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available in the maternal system, but physical limitations such as maternal capacity alters
fetal growth and number of offspring (Davies et al., 2005). Beef calves born to late
gestation nutrient restricted cows observed reduced birth weights compared to calves
from control dams (33.4 ± 1.2 and 37.2 ± 1.3 kg, respectively; LeMaster et al., 2017).
Similarly, Mongolian ewe’s nutrient restricted from day 90 of gestation to parturition
observed decreased daily fetal growth and lamb birth weight (Gao et al., 2009).
Market animals that have undergone some sort of adaptation as a result of
programming may have altered carcass composition or reduced meat yield and quality.
Nutritional status of the dam can have long lasting effects on fetal development by
permanently altering the development of adipogenesis, fibrogenesis, and myogenesis
(Karunaratne et al., 2005; Rehfeldt and Kuhn, 2006; Zhu et al., 2006; Funston et al.,
2010; Huang et al., 2010; Duarte et al., 2014; Wang et al., 2017). Maternal nutrition
during gestation may be also be associated with poor carcass composition that contain
higher amounts of adipose tissue, reduced myofibril numbers, and increased connective
tissue that results in inferior meat quality (Reynolds et al., 2006; Wu et al., 2006; Kais et
al., 2010). Protein restriction during either gestation or early postnatal life decreased
skeletal muscle mass in rats (Desai et al., 1996). Impaired adipose tissue development
was observed in nutrient restricted dams, however, subsequent offspring have observed
overcompensation to this by having increased adipose, decreased feed efficiency, and
decreased muscle mass (Zhu et al., 2006; Wang et al., 2017). Therefore, manipulation of
fetal muscle and adipose development during gestation has the ability to affect carcass
quality and value long term; especially as there is no net increase in the number of muscle
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fibers after birth (Strickland, 1978; Zhu et al., 2004). Nutrient restricted cattle during
early gestation increased calpastatin (calpain inhibitor) concentrations in fetuses (Du et
al., 2004) which may lead to decreased muscle degradation (Barnoy et al., 2000) and
suggest maternal nutrition as a mediator of fetal muscle development. Interestingly,
decreased skeletal muscle mass is suggested to predispose the animal to obesity and
glucose/insulin dysregulation in adulthood (Stannard and Johnson, 2004; Zambrano et al.,
2005; Zambrano et al., 2006) as skeletal muscle is the primary site for insulin resistance
in obese and type 2 diabetes patients (Lowell and Shulman, 2005). Nutrient restricted
ewes increased muscle fiber diameter and altered myosin distribution which may be
associated with glucose intolerance (Zhu et al., 2006). Briefly, restricted ewes observed
increased distribution of myosin IIb fibers (insulin insensitive) and decreased myosin Ia
type fibers (insulin sensitive; Zhu et al., 2006). Thus, mid to late gestation nutrient
restriction or over consumption primarily impacts muscle fiber number and overall mass
while late gestation nutrient restriction or over consumption alters adipogenesis and
overall adiposity in offspring.
Placental growth and function during gestation
Altered maternal nutrition has been associated with altered placental growth
which directly impacts both fetal growth and nutrient transport. The placenta is a
transient organ that serves as the primary connection between the maternal and fetal
circulatory systems to transport nutrients, produce hormones, remove waste, and perform
gas exchange. Gestational nutrient restriction could alter the size and weight of the
placenta as gestation is comprised of placental growth, differentiation, and
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vascularization, and fetal organogenesis (Funston et al., 2010). Reduced placental
function alters nutrient availability for fetal growth and development resulting in reduced
birth weight as well as impaired postnatal growth (Robinson et al., 2014). Maternal
nutrition may alter placental weight and induce a form of placental dysfunction that lead
to disorders such as intrauterine growth restriction and decreased birth weights
(Robinson, 2017; Sultana et al., 2017).
Sensitivity to maternal nutrition has been observed in various ruminant species
that harbor morphological similarities in tissues such as the uterus or placenta. Temporal
associations and response or adaptions of placental vasculature are species dependent. In
ruminants, the predominant sites of exchange are placentomes made up of caruncle
(maternal) and cotyledon (fetal) tissues. In sheep, the cotyledon undergoes exponential
growth during the first portion of pregnancy then tapers off (Naaktgeboren et al., 1975),
while the bovine cotyledon exhibits progressive growth throughout gestation (Reynolds
et al., 1995; Vonnahme et al., 2001). Specifically, the bovine placenta reaches a point of
full development at approximately 170 days of gestation (Bjorkman, 1954; Leiser et al.,
1997), and placental weight increases exponentially throughout gestation but is exceeded
by the exponential growth of the fetus during this time (Reynolds and Redmer, 1995).
Maternal nutrient restriction during early gestation has been observed to increase
placental weight, increase crown-rump length of fetuses, decrease the fetal to placental
weight ratio, and alter the relationship between total weight of the fetal component of the
placenta and fetal weight in singleton ewes (Haesman et al., 1998). Additionally,
undernutrition in early gestation has been associated with impaired placental
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development and vascularity of the placenta in sheep (Vonnahme et al., 2007). Similar
observations have been made in protein restriction studies in swine (Pond et al., 1991)
and undernutrition in humans (Lunney, 1998). In cattle, early gestation nutrient
restriction decreases placentome weight on day 125 of gestation and remain depressed
following a realimentation period that lasted into late gestation (day 250 of gestation; Zhu
et al., 2007). Inadequate nutrient intake during late gestation has also been observed to
increase placental weight in beef cows (Rasby et al., 1990). It has been long speculated
that the increase in placental weight is due to a compensatory mechanism responding to
reduced nutrient availability during periods of undernutrition.
In addition to physical attributes of the placenta being altered under various
maternal nutrition conditions, but the ability of the placenta to function as a nutrient
transport mechanism is impacted. Nutrient transport has been shown to be upregulated in
high-fat diet maternal models in which they experience fetal overgrowth as a result of the
heightened placental nutrient transfer (Jones, 2009). Maternal models fed a low protein
diet display down regulation of many nutrient transporters as well as a decrease in fetal
weight (Jansson et al., 2006). Further, there is evidence that expression of particular
genes, such as IGF2, can determine supply of nutrient transport from maternal to fetal
systems (Constancia et al., 2002). Additionally, gene expression may alter nutrient
transport across cell membranes, such as maternal and fetal circulations, during gestation
(Constancia et al., 2002; Reik et al., 2003; Gong et al., 2010).
Intrauterine growth restriction
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Gestational nutrient restriction may induce intrauterine growth restriction (IUGR);
a disorder associated with decreased birth weights, placental dysfunction, and impaired
postnatal health in ruminants (Vonnahme and Lemley, 2012; Robinson, 2017).
Symptoms of IUGR have been associated with a nutrient-deprived intrauterine
environment (Woodall et al., 1996a, Woodall et al., 1996b, Woodall et al., 1998). Fetuses
associated with IUGR commonly exhibit asymmetric growth due to prioritization of
growth and development of primary organs (i.e. nervous and cardiovascular) required for
survival over other organ systems. Asymmetric growth is the reduction in some organs or
structures (Anthony et al., 2003). Unlike symmetrical growth that observes uniform
reduction or growth of all organs and tissues proportionately. Interestingly, animals may
exhibit asymmetrical growth due to IUGR (in the case of early gestation nutrient
restriction) and still have normal birth weights (Long et al., 2010a).
Due to the fact that early gestation serves as a critical period of fetal tissue and
organ development, maternal nutrition may induce IUGR during this time. Long et al.
(2009) demonstrated that fetuses from Angus x Gelbveih cows nutrient restricted from
day 30 to 125 of gestation observed decreased weight and asymmetrical growth. Our
laboratory has observed success in inducing early and mid-gestational IUGR (Long et al.,
2009; Taylor et al., 2018) compared to other bovine maternal nutrient restriction models
(Camacho et al., 2014; Prezotto et al., 2016). In addition to impaired maternal
performance, asymmetrical fetal growth was observed in fetuses of early gestation
nutrient restricted cows at 110 days (Taylor et al., 2018). Fetal asymmetry has also been
observed in Angus cow’s nutrient restricted from days 110 to 190 of gestation (Taylor et
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al., 2018). Similarly, fetal weights of calves from early and mid-gestational nutrient
restricted dams were reduced in Taylor et al. (2018). Commonly, maternal nutrient
restriction models in cattle focus on late gestation as it is the period of exponential
growth for the fetus. Because of this, early and mid-gestational studies warrant further
investigation as it relates to fetal growth and development.
Sexual dimorphism
As gestation progresses, there have been reports of sexual dimorphism within
humans and livestock species. Reports of fetal sex differences have included: placental
weight, fetal weight, birth weight, and subsequent growth of offspring. Generally, males
have been reported to have heavier birth weights compared to females, but also have
increased preterm risk and infant mortality rates (Di Renzo et al., 2007) and are more
likely to experience a negative response to preeclampsia, preterm delivery, and IUGR
(Vatten and Skjaerven, 2004). These observations may be due to sex specific adaptations
of the placenta that impacts offspring growth later on in life. For example, female fetal
growth is reduced in response to a compromised pregnancy, while male fetuses grow
normally (Murphy et al., 2003; Stark et al., 2009). In a review by Clifton (2010), the
author addresses the various metabolic pathways and potential responses of the placenta
that exhibit sexual specific differences. There is limited information in beef cattle on the
effects of fetal sex on the response to maternal undernutrition. It has been shown that
during mid-gestation (day 110 of gestation), male fetuses of nutrient restricted cows had
reduced empty carcass weight (0.47 ± 0.01 kg) compared to male fetus’ of control fed
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cows (0.54 ± 0.01 kg) while there was no differences in female fetuses in empty carcass
weight; Taylor et al., 2018).
Maternal nutrient restriction during gestation specific to genotype
Interestingly, genotype may also play a role in responding to maternal nutrient
restriction and onset of IUGR in fetuses. Despite the fact that experiments have been
conducted in recent years to evaluate maternal and fetal contribution to maternal nutrient
restriction, the literature is severely lacking in regards to differences due to maternal or
fetal genotype. By mid-gestation, fetuses observed slower growth rate from Bos Indicus
cows compared to Bos Taurus cows (Ferrell, 1991; O’Rourke et al., 1991). Similarly,
fetuses harvested in early gestation from nutrient restricted dams observed greater fetal
weight in Angus cows compared to Brahman cows (Fontes et al., 2017). However,
Lemley et al. (2018) observed that maternal and fetal weight (day 180 of gestation) did
not differ between Brahman heifers and Angus heifers that underwent nutrient restriction
from days 50 to 180 of gestation. Recently, Fontes et al. (2021) performed energy
restriction on cows from 21 days prior to estrous synchronization to 28 days of gestation.
The magnitude of impact of energy restriction was greater in Bos Taurus cows compared
to Bos Indicus cows irrespective of diet (Fontes et al., 2021). Discrepancy in the literature
has been observed between Bos Indicus and Bos Taurus fetal development and growth.
Particularly, the response of Bos Indicus influenced cows compared to Bos Taurus cows
under maternal nutrient restriction conditions during early to mid-gestation. As well as
how fetal adaptation and genotype play a role in the onset and severity of IUGR.
POSTNATAL DEVELOPMENT
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Changes in the postnatal environment contribute to developmental programming
of the offspring as well. While most organs and organ systems have begun development
in the prenatal environment, a shift must occur proceeding parturition to adapt to the
postnatal environment and increase offspring survivability. Increased fetal
glucocorticoids during late gestation initiates parturition as well as plays a role in final
maturation of the organs and tissues in preparation for postnatal life. During this perinatal
period, some organ systems finalize maturation even though the primary structures have
been developed during early gestation.
Postnatal muscle and adipose tissue growth
During fetal growth and development, most muscle and adipose development is
via hyperplasia until late gestation, in which most growth is due to hypertrophy.
Additionally, adipose changes from BAT to yellow and white adipose tissue (WAT) as
the animal matures. At birth, increased amounts of BAT (containing a higher amount of
mitochondria) play a role in thermogenesis of the animal to improve survivability. Most
BAT is lost during early postnatal life to be replaced by yellow and WAT as the animal
ages. Commonly, BAT is lost during postnatal life (Clarke et al., 1997a) and does not
reappear during adulthood (Lean, 1989). Similar observations have been made in
ruminants in which BAT predominantly found in the perirenal–abdominal region, is
replaced by WAT during the first weeks of life (Symonds et al., 1992; Lomax et al.,
2007). The conversion of BAT to WAT is suggested to be due to transdifferentiation of
brown to white adipocytes as this occurs without increased apoptosis (Finn et al., 1998).
Furthermore, BAT loss is associated with switching off UCP1 gene expression within a
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few days after birth in ruminants (Casteilla et al., 1989; Clarke et al., 1997a; Finn et al.,
1998). Even when animals are maintained in a cold environment, this process becomes
irreversible and is amplified under conditions of increased food intake and accelerated
postnatal growth (Darby et al., 1996). Enhanced intramuscular adipose tissue deposition
(increased marbling) was observed in beef calves provided a high-energy
supplementation before 250 days (Corah and McCully, 2007; Du et al., 2013).
As muscle and adipose mature, responsiveness to glucose, insulin, and metabolic
status have adapted to previous environmental conditions in utero. While adipocytes are
differentiated from a similar pool of mesenchymal stem cells, there are suggestions of
different embryonic origins based on observations in mice populations (Billon et al.,
2008). Depot-specific patterns of gene expression may be due to distinct embryonic
origin differences between adipocyte depots (Gesta et al., 2007). Enhanced glucose
utilization and insulin receptor expression were observed in epididymal and intraabdominal mesenteric adipocytes from offspring of protein restricted dams (Holness,
1996; Ozanne et al., 1997). Conversely, this was not observed in subcutaneous
adipocytes by 3 months of age (Ozanne et al., 2000). This also suggests that some
adipose depots may be more or less sensitive to hormonal regulation than others.
Appetite regulation
As previously mentioned, voluntary feed intake, appetite, and energy balance is
influenced by the neuronal circuitry that regulate it. Feed intake is influenced by various
facets of feeding behavior, such as decision making, palatability, and satiety. Because of
this, feeding behavior is split into two phases: the appetitive phase and the consummatory
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phase. The consummatory involves the eating of food and satiety response. These
instinctive behaviors and physiological functions are controlled by neuronal circuitry
formed primarily during the perinatal period by activity‐independent developmental
mechanisms. (Bouret and Simerly, 2006). Modulation of feeding by both the CNS and
peripheral tissues is associated with the release and action of neuropeptides.
Neuropeptides are classified as fragments of peptide hormones that lack the activity of
the parent peptide hormone. These neuropeptides act via G coupled protein receptors
(GPCR) to regulate neuronal activity as well as local neurotransmitter activity.
The hypothalamus senses changes in circulating nutrients and hormones as well
as receive afferent neuronal signals from peripheral tissues such as adipocytes, the
pancreas, the gastrointestinal tract, and other brain regions (McMillen and Robinson,
2005). Hormones released into circulation respond to external stimuli such as
environmental signals to bind to receptors in the brain and act on the CNS, thus,
regulating development and activity (Simerly, 2002; Simerly, 2005). Because of its
signaling capabilities, the hypothalamus functions to maintain body weight and
composition through regulation of feed intake. Both appetite-stimulating and appetitesuppressing hormones bind to their respective receptors and alter signaling cascades that
will induce appropriate changes in feeding behavior.
Formation of neuronal circuitry due to activity-independent developmental
mechanisms occurs during the perinatal period (Bouret and Simerly, 2006). This circuitry
performs both behavioral and physiological functions of the organism. Interestingly, the
connection and development of neuronal circuitry in the brain are still forming during the
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first few days of postnatal life that play a role in appetite regulation. For example, the
perinatal period is a critical window for the programming of postnatal appetite in the rat
(Oscai and McGarr, 1978), however, the brains of newborn mice are more immature than
humans at this stage of life (Clancy et al., 2001). However, timing and extent of
development of neuronal connection is currently unknown in cattle.
Neuronal circuitry
The hypothalamus plays a role in maintaining homeostasis of the body and
serving as a communication tool between the nervous and endocrine systems. This
portion of the brain is associated with energy metabolism, metabolic control, and energy
expenditure. The hypothalamus is derived from the ventral portion of the diencephalon;
one of the encephalic vesicles first developed at 24 days of gestational age in the bovine
fetus (Ferreira et al., 2018). While the most rostral component, the preoptic area, is
derived from the telencephalon. A recreation of the figure from Saper and Lowell (2014)
is shown in Figure 1.2.
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Figure 1.2. Hypothalamus diagram from Saper and Lowell (2014) derived from the
rodent brain. The most rostral part of the hypothalamus, overlaying the optic chiasm, is
the preoptic area (left). The tuberal portion (center) overlays the pituitary stalk
(infundibulum, INF). The posterior hypothalamus (right) overlays the mammillary
bodies. AC, anterior commissure; AHA, anterior hypothalamic area; ARC, arcuate
nucleus; DHA, dorsal hypothalamic area; DLPO, dorsolateral preoptic area; DMH,
dorsomedial nucleus; LHA, lateral hypothalamic area; MAM, mammillary nuclei;
MNPO, median preoptic nucleus; MPO, medial preoptic area; OC, optic chiasm; PHA,
posterior hypothalamic area; PVH, paraventricular hypothalamic nucleus; SCN,
suprachiasmatic nucleus; SON, supraoptic nucleus; SUM, supramammillary nucleus;
TMN, tuberomammillary nucleus; VLPO, ventrolateral preoptic nucleus; VMH,
ventromedial nucleus.
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The hypothalamus is divided into three portions: preoptic area (rostral), tuberal
hypothalamus (middle), and the posterior hypothalamus (caudal). The middle region
contains the tuberal hypothalamus and the pituitary stalk (infundibulum; ventral surface).
This region includes the anterior and lateral hypothalamic areas and the dorsomedial,
ventromedial, paraventricular, supraoptic, and arcuate nuclei (Saper and Lowell, 2014).
This region is associated with circuitry relative to feeding, sexual behavior,
aggressiveness, autonomic response, and endocrine response (Saper and Lowell, 2014).
The hypothalamus is duplicated on either hemisphere of the brain in which the third
ventricle forms a boundary between the two sides. Primary sites of the hypothalamus that
will be discussed in the current review are: the arcuate nucleus (ARC), paraventricular
nucleus (PVN), dorsomedial hypothalamic nucleus (DMH), lateral hypothalamic area
(LHA) and the ventromedial hypothalamic nucleus (VMH). As previously stated, the
hypothalamus functions to bring in various sensory inputs and control both autonomic
nervous system and endocrine system function. To do so, hypothalamic nuclei respond to
neural inputs and circulating hormones/substrates. Nuclei of the lower brain integrate and
transmit information with the necessary peripheral systems.
In terms of feed intake and energy balance, hypothalamic regulation is based on
circulating nutrient concentrations. Hunger and satiety stimulate centers of the brain, such
as the ARC, contain neurons that traverse the blood-brain barrier (BBB) and come in
contact with the blood stream. Transfer of constituents from the peripheral blood to CSF
occurs within the choroid plexus (CP) of the brain (within the third ventricle). The ARC
lies adjacent to the median eminence, which contains hypothalamic glia that lines the
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third ventricle, and serves as the CSF barrier. Peripheral blood that has entered through
the pituitary portal system is filtered by the blood-CSF barrier. The ARC neurons connect
to other neurons in the VMH, LHA, PVN, and DMH, which project into the nucleus of
the solitary tract (NTS) in the brainstem and the dorsal motor nucleus of the vagus (main
component of the peripheral nervous system). The NTS serves as the first information
relay station of afferent cranial nerves from the local viscera. Dorsal motor nucleus of the
vagus (DMV), or dorsal vagal nucleus, is the primary vagal innervation to organs of the
gastrointestinal tract (Kalia, 1981; Lowey and Spyer, 1990; Hornby and Wade, 2011).
Bouret and Simerly (2006) performed axonal labeling in the hypothalamus of neonatal
mice in which ARC projections were determined to be immature at birth and did not
reach their targets, such as the PVN, DMH, and VMH, until the second week of life.
As the location of the ARC makes it readily accessible to episodic and tonic
hormonal signals in circulation, this component of the brain is responsible for nutrient
sensing and regulating energy balance. As the ARC traverses the BBB, it is able to
respond to signals such as leptin (Martin-Gronert and Ozanne, 2005); an adipokine
associated with suppression of appetite and long term food intake which will be
mentioned in further detail later on in the review. Neurons of the ARC express peptides
such as neuropeptide Y (NPY), agouti-related peptide (AgRP), and proopiomelanocortin
(POMC) as a means to regulate energy expenditure (Friedman and Halaas, 1998;
Schwarts, 2001) and are heavily regulated. To do so, populations of neurons expressed
are either orexigenic or anorexigenic. Orexigenic neurons serve in increase appetite, such
as NPY and AgRP found in the ARC. Whereas anorexigenic neurons are appetite
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suppressing, such as POMC neurons found in the ARC. The inverse relationship has been
observed between orexigenic and anorexigenic neurons, for instance the relationship
between POMC and AgRP (Aponte et al. 2011; Yang et al. 2011). Additionally, some of
the peptides released from the ARC are co-expressed in the PVN, such as NPY and
AgRP. Similar to the ARC, the PVN plays a role in energy intake regulation as it
functions to integrate signals from many neuronal pathways.
A potent orexigenic peptide found in the brain is neuropeptide Y (NPY); a 36
amino acid peptide of the pancreatic polypeptide family and contains several tyrosine
residues. It is one of the most abundant peptides found in the brain, widely distributed
throughout the CNS (Allen et al., 1983), and present in peripheral tissues. NPY is an
appetite-stimulating neurohormone in which exposure of the brain to NPY during early
development has been speculated to be involved in neurogenesis of the fetal brain
(Howell et al., 2003) and has been associated with altered food intake in adult life
(Varma et al., 2003). Distribution of NPY is associated with various physiological
functions, such as modulation of neuroendocrine systems and appetite regulation
(Colmers and Wahlestedt, 1993; Sizonenko et al., 1988). In addition to being present in
the brain, NPY has been identified in bovine pancreas (Myojin et al., 2000) and adrenal
glands (Mejane et al., 1985). Additionally, NPY is sensitive peripheral hormone signals,
such as ghrelin, amylin, insulin, and leptin (Wang and Leibowitz, 1997). Most NPY is
derived from the ARC, however, projections have been observed to develop in the DMH
and PVN of the hypothalamus as well (Grove and Smith, 2003). Injection of NPY into
the PVN or LHA promotes meal initiation and delays satiety which results in
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hyperphagia (Stanley et al., 1985). This is due to the fact that the first meal is prolonged
and more feed consumed. Hyperphagia encompasses an abnormal condition of hunger
and excessive eating. However, the hyperphagic effects of NPY are mediated by specific
receptor subtypes. Presently, six NPY receptor subtypes (Y1–Y6) have been cloned and
characterized (Lin et al., 2005), in which Y1 and Y5 receptors synergistically interact and
are associated with food intake (Mashiko et al., 2009).
Another appetite stimulating neuropeptide found in the brain that is co-expressed
with NPY is agouti-related peptide (AgRP). This peptide acts to increase appetite,
decrease metabolism, and decrease energy expenditure. This neuropeptide is a 112 amino
acid synthesized from NPY containing cell bodies (Backberg et al., 2004). AgRP
primarily functions through activation of the hypothalamic pituitary adrenocortical axis
(HPAA) by stimulating the release of adrenocorticotropic hormone (ACTH) which in
turn stimulates the release of cortisol into circulation. Similar to NPY, AgRP is
stimulated by ghrelin and inhibited by leptin. Leptin inhibits NPY and AgRP from
releasing orexigenic peptides. Neurons from the AgRP of the PVN will inhibit oxytocin
neurons (required for feed intake) as oxytocin neurons descend into the dorsal vagal
complex of the medulla (Lee and Blackshaw, 2014).
Anorexigenic regulation of the ARC on feed intake is performed by the
neuropeptide precurser pro-opiomelanocortin (POMC) neurons. The POMC serves as a
precursor for adrenocortocotropin (ACTH) and β-endorphin, which participate in the
regulation of cell proliferation and neuronal differentiation (Angelogianni et al., 2000).
The POMC gene also expresses melanocortin peptides, such as alpha melanocyte

40

stimulating hormone (α-MSH). Melanocortin peptides are associated with metabolism
and control of body weight. Additionally, the orexigenic neuropeptide AgRP serves as an
agonist of melanocortin receptors.
Other negative regulators mentioned in the literature are: leptin, bombesin,
glucagon-like peptide-1 (GLP-1), corticotropin releasing hormone (CRH),
cholecystokinin (CCK), cocaine and amphetamine-regulated transcript (CART). To
summarize, appetite-stimulating neurons are inhibited by leptin while appetite-inhibiting
neurons are stimulated by leptin (Mercer et al., 1997).
Neuronal growth factors
The neurotrophin protein family functions to promote differentiation of nerve
cells during fetal development. Brain derived neurotrophic factor (BDNF) is a protein
that promotes differentiation (Binder and Scharfman, 2004), maturation (Acheson et al.,
1995), maintenance of neurons (Huang and Reichardt, 2001), and stimulates
neurogenesis during fetal development (Zigova et al., 1998; Benraiss et al., 2001). It
binds to tyrosine kinase receptor (TrkB; Kafitz et al., 1999) found in found in the CNS
and peripheral tissues. While BDNF is most associated with long-term memory
(Bekinschtein et al., 2008), it also serves a role as the most active growth factor to
improve synaptic plasticity (Wardle and Poo, 2003) and regulates both stimulatory and
inhibitory synaptic signals (Tyler et al., 2002). Exogenous supplementation of BDNF in
tissue cultures increased dendritic length as well as modulated specific branching and
growth patterns, but only when neurons were active enough to respond to the action of
BDNF (Bus et al., 2011; Pillai et al., 2012; Hofer and Barde, 1988). Moreover, BDNF
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may be regulated during transcription, translation, and post-translational modifications
(Lubin et al., 2008). Disruption of the BDNF gene impairs both brain and sensory
neuronal development, but not motor or structural morphology of the brain (Jones et al.,
1994). This suggests that the expression of BDNF may also be sensitive to environmental
conditions without damaging overall brain function.
Fibroblast growth factors (FGF) stimulate and differentiate various endothelial
cells, such as mesoderm- and neuroectoderm-derived cells, as well as promote cell
migration. Both acidic (FGF1/FGFa; Gospodarowicz et al., 1975) and basic
(FGF2/FGFb; Gospodarowicz, 1974) forms of FGF play a role in endothelial cell
development and regulation. Acidic FGF has only been detected in the brain and retina
(Lobb and Fett, 1984; Baird et al., 1985; Bohlen et al., 1985; Thomas et al., 1984),
whereas basic FGF has been found in CNS and peripheral tissues. Overall, FGFa exhibits
reduced potency (30 to 100 fold less) compared to FGFb in the brain (Esch et al., 1985;
Bohlen et al., 1985). However, both FGFa and FGFb are closely related mitogens that
share 55% homology (Esch et al., 1985) and binding sites, however differ in affinity to
each respective binding site. The FGFs primarily exhibit mitogenic activity in the brain,
for example, FGFb stimulates proliferation of precursor cells in vitro in the rodent
(Gensburger et al., 1987). Presence of specific FGF receptors is also required for proper
formation of the mid and hind brain and associated organization (Trokovic et al., 2005;
Blak et al., 2007). In adults, FGF also functions to mediate metabolism, energy, and bile
homeostasis (Potthoff et al., 2012; Hu et al., 2013; Long and Kharitonenkov, 2011; Itoh,
2011).
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Programming energy balance
Findings in the literature supports the idea that there is a relationship between
perinatal nutritional and programming of energy-balance. Previously, caloric restriction
and overfeeding during gestation have been observed to induce long lasting alterations in
energy balance of offspring in postnatal life (Levin, 2006; Plagemann, 2006; MartinGronert and Ozanne, 2005; McMillen et al., 2005; Ong, 2006). However, stimulated
feeding behavior during postnatal life has also been observed to induce similar long-term
consequences and induction of metabolic syndrome. However, for similar behavior to be
observed at a different point in development/during a different critical period after
general establishment of the CNS, a different mechanism of action and regulation must
be employed.
This idea is supported by the observations that altered perinatal nutrition can
predispose an individual toward obesity and type 2 diabetes (Lau and Roger, 2004;
Rogers, 2003; Cruz et al., 2005). Additionally, over eating during early postnatal life of
rats (three pups per litter) observed increased weight gain and fat deposition, followed by
hyperphagia, obesity, hyperleptinemia, hyperglycemia, hyperinsulinemia, and insulin
resistance (Plagemann et al., 1999a; Plagemann et al., 1999b; Plagemann et al., 1992).
Animals under similar conditions also observed neuronal responsiveness to insulin and
leptin in the hypothalamic ARC and VMN (Plagemann et al., 1999a; Plagemann et al.,
1999b; Plagemann et al., 1992), indicating that circulating hormones may play a role in
altered feeding behavior via hypothalamic modulation. However, no findings in the
literature currently support whether the previously observed bouts of hyperphagia were a
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result of programming of the appetite regulatory neuropeptides. A potential programming
mechanism incorporates fetal exposure to excess glucocorticoid hormones (Seckl et al.,
2000, Langley-Evans, 1996a; Long et al., 2011; Long et al., 2013; Long et al., 2015).
HORMONAL REGULATION
Development of appetite control centers of the brain that regulate food intake,
body weight, and adiposity may be influenced by peripheral hormones in circulation at
critical periods of development (Bouret and Simerly, 2006). These hormones may serve
as important cues for stimulated development of neuronal circuitry. In terms of
developmental programming, hormones act on fetal growth directly (e.g. altered gene
expression) and indirectly (e.g. altered placental growth, fetal metabolism, growth
factors; Fowden and Forhead, 2001; Fowden, 2003). This encompasses periods of critical
development in utero and during early postnatal life in offspring.
LEPTIN
General
Since its discovery, the satiety hormone leptin has been associated with feed
intake and energy balance. As leptin is predominantly secreted by adipocytes, it plays a
role in body energy regulation as it acts in both a stimulatory and inhibitory fashion.
Leptin down regulates feeding behavior and stimulates energy expenditure via neural and
endocrine mechanisms in mammals. By doing so, this enables maintenance of normal
body weight and composition. Thus, leptin has been associated with maturation of the
hypothalamic circuits controlling food intake (Yura et al., 2005; Vickers et al., 2008) via
regulation of the autonomic nervous system and synthesis of thyroid hormones (Ahima
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and Flier, 2000a). It has also been suggested to promote development of appetite control
centers of the brain during early postnatal development (Yura et al., 2005; Bourat and
Simerly, 2006; Long et al., 2011).
Origin
It was initially proposed that the amount of energy stored in adipose tissue was
associated with the balance between calories and energy expenditure (Kennedy, 1953).
Leptin was discovered by Zhang et al. (1994) during house mice experimentation for
positional cloning in which they determined a molecule was the missing link between
energy balance and the obese gene. During these studies, it was suggested that there was
a circulatory element that were not in ob/ob (leptin deficient) mice compared to db/db
(leptin receptor deficient) mice. Later studies determined that supplementation of leptin
to ob/ob mice would alleviate obesity while db/db mice were unresponsive (Coleman,
2010). The leptin gene encodes a 4.5 kilobase mRNA transcript that is transcribed into a
highly conserved 167-amino acid protein (Zhang et al., 1994). Previously, the first of the
recessive obesity mutation of the obese gene (Ob) occurred in 1950 (Ingalls et al., 1950)
in which a single gene mutation was linked to obesity and type II diabetes in house mice
(Friedman et al., 1991; Ingalls et al., 1996). Then, Zhang et al. (1994) determined the
presence of leptin in Ob gene expression. Leptin was named from the Greek work
‘leptos’ meaning thin. Leptin is characterized as an appetite-regulating hormone
produced within peripheral tissues that impacts brain development to affect downstream
pathways. This is further supported by the observations that food intake, body weight,
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and body fat were markedly decreased when leptin was injected into leptin-deficient mice
(Halaas et al., 1995).
Structure and characteristics
Leptin is a highly conserved 167-amino acid protein (Zhang et al., 1994) encoded
by the leptin gene (Ob) found on chromosome 7 with a molecular weight of 16 kD.
Leptin function is similar across species due similar secondary and tertiary structures
(Denver et al., 2011). The structure of leptin is similar to cytokines (Madej et al., 1995;
Zhang et al., 1997) and as such belongs to a family of long-chain helical cytokines
(Zhang et al., 1997). This gene family includes growth hormone, prolactin, and ciliary
neurotrophic factor.
Leptin is referred to as an adipokine as it is predominantly produced in adipocytes
to be released into circulation. Leptin is also produced in smaller amounts in the placenta
and gastric parietal cells. As previously mentioned, it was previously believed that the
total mass of adipose tissue was determined by the number of adipocytes developed
during gestation and their respective size during postnatal growth (Spalding et al., 2008).
However, this is not completely true as adipocyte number can increase postnatally
(Helper, Vishvanath, and Gupta, 2017). Total mass of adipose in the body is positively
associated with the amount of leptin in circulation (Frederich et al., 1995). Moreover, the
amount of leptin expressed is relative to energy storage. Human and animal obesity
models have observed decreased leptin expression due to increased adipose Ob mRNA
and serum leptin levels (Maffei et al., 1995; Frederich et al., 1995; Considine et al., 1995;
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Hamilton et al., 1995; Lonnqvist et al., 1995). Additionally, leptin is stored in limited
quantities (Barr et al., 1997).
Signaling by hormones in circulation occur in either an episodic or tonic manner
(Halford and Blundell, 2000). Both manners of signaling contribute to feeding behavior
regulation in terms of duration and severity of the response. An episodic hormone
signaling response is commonly short term and associated with a meal event. Tonic
signaling is associated with homeostatic regulation of metabolism by the body to
maintain energy balance. Leptin works via tonic signaling to influence hypothalamic
activity (Bouret and Simerly, 2006) as it does not fluctuate due to individual meal events
or behave as an episodic signal (Korbonits et al., 1997).
Ob gene
The Ob gene encodes a 4.5 kilobase mRNA transcript (three exons separated by
two introns) that is transcribed into a highly conserved 167-amino acid protein. Cyclic
AMP (cAMP), glucocorticoid response elements, and CCATT/enhancer and SP-1
binding sites comprise the Ob gene promoter region (Gong et al., 1996; Hwang et al.,
1996; Miller at al., 1996). Binding sites for thiazolidinediones and catecholamines are
found on the Ob promoter region (Gong et al., 1996; Hwang et al., 1996), indicating
potential mitigating action on leptin secretion.
Mutations of the Ob gene have been observed to cause early onset obesity in mice
(Zhang et al., 1996; Halaas et al., 1995; Pelleymounter et al., 1995; Campfield et al.,
1995). In humans, a frame shift mutation may occur due to a deletion of a single guanine
nucleotide (codon 133) that produces a degraded truncated leptin protein (Rau et al.,
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1999). This truncated protein has been associated with hypogonadism and morbid obesity
(Strobel et al., 1998). In ob/ob mice, a cysteine to threonine substitution results in a stop
codon (at 105) that yields a truncated leptin protein that cannot be secreted (Zhang et al.,
1994; Frederich et al., 1995). Complete deletion of the gene, as in the case of mice
lacking the leptin gene, observe animals that are obese, diabetic, cold intolerant, and
hypoactive (Zhang et al., 1994; Tartaglia et al., 1995).
Leptin receptors
Leptin receptors are highly expressed in regions of the CNS involved in energy
balance, such as the hypothalamus (Elmquist et al., 1998a) as leptin performs regulatory
and developmental function on appetite centers in the brain (Cohen et al., 2001; McMinn
et al., 2005; Balthasar et al., 2004). Additionally, the greatest expression of ObR has been
observed in the CNS of monogastric species (Fruhbeck, 2001), especially in the ARC
(Elmquist et al., 1998a). Leptin receptors are also highly expressed in portions of the
brain associated with feed intake such as the ARC (Schwartz et al., 2000) as well as a
dense populations of neurons that respond to leptin (Cone et al., 2001). Leptin receptors
(ObR) are commonly present in three forms: the secreted form (ObRc), the long form of
the receptor (ObRb) and the short intracellular domain receptor or short form of the
receptor (ObRa). Both Ob and ObR are already highly expressed in the brain (Tartaglia,
1997). Conversely, Ji et al. (1998) did not observe Ob expression in the brain of beef
cattle. While the three forms are the most common, leptin receptors exist as six isoforms
generated from alternative splicing of the leptin receptor gene. The isoforms share a
common binding domain but contain different intracellular domains. Whereas ObRb
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contains an extended intracellular domain that can be phosphorylated at three tyrosine
residues via Janus Kinase 2 (JAK2). Of the three tyrosine residues of the long form
receptor, phosphorylation of Y985 and Y1138 and their specific physiological functions
are relative to the scope of the current study. The Y985 tyrosine residue activates mitogen
activated protein kinase activity (MAPK) signaling as well as mediates negative feedback
of leptin signaling. The Y1138 tyrosine residue phosphorylates signal transducer and
activator of transcription 5 (STAT5) signaling to mediate energy homeostasis and
neuroendocrine function.
Only the long form has been observed to be fully functional and contribute to the
effectiveness of leptin (Tartaglia, 1997; Myers et al., 2008), whereas the short form of the
receptor has been observed to contribute to leptin transport (Hileman et al., 2002) and
catecholamine synthesis (Yanagihara et al., 2000). Leptin exerts a hypophagic (decreased
appetite and feed consumption) effect due to neuronal and endocrine interaction with the
hypothalamus and medulla when the functional form of the leptin receptor (ObRb) is
present (Bjorbaek et al., 1997). Additionally, expression of the Ob gene has been
observed to serve as a more relevant index associated with body fat content compared to
ObRb expression in cattle (Ren et al., 2002). As previously mentioned, leptin has been
associated with feed intake and energy balance. To perform this action, leptin is involved
in the regulation of neuropeptides co-expressed from hypothalamic tissues predominantly
via ObRb binding (Elias et al., 1999; Fei et al., 1997; Hillebrand et al., 2002; Mercer et
al., 1996).
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The ObR have been previously detected in AT depots (no difference in expression
among depots) and hypothalamus samples in dairy cattle (Chelikani, Glimm, and
Kennelly, 2003), which supports the idea that leptin may have multiple physiological
functions in cattle. Expression of ObR is proportional to adipocyte size or level of body
fat (Houseknecht and Portocarrero, 1998; Ahima and Flier, 2000b; Ehrhardt et al., 2000).
Interestingly, bovine adipose tissue treated with dexamethasone (100 nM) in vitro had
stimulated leptin expression (Houseknecht et al., 2000). Whereas ObRb mutations
impaired downstream signaling and observed a diabetic phenotype and infertility (Chen
et al., 1996; Lee et al., 1996; Chua et al., 1996; Bates et al., 2003).
Unger et al. (1999) speculated that leptin receptor dysfunction in pancreatic islets
and cardiac muscle lead to deposition of triglycerides in non-adipocyte tissues. This idea
of triglyceride harboring has been previously addressed as a potential adaptation to
nutrient restriction in utero. Triglyceride storage when resources are in excess ensures
nutrient availability for the fetus when resources are limited. On the other hand this may
predispose animals to develop leptin resistance due to pre-exposure to a nutrient
restricted environment in utero as a means to store fat when nutrients are in surplus
(Breier et al., 2001).
Transportation of leptin
Leptin is predominantly secreted from adipose tissue located in the periphery, but
is known for action on neural development in the brain. To do so, leptin must traverse the
BBB in order to perform its respective action on nervous tissue. First leptin must be
secreted from the adipocytes to be released into the general circulation. Then transfer of
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leptin from the peripheral blood to CSF occurs within the choroid plexus (CP) of the
brain (within the third ventricle). The ARC lies adjacent to the median eminence, which
contains hypothalamic glia that lines the third ventricle, and serves as the CSF barrier.
Peripheral blood that has entered through the pituitary portal system is filtered by the
blood-CSF barrier. Schwartz et al. (1996) observed that plasma leptin entered CSF
proportionally to the amount of body adiposity exhibited by the patient. However, the
efficiency of plasma leptin transfer to CSF was greatest in patients with the lowest
amount of plasma leptin (Schwartz et al., 1996). This indicates that there is a transport
mechanism mediating the amount of leptin crossing the BBB into CSF from the general
circulation.
Though peripherally administered leptin enters the mediobasal hypothalamus and
ARC due to a BBB modification that allows the passage of large molecules as observed
in ICV experiments. While the exact transport mechanism of leptin transport remains
unclear, it does act independently of targeted receptors. Maness et al. (2000) injected
radioiodinated leptin into ob/ob and db/db mice and observed transport of leptin
irrespective of the presence of receptors. Also, the ARC is generally protected from the
general circulation by the BBB due to its location within the brain. As previously stated,
the ARC lies adjacent to the median eminence, which contains hypothalamic glia that
lines the third ventricle, and serves as the CSF barrier. Peripheral blood that has entered
through the pituitary portal system is filtered by the blood-CSF barrier. This prevents
circulating signals from passively reaching ARC neurons from the general circulation.
Interestingly, recent studies have reported axonal plasticity as a means to overcome brain
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barrier restrictions. This is necessary for blood components to communicate with neural
networks for energy balance regulation. Due to its proximity to the ME, fenestrated
capillaries near ARC neurons have been observed to extend from the ME (Langlet et al.,
2013). This has been speculated as mode of leptin diffusion to the neurons of the ARC.
Leptin signaling mechanisms
In adult animals, leptin activity has been suggested to perform signaling via target
dependent mechanisms or binding to receptors found in the brain. Brain specific knock
out (KO) studies were performed in mice in which neuron-specific and hepatocytespecific disruption of the ObR was induced (Cohen et al., 2001). A negative correlation
of obesity and level of ObR was observed in the neuron-specific KO mice, elevated
plasma circulation of leptin, glucose, insulin, and corticosterone, as well as increased
AgRp and NPY in the hypothalamus was observed (Cohen et al., 2001). This data
suggests that site of leptin’s anorectic actions is in the CNS. In overfed postnatal rodents,
leptin observed greater inhibitory actions in the VMN compared to inhibitory action on
neurons in the ARC (Davidowa et al., 2000; Davidowa et al., 2001). This may be due to
the fact that the ARC contains the most neurons directly responding to leptin (Elmquist et
al., 1998b; Schwartz et al., 2000; Cone et al., 2001) which is further supported by
previous observations pertaining to the importance of leptin receptor signaling in the
ARC (Morton et al., 2003; Balthasar at al., 2004; Coppari et al., 2005). Regulation of
glucose homeostasis by leptin is mediated through the ARC (Coppari et al., 2005).
However, once the neuronal circuitry has been established, leptin function is
limited, whereas during the critical period of neuronal development during early postnatal
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life, leptin function is more diverse. For example, the critical period coincides with the
naturally occurring surge in leptin in mice, however, DMH and PVH projections occur
prior to the leptin surge (Bouret et al., 2004a) and are not impaired in ob/ob mice (Bouret
et al., 2004b). Interestingly, DMH neurons highly express leptin receptors (Elmquist et
al., 1998a), suggesting that portions of the hypothalamus that are developed prior to the
leptin surge may not require or be influenced by leptin.
Bouret et al. (2004b) performed Dil axonal labeling to observe projection
development in neonatal mice. Daily injections of leptin between 4 and 12 days of
postnatal age restored projection patterns of PVH and ARC axons in ob/ob mice.
Conversely, treatment of adult ob/ob mice with leptin did not restore projections from the
ARC to the PVH (Bouret et al., 2004b). Whereas DMH suggests that portions of the
hypothalamus may not require or be influenced by leptin, the ARC and PVH suggest that
direct action of leptin on the brain is required for other portions of the hypothalamus.
Leptin administration to neonates (6 to 16 days of age) stimulates cFos expression in
POMC neurons (Bouret et al., 2004b). Conversely, administration of leptin in ob/ob mice
during the first 2 weeks of life did not differ from the control group in regards to milk or
food intake, oxygen consumption, body weight, or epididymal fat pad weight (Mistry et
al., 1999). Overall, this supports the idea that alteration to neuronal circuitry occurs
during early postnatal life and no effect will occur once the animal has reached
adulthood.
Leptin activates cytokine-like signal transduction via ObRb binding (Ghilardi et
al., 1996; Baumann et al., 1996; Vaisse et al., 1996). Leptin stimulates intracellular Janus
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tyrosine kinases (JAKs) via transphosphorylation and phosphorylation of tyrosine
residues on the ObRb (Ihle, 1995). Similarly through Ob-Rb binding, leptin stimulates
signal transducers and activators of transcription (STAT) proteins (Bjorbaek et al., 1997).
Once phosphorylated, STAT proteins will dimerize, translocate to the nucleus, and
activate gene transcription (Heinrich et al., 1998).
This review acknowledges that leptin impacts expression of components involved
in signaling pathways directly in adulthood. Ewes administered leptin via ICV infusions
observed increased expression of suppressor of cytokine signaling 3 (SOCS3), which
plays a key role in leptin regulation and signaling (Szczesna and Zeiba, 2015). Similarly,
leptin administration alters SOCS-3 expression in the ARC and NPY and POMC mRNA
expression (Proulx et al., 2002). Lack of downstream signaling of leptin binding to
neuronal receptors has also been associated with obesity induced by leptin insufficiency
(associated with impaired leptin signaling) or decreased efficiency of BBB leptin
transporters as well (Szczesna and Zeiba, 2015). For example, disrupted signal
transduction pathways may be due to uncoupled leptin from ObR due to increased plasma
leptin concentrations as observed in obese patients (Ahima and Flier, 2000b).
Function
Breier et al (2001) first suggested that adipose tissue, the brain, endocrine system,
and leptin contribute to regulation of body fat stores through coordinated regulation of
feeding behavior, autonomic nervous system activity, and metabolic regulation. Because
of this, elevated leptin secretion has been observed during early postnatal life in
numerous mammalian species (Ahima et al., 1998). This surge has been associated with
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survivability during early postnatal life as it maximizes food intake and maintains
thermoregulation (Rayner et al., 1997; Smith and Waddell, 2003).
Leptin stimulates neuronal activity in the PVH, DMH, and LHA that is associated
with the arrival of arcuate projections to each nucleus (Bouret et al., 2004b). This is
supported by the observed increase of c-Fos following leptin treatment (Bouret et al.,
2004b). The expression of the proto-oncogene c-Fos has also been linked to brain
development as it plays a role in cell proliferation and differentiation. As a member or the
FOS family, c-Fos heterodimerizes with members of the JUN family to form
transcription factor activator protein (Velazquez et al., 2015a). Additionally, Valesquez et
al. (2015b) observed impaired brain development in c-Fos -/- mice. Up-regulated c-Fos
expression in the PVH after leptin treatment may play a role in trans-synaptic regulation
(Morgan et al., 1991; Armstrong et al., 1993). Axon densities of neurons from the ARC
are reduced in ob/ob neonates and further diminish over time (Bourat and Simerly, 2006).
Leptin was also intended to prevent early onset of obesity via action on the brain
(Pellymounter et al., 1995; Campfield et al., 1995) due to influencing orixigenic and
anorexigenic activity and leptin sensitivity (Yura et al., 2005). Projections from both
orexigenic and anorexigenic neurons are affected (Bourat and Simerly, 2006). This
suggests that leptin participates in both local and extensive developmental influence.
Leptin is detectable as early as 18 weeks of gestation in human infants and
progressively increases in circulation after 32 weeks (Jaquet et al., 1998; Cetin et al.,
2000; Sarandakou, 2000). Additionally, plasma leptin concentrations are positively
correlated with fetal growth and body mass indexes of infants (Cinaz et al., 1999). In
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adults, leptin serves as a signal in a negative feedback loop to prevent obesity. This action
is due to increased leptin secretion proportional to an increase in fat mass intended to
maintain a constant body weight in humans (Cinti et al., 1997). Montague et al. (1997)
described individuals lacking leptin signaling as having “continuous and voracious food
seeking behavior.”
In rodents, leptin has a characteristic peak from postnatal days 8 to 21 (Proulx et
al., 2001; Yura et al., 2005; Delahaye et al., 2008). The peak observed in newborn
rodents is associated with appetitic control center development in the brain and altered
leptin peaks may increase onset of obesity in adulthood (Long et al. 2011). A premature
leptin surge increases projection density of the ARC to PVN (Lee and Blackshaw, 2014).
However, maternal nutritional status may impair formation of ARC projections due to
altered leptin secretion during earlyt postnatal life. Offspring of nutrient restricted rats
observe an inhibited leptin surge (Delahaye et al., 2008) while subsequent offspring of
obese rats observe an amplified and prolonged leptin surge during early postnatal life
(Kirk et al., 2009).
Increased concentrations of plasma leptin during the early postnatal period occur
in calves and sheep (LeMaster et al., 2017; Long et al., 2010; Long et al., 2013; Long and
Schafer 2013, Shasa et al., 2015). Cattle exhibit increased leptin from 1 to 4 days of age
(Long and Schafer, 2013) while sheep observe a surge from days 5 to 9 of age (Long et
al., 2011). However, diet induced maternal obesity eliminated this postnatal peak in sheep
(Long et al., 2011). In ruminants, increased plasma cortisol concentration during the first
24 to 48 hours of postnatal life is associated with decreased plasma leptin concentrations
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during this period (LeMaster et al., 2017; Long et al., 2010; Long et al., 2013; Long and
Schafer 2013; Shasa et al., 2015). Calves with reduced plasma leptin concentrations
during the first 20 days of postnatal life had increased feed intake during a 10 week ad
libitum feeding trial at ~14 months of age (Tipton et al., 2018). Although further
investigation is required to tease out the mechanism of leptin signaling and voluntary
feed intake regulation via altered appetite center development, this data supports the idea
that leptin contributes to regulation of voluntary feed intake in ruminants.
Regulation of leptin
The hypothalamus regulates leptin activity in response to feeding and glucose
homeostasis (Bourat and Simerly, 2006), predominantly via the ARC (Coppari et al.,
2005). Previously, researchers speculated that leptin served as a hormonal mediator of
nutrient-sensing that influences metabolic programming (Bourat and Simerly, 2006).
Two adaptor molecules serve as negative feedback on leptin signaling: suppressor of
cytokine signaling (SOCS3) and phosphotyrosine phosphatase-1B (PTP1B; Szczesna and
Zeiba, 2015). Ewes administered leptin via ICV infusions observed increased expression
of SOCS3, which plays a key role in leptin regulation and signaling (Szczesna and Zeiba,
2015).
A member of the SOC family, SOCS3 functions as STAT inducing inhibitors
(SSI) primarily to negatively regulate cytokines as the SH2 domain of the SOC protein
binds to phosphorylated tyrosine of JAK proteins (Endo et al., 1997). While the
conserved 40 amino acid sequence known as the SOCS-box participates in preventing
SOCS proteins degradation (Kamura et al., 1998). Activity of SOCS3 is associated with
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contributing to leptin resistance due to increased ceramide synthesis (Yang et al., 2009).
Ceramide makes up the backbone of all sphingolipids (made up of a sphongosine and
fatty acid), a waxy lipid, participates in differentiation, proliferation, and apoptosis, and
inflammation of cells (Hannun and Obeid, 2002). Ceramide is synthesized under
proinflammatory conditions, cytokines, oxidative stress, and increased free fatty acids
(Hannun and Obeid, 2002; Yasukawa et al., 1999), similar characteristics of obese
adipose tissue.
Leptin secretion is also regulated by factors such as inflammatory cytokines and
glucocorticoids (Dagogo-Jack, 2001). Leptin synthesis is stimulated by the presence of
infection and increased endotoxin and cytokines in circulation (Bornstein et al., 1998;
Sarraf et al., 1997; Janik et al., 1997). Increased leptin production due to increased
cytokine concentrations may collectively contribute to weight loss associated with
increased periods of inflammation (Sarraf et al., 1997; Schwarzt et al., 1997).
Leptin secretion has been previously observed to respond to glucocorticoids. This
will be discussed in detail later on in the chapter. Similar profiles of glucocorticoid
administration have been observed in offspring born to dams that underwent periods of
nutrient restriction during gestation (LeMaster et al., 2017). Maternal undernutrition
altered pituitary and adrenal glucocorticoid receptor, hypothalamic CRH and POMC, and
ACTH mRNA abundance (McMillen and Robinson, 2005; Fowden et al., 2005). Longterm reduction of food intake was observed in ob/ob mice when leptin injections were
performed during the neonatal period (Bouret et al., 2004a). Similarly, neonatal female
rats born to nutrient restricted dams that were treated with leptin did not observe
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development of metabolic syndrome or associated diseases in adulthood (Vickers et al.,
2005). While nutrient restricted rodents (30% intake) observed hyperinsulineamia,
hyperleptinaemia and compensatory leptin production in pancreatic B cells (Vickers et
al., 2001).Mice born to intake restricted dams during gestation observed greater adipose
mass accumulation compared to mice born to control fed dams (Vickers et al., 2005;
Yura et al., 2005). In intake restricted rodents, Vickers et al. (2005) observed that daily
injections of leptin (day 3 to 13 of postnatal age) normalized caloric intake, body weight,
adiposity, and plasma glucose. Yura et al. (2005) then suggested that restricted prenatal
diet altered the leptin surge due to observations from mice born to intake restricted dams.
The altered leptin surge may play a role in long-term consequences on weight gain,
glucose homeostasis and leptin sensitivity. They further demonstrated that a premature
leptin surge also yielded offspring with increased weight gain on a high-fat diet (Yura et
al., 2005). In humans, concentration of leptin in neonates has been associated with longterm appetite. During infancy, leptin levels of the umbilical cord are inversely related to
growth rate. Newborns with decreased birth weight and decreased cord leptin
concentrations are predisposed to develop metabolic syndrome in adulthood (Ong et al.,
2000). Interestingly, this temporal pattern is concomitant to leptin function and activity
in most mammals (Ahima et al., 1998; Rayner et al., 1997; Smith and Waddell, 2003).
In a sheep obesity model, lambs born to obese ewes did not differ in birth weight
from lambs born to control-fed ewes (Ford et al., 2009). However, F1 lambs born to
obese ewes were hyperinsulinemic, hyperglycaemic, and had greater fat mass at birth
compared to lambs born to control-fed ewes (Ford et al., 2009; Zhang et al., 2011). When
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the F1 lambs reached adulthood and underwent an ad libitum feeding trial, the F1 lambs
born to obese ewes observed increased appetite, adiposity, and insulin resistance (Long et
al., 2010). This behavior may be due to impaired leptin peaks observed in offspring of
overfed ewes as these offspring observed increased plasma cortisol concentrations (Long
et al., 2011). Ad libitum feeding in late gestation reduces leptin mRNA abundance in
adipose tissue in sheep (Bispham et al., 2003). Meaning that the dams observed
decreased leptin expression which may have been passed to the offspring and exhibit
transgenerational behavior. When sheep were born to nutrient restricted (40%) dams and
then allowed a realimentation period to allow for postnatal catch-up growth, the
subsequent offspring went from patterns of decreased growth to obesity (Dellschaft et al.,
2015). These offspring developed insulin and leptin resistance more severely than
offspring born to nutrient restricted dams alone (Dellschaft et al., 2015). These data
suggests that the hormonal regulating action of leptin may overcompensate and cause
adverse conditions in the animal in adulthood.
Leptin deficiency, insensitivity, and resistance
Leptin has been deemed as an essential regulator of energy homeostasis due to the
onset of severe obesity in deficient animals (Friedman and Halaas, 1998; Farooqi and
O'Rahilly, 2005). While leptin signaling is dependant upon leptin binding to its respective
receptors in the brain as well as proper development of neuronal clusters of the
hypothalamus for rapid neuronal communication. Leptin deficiency has been associated
with impaired extension of axons as ob/ob mice have observed impaired ARC projections
(Bouret and Simerly, 2006). Additionally, defective action of SOCS3 in the leptin
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signaling cascade has been speculated to induce desensitization of leptin receptor
signaling (Ahima and Flier, 2000a; Seufert et al., 2000).
Peripherally administered leptin enters the mediobasal hypothalamus and ARC
due to a BBB modifaction that allows the passage of large molecules. A proposed
mechanism of leptin insensitivity/resistance may be due to defective leptin transfer to the
CNS (Caro et al., 1996). Adam and Findlay (2010) utilized an obese sheep model to
determine if leptin resistance was due to decreased blood-brain leptin transfer or
insensitivity. Briefly, sheep were sorted by leanness (obese versus lean) as well as
administered leptin (0.5 mg leptin / kg BW) via intracerebroventricular (ICV) cannulae to
detect leptin concentrations in blood and CSF. Obesity did not affect leptin sensitivity of
the brain, but did impair leptin transport across the BBB (Adam and Findlay, 2010).
GLUCOCORTICOIDS
General
As previously mentioned, glucocorticoids may play a role in pathophysiological
mediation in obesity (Bujalska et al., 1997). They are involved in metabolism of
carbohydrates, proteins, fats, and play a role in inflammatory response. Glucocorticoids
are primarily associated with the maturation of specific fetal tissues during late gestation,
such as the lungs, liver, kidneys, and gut. These organs observe maturational changes in
preparation of the transition from prenatal to postnatal life and take over the functions of
the placenta. However, it wasn’t until Liggins discovery of the action of glucocorticoids
as a means to accelerate fetal lung development in sheep (Liggins 1969) that clinical
trials were performed. This lead to decreased morbidity and mortality of infants when
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mothers were treated with synthetic glucocorticoids during late gestation (Liggins, 1969;
Liggins and Howie, 1972).
Origin
Glucocorticoids were first discovered in the 19th century when patients responded
well to adrenal extracts when diagnosed with Addison’s disease (reviewed by Ten et al.,
2001) due to adrenal insufficiency as indicated by chronic fatigue, muscular
degeneration, weight loss, and skin darkening. By 1946, Edward Kendall isolated four
steroidal compounds from adrenal extracts, names A, B, E, and F, respectively (reviewed
by Simoni et al., 2002) in which compound E would become synthesized and named
cortisol (Sarett, 1946).
The adrenal glands are endocrine glands that perform several physiological
functions. Each gland is separated into an outer cortex and inner medulla region. In which
the adrenal cortex is divided into three layers that function solely on hormone production:
the zona glomerulosa, the zona fasciculate, and the zona reticularis. Mineralcorticoids are
produced in the zona glomerulosa. The glucocorticoids cortisol and hydrocortisone are
produced in the zona fasciculata. Finally, the zona reticularis produces androgens. The
adrenals secrete basal levels of each respective hormone; however, each zone responds to
adrenocorticotropic hormone (ACTH) released from the anterior pituitary. Cortisone is
the inactive form of cortisol due to the enzymatic action of 11β-hydroxysteroid
dehydrogenase (11βHSD); a reversible reaction.
Structure and characteristics
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Corticosteroids include both glucocorticoids and mineralcorticoids as they are
steroid hormone products of the adrenal gland. Glucocorticoids, or glucocorticosteroids,
are synthesized in the zona fasciculate from cholesterol precursors. The anterior pituitary
releases ACTH to stimulate the production of cortisol in the adrenal glands.
Steroidogenesis is initiated via increased steroid acute regulatory protein and cytochrome
P450 side-chain cleavage. This step is the rate limiting step of steroidogenesis in which
cholesterol is converted to pregnenalone.
Glucocorticoids primarily function to regulate glucose metabolism as they bind to
glucocorticoid receptors found throughout the body of vertebrates. Glucocorticoids, such
as cortisone and hydrocortisone, differ from mineralcorticoids and other sex steroids,
such as estrogens and testosterone, due to their target cells, receptor specificity, and
activity. In terms of activity, glucocorticoids are commonly classified as immunological
acting or metabolic acting. In terms of immunological activity, glucocorticoids upregulate the expression of anti-inflammatory proteins and down-regulate the expression
of proinflammatory proteins. Metabolically, glucocorticoids participate in glucose
metabolism regulation via stimulation of gluconeogenesis (GNG) which synthesizes
glucose from non-hexose substrates (i.e. amino acids and glycerol) in addition to
stimulating the upregulation of enzymes involved in GNG. As a means of glucose
conservation in tissue, this may induce inhibited glucose uptake by muscle and adipose
tissue.
Glucocorticoids are commonly classified as either endogenous or synthetic. The
primary endogenous glucocorticoid in primates, guinea pigs, and sheep is cortisone and
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corticosterone in rodents. Synthetic glucocorticoids that have similar structural backbone
to endogenous cortisol are beclomethasone and prednisolone, but have additional methyl
and hydroxyl groups as well as a modification at carbon 9. Fluorinated synthetic
glucocorticoids betamethasone and dexamethasone contain a modification at carbon 9.
Synthetic glucocorticoids for treatment are selected based on route of administration,
duration, and intensity (Speight et al., 1987). Additionally, some synthetic
glucocorticoids, such as dexamethasone or betamethasone, are not affected by 11βHSDS
and readily cross the placenta while others, such as prenesilone are rapidly inactivated by
11βHSDS (Brown et al., 1996).
Glucocorticoid receptors
Glucocorticoid receptors are members of the nuclear receptor family of
intracellular receptors. Glucocorticoid receptors are classified as two types: type 1 are
glucocorticoid receptors predominantly bound by mineralcorticoids (MR) while type 2
are predominantly bound by glucocorticoids (GR). The GR was identified as being the
main receptor responsible for the physiological effects of glucocorticoids. While both GR
and MR are closely related, GR is only activated by glucocorticoids whereas MR is
activated by either mineralcorticoids or glucocorticoids (Reul et al., 1985). Additionally,
glucocorticoid infusion alters expression of the type 2 glucocorticoid receptor (Gicquel et
al., 2008). Synthetic glucocorticoids can function and bind to either GR or MR.
Production
Steroidogenesis is the generation of steroids hormones from cholesterol as
synthesized by a variety of tissues. An important rate limiting step of steroidogenesis is
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the initial transformation of cholesterol to pregnenalone within the cell. This is initiated
by steroid acute regulatory protein and cytochrome P450 side-chain cleavage, which is
stimulated by release of ACTH from the anterior pituitary which will increase the
synthesis of cortisol.
Animals exhibit increased concentration of circulating glucocorticoids during late
gestation; however, the magnitude and timing of the surge vary across species (Fowden
and Silver, 1995; Wood and Cudd, 1997). Most species observe a prepartum cortisol
surge due to increased adrenal secretion. Conversely, the rat and horse, observe decreased
plasma corticosteroid binding globulin, which allows for increased glucocorticoids in
circulation (Challis et al., 1993; Wood and Cudd, 1997). In cattle, Smith et al. (1973)
analyzed maternal serum glucocorticoid concentrations 26 days prepartum to 9 days
postpartum. Briefly, circulating glucocorticoid concentrations remained constant (5.1
ng/mL) until 12 hours prior to parturition, doubled closer to term (10.3 ng/mL), then
increased 50% (16.7 ng/mL) at birth. Maternal circulating glucocorticoid concentrations
returned to basal levels following parturition (5.1 ng/mL) during the postpartum period.
This supports the idea that fetal exposure to increased glucocorticoids prior to parturition
occurs the last few weeks of gestation.
Interestingly, glucocorticoid concentrations in fetal circulation are lesser
compared to maternal circulation. Maternal glucocorticoids are transported to fetal
circulation via a concentration gradient and are regulated by placental 11βHSDS, in
which maternal glucocorticoids and cortisol are enzymatically converted into metabolites
(Fowden and Forhead, 2004) which restricts fetal exposure to maternal glucocorticoids
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(Fowden and Forhead, 2004). Moreover, limited fetal glucocorticoid concentrations lead
to limited effect on target tissues. However, fetal cortisol concentrations become elevated
prior to parturition (Challis et al., 1993; Wood and Cudd, 1997).
Functions in utero
Exogenous glucocorticoid administration can induce premature maturation of
specific tissues during late gestation (Silver, 1990; Liggins, 1994; Fowden, 1995).
Glucocorticoids exhibit several functions during gestation, including increased
proliferation and differentiation of trophoblast cells (Malassine and Cronier, 2002;
Audette et al., 2010). Because of this action, authors have proposed that a mechanistic
approach to developmental programming may be due to glucocorticoid hormones (Seckl
et al., 2000; Langley-Evans, 1996a), as maturation of fetal tissues is not required in utero
because the fetus is supported by the placenta during this time (Fowden and Forhead,
2004). As well as the fact that glucocorticoids induce structural and functional changes in
several tissues that is required for postnatal life (Liggins, 1994).
Increased concentrations of fetal glucocorticoids can alter activity of the
hypothalamic–pituitary–adrenal (HPA) axis as it becomes functional in utero and then
becomes more responsive prior to parturition (Gicquel et al., 2008). The HPA axis is an
example of a negative feedback system, in which cortisol itself acts as a direct inhibitor
of both CRH and ACTH synthesis. As glucocorticoids are released into the circulation by
the adrenal gland, they interact with glucocorticoid receptors of the pituitary,
hypothalamus and hippocampus, which alter downstream binding during periods of
stress.
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Embryonic exposure to glucocorticoids may be due to glucocorticoids from
maternal circulation and direct stimulation of the fetal HPA axis (Giquel and Simerly,
2008), or indirectly as nutrient supply may alter regulation of endocrine cross-talk across
the placenta between the maternal and fetal circulatory systems (McMullen et al., 2012).
Furthermore, rodents and humans have observed altered basal and stress-induced
glucocorticoid responses post-natally when exposed to excess fetal glucocorticoids at
critical periods of development during gestation (Levitt et al., 1996; Matthews et al.,
2002). Glucocorticoid exposure during critical periods of development can result in
impaired renal development, hypertension, glucose tolerance, and insulin resistance
(Giquel and Simerly, 2008). Fetal HPA ay also respond to stress-induced by the maternal
environment, a response which potentially impairs its own responsiveness in postnatal
life (Bloomfield et al., 2003; Fisher et al., 2010).For example, impaired feedback control
of the HPA axis is observed in obese individuals which is associated with the onset of
insulin resistance, hypertension, and metabolic syndrome (Andrews et al., 2002).
Glucocorticoid action is determined by: 1) the HPA axis 2) systemic
glucocorticoid levels and 3) local enzymatic conversion determined by the expression of
GR and 11βHSD (Stewart and Krozowski, 1999). Glucocorticoid exposure alters activity
of 11βHSD isoforms types 1 and 2 (Gicquel et al., 2008). Enzymatic action occurs
primarily due to the action of 11βHSD type 1 (11βHSD1), an 11-oxoreductase, that
converts inactive cortisone to active cortisol and stimulates activation of intracellular GR.
Conversely, 11βHSD type 2 (11βHSD2), an 11-dehydrogenase, converts active cortisol
to inactive cortisone, and preserves MR specificity to aldosterone (Bamberger et al.,
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1996; Stewart and Krozowski, 1999). Placental control of glucocorticoid action is
primarily due to the action of 11βHSD2 to convert cortisol to the inactive form (Edwards
et al., 1996). This process is critical, as it allows the fetus to develop and control its own
regulation of development, rather than being primarily driven by maternal circulation.
Reduced 11ßHSD2 activity in the placenta would result in fetal overexposure to
glucocorticoids which may alter growth, gene expression, and fetal development.
Impaired 11ßHSD2 has been observed to lead to fetal overexposure to maternal
glucocorticoids which lead to reduced birth weight and hypertension (Edwards et al.,
1993).
Synthetic glucocorticoid administration during gestation has become a commonly
accepted practice following the findings of Liggins (1969) in which he discovered the
action of glucocorticoids as a means to accelerate fetal lung development in sheep.
Pregnant ewes administered exogenous synthetic glucocorticoids gave birth to lambs with
improved survivability when born prematurely (Liggins 1969). This data lead to clinical
trials in which decreased morbidity and mortality of infants were observed when mothers
were treated with synthetic glucocorticoids during late gestation (Liggins, 1969; Liggins
and Howie, 1972).
Pregnant rats administered either the synthetic glucocorticoid dexamethasone or the
11HSD2 inhibitor carbenoxolone observed decreased mean birth weight and elevated
arterial blood pressure in the adult offspring (Benediktsson et al., 1993; Lewitt et al.,
1996; Lindsay et al., 1996a). The 11HSD2 inhibitor carbenoxolone metabolizes
corticosterone to the inactive form 11-dehydrocorticosterone. Administration of
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carboxolone was further examined in rodents and observed decreased birth weight,
induced hypertention, and impaired glucose tolerance in offspring (Lindsay et al.,
1996a, Lindsay et al., 1996b).
Functions in postnatal life
As previously stated, HPA axis activity is enhanced in postnatal life, due to
increased basal circulating cortisol concentrations and an increased adrenal response to
ACTH in adulthood (McMillen and Robinson, 2005; Fowden et al., 2005; Matthews,
2002; Lesage et al., 2001). During postnatal life, cortisol stimulates maturation of adrenal
medulla development which increases epinephrine and norepinephrine availability for
glucogenic and lipolytic pathways (Barnes, 1977). Glucocorticoids also play a role in
ensuring nutrient supply during early postnatal life by increasing glucose storage as
glycogen, stimulating production of enzymes responsible for glucose mobilization from
both glycogen and other precursors (Fowden et al., 1993; Fowden et al., 1995).
In visceral adipose tissue, increased 11βHSD1 activity is observed in obese
patients (Bujalska et al., 1997; Paulmyer-Lacroix et al., 2002; Rask et al., 2002). Cortisol
has been observed to up-regulate 11βHSD1 mRNA expression in human adipocytes and
tissues in vitro (Engeli et al., 2004) which would further stimulate the production of
cortisol as as 11βHSD1 converts cortisone to cortisol. Increased expression of GR and
11βHSD1 in adipose tissue has been associated with obesity in humans (Wake and
Walker, 2004). Similarly, overfed neonatal rodents observed increased expression of GR
and 11βHSD1 in visceral adipose tissue (Boullu-Ciocca et al., 2005). In sheep, increased
glucocorticoid activity in adipose tissue during early postnatal life was concomitant to
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decreased plasma concentrations of cortisol and leptin (Bispham et al., 2002). This may
also induce altered 11βHSD activity as glucocorticoid activity is related to 11βHSD
mRNA abundance (Whorwood et al., 2001).
Regulation of glucocorticoids
Altered plasma cortisol concentrations have been observed in obese humans and
are associated with dysfunctional cortisol secretion and clearance (Jessop et al., 2001;
Rask et al., 2002). Dietary maternal protein restriction and decreased placental 11BHSD
activity increases transplancental transfer of maternal glucocorticoids (McMillen and
Robinson, 2005; Fowden et al., 2005; Seckl, 2004). For example, low-protein diets
decreased placental 11HSD2 activity (Langley-Evans, 1996a; Langley-Evans, 1996b),
which would increase the amount of glucocorticoids able to traverse the placenta and get
into circulation. Also, cortisol in circulation is free and not bound by a high affinity
binding protein, such as transcortin or corticosteroid binding protein.
Ovine and rodent models of maternal synthetic glucocorticoid administration
(dexamethasone and betamethasone, respectively) during gestation observed altered
glucocorticoid receptor mRNA expression throughout adulthood of subsequent offspring
(Levitt et al., 1996; Sloboda et al., 2008). Pregnant ewes administered either
dexamethasone (12 mg/day) or cortisol (120 mg/day) during mid-gestation resulted in
hypertensive offspring by 3 months of age (Dodic et al., 1998; Dodic et al., 2002). There
is also evidence that synthetic glucocorticoids may have deleterious long-term effects on
endocrine, renal, and metabolic function across multiple generations (Long et al, 2013b).
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As previously stated, periods of maternal nutrient restriction resulted in similar
profiles as glucocorticoid treatments. Restricted intake, 50% reduction in energy intake,
increased both maternal and neonatal glucocorticoids in rodents (Lesage et al., 2001).
Adipose of offspring born to nutrient restricted (28 to 80 days of gestation) ewes
exhibited increased glucocorticoid receptor mRNA (Whorwood et al., 2001). Maternal
undernutrition during gestation caused plasma cortisol concentrations to increase in
maternal circulation, but not in fetal concentration of sheep (Edwards and McMillen,
2001). Maternal nutrient restriction during gestation has also decreased concentrations of
insulin, insulin-like growth factors, and thyroid hormones in humans (Bauer et al., 1995;
Clarke et al., 1998), which contribute to the regulation of adipose tissue development
(Symonds et al., 1995).
RELATIONSHIP OF LEPTIN AND GLUCOCORTICOIDS
Glucocorticoid administration may regulate leptin concentrations in the early
postnatal ruminant CNS (De Kloet et al., 1998). Glucocorticoids may act directly in
peripheral tissues by regulating preadipocyte differentiation and adipocyte metabolism
(Kissebah and Krakower, 1994) adipocyte metabolism, and regulate adipocyte gene
expression (Rebuffe-Scrive et al., 1988). Glucocorticoids stimulate leptin synthesis in
adipocytes in vitro (Slieker et al., 1996; De Vos et al., 1995); however, glucocorticoid
administration may contribute to insulin resistance due to altered adipose tissue (Joyner et
al., 2000).
Leptin expression increases concomitantly to increased glucocorticoids in humans
(Cizza et al., 1997) and exhibits an inverse relationship between leptin secretion and
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cortisol and ACTH (Lincinio et al., 1997). Ishida-Takahasi et al. (2004) performed an
experiment in rodents in which animals received a dexamethasone ICV infusion prior to a
leptin ICV infusion. Observations of the study included antagonistic action of
dexamethasone on leptin via impaired leptin-induced signaling pathways JAK/STAT and
MAPK signaling cascades (Ishida-Takahasi et al., 2004).
Previous reports of maternal nutrition models during gestation show altered leptin
serum concentrations during early postnatal life and the impact of altered leptin
concentrations on feed consumption and body composition of subsequent offspring in
adulthood. LeMaster et al. (2017), nutrient restricted cows for the last 100 days of
gestation designed to lose 1 body condition score (BCS) produced offspring that observed
decreased leptin and increased cortisol concentrations at birth. Rather than incorporate a
nutritional stimulus or insult during gestation, administration of a glucocorticoid has been
studied recently as cortisol and leptin have previously observed an inverse relationship in
rodents (Daniels, 1972). Long and Schafer (2013) observed that cattle exhibit an increase
of leptin from about 1 to 4 days of postnatal life concomitant to elevated cortisol at birth
that decreases over the next 5 days of life. In sheep, administration of dexamethasone to
F0 mothers has been observed to eliminate the neonatal leptin peak in F2 female
offspring (Long et al., 2013). In addition to elevated circulating cortisol concentrations,
F2 offspring observed increased appetite, weight gain, and adiposity during an ad libitum
feeding challenge accompanied by decreased insulin response to an intravenous glucose
tolerance test (Long et al., 2013). While ruminants with increased cortisol the first 24-48
hours of life observed decreased plasma leptin concentrations during the early postnatal
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period (LeMaster et al., 2017; Long et al., 2010; Long & Schafer, 2013; Shasa et al.,
2015). As glucocorticoids have been reported to decrease leptin concentrations,
administration at birth may serve as a tool to alter endocrine status and associated brain
development. Recently, use of an exogenous glucocorticoid infusion at birth in cattle has
been observed to alter leptin concentrations from days 1 to 17 of age in early postnatal
beef calves (Lewis et al., 2019). Further investigation is required on the action of
glucocorticoid administration on circulating leptin concentrations in cattle.
IMPLICATIONS IN LIVESTOCK
General
Voluntary feed intake of beef cattle used in production is neuronally regulated.
Leptin is associated with suppression of appetite and long term food intake as it promotes
development of appetite control centers of the brain during early postnatal development.
The control of appetite in the brain influences feeding behavior in adulthood, particularly
when the animal is on a high nutritional plane or challenged during ad libitum periods. In
the beef industry, animals intended for meat consumption spend their final phase of life
under feedlot conditions. During this time, producers observe the highest input cost due
to feed. Incorporation of management tools to decrease feed costs/input will improve
overall production costs.
Voluntary feed intake
Voluntary feed intake (VFI) consists of the feed eaten by an animal when feed is
available ad libitum. Feed intake is a contributing factor to performance of livestock
species intended for meat and is influenced by feeding behavior. In beef production, feed
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intake is affected by physiological, environmental, and genetic factors. Some contributing
factors in intake are: forage availability, palatability, feeding drive, satiety, toxicity of the
ration, nutrient deficiencies, and physical form of the feed, ionophore use, environment,
and management practices. Some selection tools to improve VFI have been suggested,
such as selecting for improved feed intake EPDs or measuring residual feed intake (RFI).
However, directly impacting feeding behavior and feeding drive of the animal during
brain development may serve as a direct mechanism of action on improving VFI.
Early rodent studies observed greater body weights of rats from small litters
compared to rats from larger litters in adult life (Oscai and McGarr, 1978), which authors
attributed to greater VFI after weaning. The amount of food consumed pre-weaning was
suggested to influence subsequent food intake post-weaning (Oscai and McGarr, 1978).
However, forced overfeeding induced weight gain that inhibits VFI in rats (Harris et al.,
1986; Harris, 1996). Furthermore, nutrient restricted rodents (30% intake) exhibit
hyperinsulineamia, hyperleptinaemia and compensatory leptin production in pancreatic B
cells (Vickers et al., 2001), in which conditions worsened when animals underwent
periods of overfeeding (Vickers et al., 2001). Subsequent offspring of undernourished
rats observed improved VFI during early postnatal life when cross-fostered with ad
libitum-fed dams, VFI increased over time, and improved based on postnatal nutrition
(Vickers et al., 2000).
Subsequent offspring from nutrient restricted ewes during mid to late gestation
observed increased gain per unit feed when fed a high quality ad libitum diet (George et
al., 2012). Periods of nutrient restriction are commonly associated with decreased birth
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weights and low birth weight lambs observed increased VFI during early postnatal life
(Greenwood et al., 1998). Interestingly, animals born to obese dams did not observe the
traditional leptin peak observed during early postnatal life (Long et al., 2011) which
suggests that these animals may have had impaired appetite control center development
in the brain. This suggests that impaired brain development of these centers improved
VFI and allowed the animal to consume more as well as deposit more adipose tissue
when exposed to elevated nutritional plane in adulthood (Long et al., 2011). This
hypothesis is further supported as calves with decreased plasma leptin concentrations the
first 20 days of life observed increased feed intake during a 10 week ad libitum feeding
trial at 14 months of age (LeMaster et al., 2017).
Previously, models of maternal nutrition during gestation have reported altered
leptin concentrations during early postnatal life and their impact on feed consumption and
body composition of subsequent offspring in adulthood. Long et al. (2010a) observed that
a leptin surge was not present within the first 11 days of life in lambs born to obese ewes
fed at 150% of NRC Requirements (NRC, 2000). Whereas in LeMaster et al. (2017),
nutrient restricted cows for the last 100 days of gestation designed to lose 1 body
condition score (BCS) produced offspring that observed decreased leptin and increased
cortisol concentrations at birth. Heifers born to nutrient restricted dams during the last
100 days of gestation observed greater feed consumption compared to heifers born to
dams that were control-fed or control-fed with a protein supplement (LeMaster et al.,
2017).
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Rather than incorporate a nutritional stimulus or insult during gestation,
administration of a glucocorticoid has been under examination as cortisol and leptin have
previously observed an inverse relationship. Glucocorticoids have been reported to
decrease leptin concentrations and may serve as a tool to alter endocrine status and
associated brain development. Previously, Long and Schafer (2013) observed that cattle
exhibit an increase of leptin from about 1 to 4 days of postnatal life concomitant to
elevated cortisol at birth that decreases over the next 5 days of life. Administration of
synthetic glucocorticoids, such as dexamethasone, during mid-gestation observed
increased cortisol and decreased leptin concentrations in grand offspring (Long et al.,
2013). Additionally, ruminants with increased cortisol the first 24 to 48 hours of life
observed decreased plasma leptin concentrations throughout the early postnatal period
(LeMaster et al., 2017; Long et al., 2010b; Long and Schafer, 2013; Shasa et al., 2015).
Recently, use of an exogenous glucocorticoid infusion at birth in cattle has been observed
to alter leptin concentrations from days 1 to 17 of age in early postnatal beef calves
(Lewis et al., 2019). However, further investigation is required to determine if altered
leptin concentrations impact appetite control center development during early postnatal
life.
Lewis et al. (2019) performed administration of hydrocortisol sodium succinate at
3.5 μg/kg of BW within 4 h of birth in Angus calves from dams of similar body
condition. Birth weight was not different between treatments (averaged 38.3 ± 1.4 kg),
cortisol treated calves observed decreased leptin concentrations from 1 to 13 days of age,
and no difference in BW from 60 to 150 d of age. Limited research has been performed
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on exogenous glucocorticoid administration and postnatal leptin secretion in beef cattle.
Previously, administration of a synthetic glucocorticoid, dexamethasone, in perinatal
dairy calves at 15 μg/kg of BW did not alter leptin concentrations from 1 to 4 days of age
(Blum et al., 2005). Thus, leptin concentrations may be altered in livestock species and
potentially used as a management tool for altering appetite control centers of the brain.
Impact on the beef industry
The conversion of feed into units of gain/animal tissues in the post-weaning
animal impacts production cost (Tess and Kolstad, 2000; Herd and Bishop, 2000).
Increased food efficiency will improve animal performance so long as it is not
confounded by compromised physiology, growth, and development. Feed efficiency is
based on the units of weight gain produced by the animal divided by the amount of feed
required to do so. Thus, increased feed provided to the animal and consumed should
increase weight gain of the animal. By improving VFI, the animal will consume more
feed in a shorter duration of time due to the lack of neural communication allowing the
animal to feel satiated. Greater energy intake and reduced number of days on feed will
reduce the overall amount of maintenance energy required to develop the animal to
achieve a marketable weight. Because of this increased weight gain relative to their
maintenance requirement per day (Tedeschi et al., 2006), feed efficiency could be
improved.
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Abstract
To examine the effects of endophyte–infected tall fescue during late gestation on
maternal and offspring performance, multiparous Angus cows (n = 40) were bred via AI
and allocated into grazing treatments: toxic (E+) or nontoxic (E-) endophyte tall fescue.
Cows body weight (BW), body temperature, body condition score (BCS), and respiration
rate were recorded and blood samples collected on 180, 210 and 240 days of gestation.
Calf’s BW were recorded at birth and weaning. Cow/calf pairs were managed as one
group on nontoxic pasture from calving until weaning (180 days of age). Body weight
decreased (P = 0.022) and body temperature increased (P < 0.0001) at day 240 in E+
compared to E- cows. BCS did not differ (P = 0.891) between treatments. Respiratory
frequency increased (P = 0.003) in E+ compared to E- cows. Ergovaline concentration of
urine increased (P = 0.003) at day 210 and 240 in E+ compared to E- cows. Prolactin
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concentrations decreased (P < 0.0001) at day 210 in E+ compared to E- cows. Birth and
weaning weight decreased (P < 0.05) in calves from E+ cows compared to E- cows.
Overall, grazing endophyte-infected tall fescue reduced maternal and subsequent
offspring BW.
Key words: beef cattle, calf development, tall fescue, endophyte, fescue toxicity
1 Introduction
Tall fescue (Lolium erundinaceum) is the most widely grown perennial grass in
Argentina, with 3.5 million hectares (30% total cultivated pasture area), predominantly in
the Humid and Sub-humid Pampas [1]. It is also a major forage species in the
Southeastern United States, covering approximately 14 million hectares of [2]. A
majority of tall fescue contains the endophyte Neotyphodium coenophialum, which
produces ergot alkaloids (ergovaline, ergovalinine, etc). Ingestion of toxic endophyte–
infected tall fescue by grazing livestock results in a condition known as fescue toxicosis,
which has been known to reduce animal growth and weight gain [3,4], conception rate
[5,6], milk production [7], and blood components [8,9].
To reduce the effects of ergot alkaloids on reproductive performance, fescue
pastures are traditionally grazing during autumn and winter. This period of time often
corresponds to the second half of gestation in cattle. Little is known about how ergot
alkaloids impacts bovine fetal growth. It has been observed that ergovaline induces
constriction of blood vessels pertinent to fetal growth and development [10,11,12,13,14].
Other factors potentially attributed to reduced fetal growth include decreased volatile
fatty acid (VFA) absorption due to increased ruminal ergot alkaloid concentrations [15]
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which have the potential to decrease metabolic rate, and overall, reduce feed intake and
weight gain [16]. The objective of this study was to determine the effect of grazing toxic
endophyte-infected tall fescue during late gestation on maternal performance and preweaning performance of subsequent offspring.
2 Materials and Methods
2. 1 Ethical consideration
The institutional Animal Care and Use Committee of INTA-CERBAS approved
all animal procedures used in this study (Approval No 107). The experiment was
conducted and maintained in Cuenca del Salado Experimental Station (Buenos Aires,
Argentina).
2.2 Animals
One hundred twenty two (122) Angus multiparous cows were synchronized using
a controlled internal drug-realizing device (Cronipres®, Biogénesis-Bago, Argentina) for
7 days, and upon removal of the device, 500µg of cloprostenol (Ciclase DL®, Syntex,
Argentina) and 1 mg of estradiol benzoate (Benzoato de Estradiol Syntex®, Argentina)
were administrated intramuscularly. Artificial insemination (AI) was performed 48 hours
later using semen from a single Angus sire. At 30 days post AI, 40 pregnant cows were
identified pregnant to AI via transrectal ultrasonography and selected for the study.
2.3 Experimental design
Cows were managed on a common pasture during early to mid-gestation. At 180
days of gestation, cows were blocked by parity and body weight (BW) and randomly
allocated into one of two grazing treatments: toxic endophyte tall fescue (`Kentucky-31´;
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E+) or nontoxic endophyte tall fescue (`BarOptima´; E-). Cows (n = 20 per treatment)
remained on grazing treatments until calving. The E+ pastures consisted of a longestablished ‘Kentucky-31’ cultivar. The E- pasture was stablished in March of 2013 using
a nontoxic `BarOptima´ tall fescue. Both pastures were closed (no grazing) from October
1, 2013 to May 7, 2014 when the trial was initiated.
2.4 Forage quantification
Forage availability was quantified in both pastures and surfaces assigned to both
treatments were adjusted to provide similar DM forage availability between treatments.
Pasture composition and analysis are depicted in Table 1. Pastures were sampled at 3
different locations within each pasture using a 0.093 m square every 16 days, and forage
was cut at ground level using shears. The samples were frozen at -20 °C until sent for
analysis. Forage samples chemically analyzed for dry matter, organic matter, and crude
protein using procedures by the Association of Official Analytical Chemists [17] and dry
matter digestability and neutral detergent fiber were determined using the methods
outlined by Van Soest [18].
2.5 Maternal measurements
Cows BW, body condition score (BCS), body temperature, respiration rate, and
cotyledon diameter were recorded at 180, 210 and 240 days of gestation. Cotyledon
diameter was measured in five cotyledons per cow using transrectal ultrasonography
(Aquila pro, Esaote Europe B.V. Maastricht, NL; 6 MHz probe). Cotyledon diameter was
measured by averaging diameters of both the widest and narrowest portion of each
cotyledon. All cows were allowed to calve naturally, and after calving, calves and their
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dams were managed as one group endophyte free pasture until weaning of calves at ~180
days of age.
Body weights and BCS of cows were recorded at calving (less than 12 h after
calving) and at weaning. Bull calves were castrated at 5 month of age. Calf BW was
recorded at birth and at weaning. Adjusted 205-day weaning weight was computed using
Beef Improvement Federation guidelines without the age of dam or sex of calf
adjustments [19]. Calves removed or lost from the E- treatment group of the study
consisted of one stillborn calf, one dam (death post parturition), and four cows did not
calve in designated time interval (± 10 days from expected parturition to AI date). Data
from these associated calves were removed from statistical analysis. Final number of
calves after statistical removal were: E- (n = 14) and E+ (n = 20).
2.6 Milk sample collection
Milk production was assessed with a portable milking machine equipped with a
milk meter in line (TrueTest, Auckland, New Zealand) at day 30, 60, 120 and 200 ± 10 of
lactation on the same 4 E- and 6 E+ chosen at random. At ~12:00 p.m. cows were
separated from calves and each cow was injected intramuscularly with 10 IU of oxytocin
(Over®, Argentina) to facilitate milk letdown. Cows were milked 5 min after injection
and calves were fitted with strong nose plates and remained with their dams in the same
paddock. The following day, at ~06:00 a.m., cows were milked again with the same
protocol [20]. Homogenized milk samples were collected from each cow at each milking
to determine milk protein, fat, lactose, total solid (IDF 141C:2000 Bentley Instruments,
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Chaska, MN, USA) and urea (Chemspec 150, Bentley Instruments, Chaska, MN, USA)
in Dairy Laboratory LABVIMA, Buenos Aires, Argentina.
2.7 Blood collection and assay
Cow blood samples were collected at 180, 210 and 240 days of gestation using a
12 ml syringe via the jugular vein. For prolactin analysis, blood was stored in a 7.5 ml
glass tube and allowed to clot at room temperature before being centrifuged at 1,500 rpm
for 15 minutes. Serum was stored at -20 °C for subsequent analysis. Cow serum was
analyzed for prolactin via a double anti-body RIA [21]. Intra-assay and interassay CV
was 8.4% and 7.8% respectively. For hematologic analysis, blood samples were stored in
room temperature (approximately 20 °C) and analyzed within 8 hours after blood
collection. Hematologic parameters were measured using the Mindray™ BC5150
hematology analyzer (Mindray Medical International Limited, Mahwah, NJ, USA).
Blood smears were stained using May-Grünwald Giemsa (microscopy 100X).
Presuckled glucose blood concentrations were determined in calves at birth.
Glucose concentration was determined in whole blood with a hand-held electronic
glucometer (Abbott©, UK) immediately after blood samples were taken [22].
2.8 Urine collection and assay
Cow urine samples were collected at 180, 210 and 240 days of gestation.
Approximately 25 ml of urine was collected in sterile plastic containers and immediately
refrigerated for further analysis. Urination was induced through massages in the comb
region. Urinary alkaloid and creatinine concentrations were determined using
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commercially available kits (Phytoscreen urine alkaloid kit, Agrinostics, Inc.,
Watkinsville, GA) following the manufacturer’s instructions [23].
2.9 Placental collection
Immediately after calving, five whole placentas from E- cows and four whole
placentas from E+ cows were collected. Placentas were weighed and all cotyledons were
counted.
2.10 Offspring measurements
Less than 12 hours postpartum, calf sex, birth weight, and the following
measurements on the calf were recorded: head circumference (measurement collected
around parietal bone and mandible just posterior to eye orbits), body length (linear
distance along the vertebral column from the occipital bone to the first coccygeal
vertebra), abdominal girth ( circumference around the abdominal cavity at the umbilicus),
hip height (linear distance from the trochanter major of the femur to the floor), femur
length (linear distance from the head of the femur to the stifle), heart girth (posterior to
foreleg), and cannon bone circumference (narrowest point of metacarpus). All body
measurements were collected when the animal was standing naturally; head raised and
weight on all four feet. Head measurements were collected while the animal was
restrained. Body mass index (BMI) of newborn calves was calculated by dividing the
birth weight of each calf by the square of body length.
2.11 Statistical analyses
Cow/calf was considered the experimental unit. Maternal prolactin and ergovaline
on each day of collection, maternal BW and BCS at calving and weaning were analyzed
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as an ANOVA using the GLM procedure of SAS (SAS Institute Inc., Cary, NC, USA)
with treatment as a fixed effect in the model statement. Gestation length, calf BW at
parturition and morphometrics were analyzed as an ANOVA using the MIXED
procedure of SAS with treatment as a fixed effect and calf sex as a random effect in the
model. Maternal BW, BCS body temperature, respiration rates, cotyledonary diameter
and blood measurements and serum prolactin concentrations during gestation along with
maternal milk yield and composition were analyzed as a repeated measure analysis using
the MIXED procedure of SAS with treatment, day, and their interaction in the model
statement as fixed effects. The covariance structure selected based on the fit of statistical
parameters in the model was autoregressive. Mean separation was determined using
LSMEANS with PDIFF in SAS following a significant (P ≤ 0.10) preliminary F-test.
Data are presented as least squares means ± standard error of the mean and considered
significantly different when P ≤ 0.05, and a tendency was indicated when statistical
probability was between P = 0.051 and P ≤ 0.10.
3 Results
3.1 Maternal measurements
Maternal BW and BCS results during gestation are depicted in Table 2. Cow BW
exhibited a treatment by day interaction (P = 0.030) where E+ cows were decreased (P =
0.022) at day 240 compared to E- cows. Cow BCS decreased (P = 0.029) as gestational
day increased, but was not different (P = 0.891) between treatments. Body temperature
exhibited a treatment by day interaction (P = 0.013) where E+ cows temperature was
greater (P < 0.0001) at day 240 compared to E- cows. Respiratory frequency was
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increased (P = 0.003) in E+ cows compared to E- cows. Cotyledon diameter measured by
ultrasound increased (P < 0.0001) as gestational day increased, but was not different (P =
0.627) between treatments.
Gestation length was decreased (P = 0.038) in E+ cows (273.54 ± 1.1 days)
compared to E- cows (277.35 ± 1.3 days). Maternal body condition at calving was not
different (P = 0.731) between treatments and averaged 2.79 ± 0.54 BCS. Maternal BW at
calving was not different (P = 0.324) between treatments and averaged 442.57 ± 13.56
kg. Maternal body condition at weaning was not different (P = 0.983) between treatments
and averaged 2.57 ± 0.13 BCS. Maternal BW at weaning was not different (P = 0.250)
between treatments and averaged 443.75 ± 13.08 kg.
3.2 Milk analysis
Milk analysis results of samples from lactating cows are depicted in Table 3.
Milk yield increased (P = 0.003) day 60 of lactation, but was not different (P = 0.291)
between treatments. Percent fat was not different (P = 0.371) between treatments.
Percent protein increased (P < 0.0001) at day 60 of lactation, but was not different (P =
0.709) between treatments. Percent lactose increased (P = 0.038) at day 60 of lactation,
but was not different (P = 0.419) between treatments. Total solids were not different (P >
0.100) between treatments or day of lactation. Milk urea nitrogen increased (P < 0.0001)
at day 60 of lactation, but was not different (P = 0.674) between treatments. For all milk
variables, there was a non-significant treatment by day interaction (P > 0.46).
3.3 Blood analysis
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Prolactin concentrations exhibited a treatment by day interaction (P < 0.0001)
where prolactin of E+ cows was decreased (P < 0.0001) at day 210 and tended to increase
(P = 0.0873) at day 240 compared to E- cows (Figure 1).
Hematologic results of blood samples from gestating cows are depicted in Table
4. Leucocytes exhibited a treatment by day interaction (P = 0.011) where E+ cows were
increased (P = 0.021) at day 240 compared to E- cows. Erythrocytes exhibited a
treatment by day interaction (P = 0.019) where E- cows decreased (P < 0.0001) from day
180 to 210, followed by an increase (P = 0.014) from day 210 to 240 of gestation.
Similarly, erythrocytes of E+ cows decreased (P = 0.005) from day 180 to 210, however,
tended to increase (P = 0.096) from day 210 to 240 of gestation. Hemoglobin and
hematocrit was decreased (P < 0.0001) as gestational day increased, but were not
different (P > 0.050) between treatments. Volume corpuscular mean (VCM) tended to
exhibit a treatment by day interaction (P = 0.061) where E+ cows were increased (P =
0.090) at day 240 compared to E- cows. Hemoglobin corpuscular mean (HCM) exhibited
a treatment x day interaction (P = 0.020) where E+ cows were increased (P = 0.049) at
day 240 compared to E- cows. Mean corpuscular hemoglobin concentration (MCHC) and
platelet count were not different (P > 0.100) between treatments or gestational day.
Glucose concentrations of pre-suckled calves was decreased (P = 0.0003) in
calves from E+ cows (90.29 ± 4.27 mmol/L) compared to calves from E- cows (117.23 ±
5.06 mmol/L).
3.4 Urine analysis
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Ergovaline concentration was increased at day 210 (P = 0.017) and day 240 (P =
0.002) in E+ cows compared to E- cows (Figure 2).
3.5 Placental measurements
Placental weight was not different (P = 0.247) between treatments and averaged
4.06 ± 0.53 kg in E- cows and 3.23 ± 0.74 kg in E+ cows. Placental efficiency tended to
be increased (P = 0.094) in E+ cows (14.61 ± 2.42) compared to E- cows (9.05 ± 1.35).
3.6 Offspring measurements
Morphometric measurements of subsequent offspring at birth are depicted in
Table 5. Birth weight was decreased (P = 0.021) in calves from E+ compared to E- cows.
Birth weight of male offspring was increased (P = 0.039) compared to female offspring.
Body length, abdominal girth, hip height, and femur length were not different (P > 0.050)
between treatments or sex. Body mass index was decreased (P = 0.044) in calves from
E+ compared to E- cows, additionally, female offspring were leaner (P = 0.020) than
male offspring. Weaning weight was decreased (P = 0.055) in calves from E+ compared
to E- cows, but not different (P = 0.482) between calf sex was observed.
4 Discussion
4.1 Maternal conditions
In the current study, maternal BW was decreased, in cows grazing toxic
endophyte-infected tall fescue compared to cows grazing non-toxic tall fescue by late
gestation. However, even though maternal BCW decreased as gestation progressed, there
was no effect of grazing treatment. Additionally, body temperature and respiratory
frequency were increased in cows grazing toxic endophyte-infected tall fescue. Similar
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results were observed in beef cows grazing endophyte-infected tall fescue observed
decreased BCS (3.8 ± 0.15), increased body temperature (39.6 ± 0.12 o C), and increased
respiratory frequency (52.0 ± 1.4 breathes/minute) [5].
Traditionally, as gestation progresses, the size of the placentome increases [24],
which is supported by the data in the current study in which cotyledon diameter as
measured by ultrasound increased as gestation progressed. However, limited research has
been performed on cotyledon growth during fescue supplementation and in the current
study, cotyledon diameter was not impacted by treatment.
Cows grazing toxic endophyte-infected tall fescue observed longer periods of
gestation, which contrasts observations in mares grazing endophyte-infected tall fescue in
which they may have a prolonged gestation up to a month [25,26]. Maternal BCS and
BW at calving and at weaning did not differ between treatments in the current study.
Both Fanning [27] and Watson [28] observed similarities in heifers and cows fed
endophyte-infected tall fescue. However, studies by Watson [28] observed reduced BW
and BCS of dams on infected fescue, which contrasts with current findings.
4.2 Milk analysis
Altered milk yield, percent fat, percent protein, percent lactose, and milk urea
nitrogen were observed in the current study due to the day of lactation rather than any
impact of treatment. Previous research has observed decreased milk yield in dams on
endophyte-infected fescue compared to endophyte free forage [29,30]. For example,
Baldwin [30] observed reduced milk yield in Holstein heifers fed endophyte-infected
fescue seed during late lactation and the dry period, however, no differences were
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observed in subsequent lactations. Additionally, reduced milk yield and fat percentages
were observed in Angus and Brahman cows fed endophyte-infected fescue year round at
100% infection rate [31]. Initial studies in dairy cows observed reduced milk production
as well [32]. However, the current study observed no difference due to grazing
endophyte-infected tall fescue. Similar results were observed in lactating ewes fed
endophyte-infected hay where no negative impacts on milk quantity or quality occurred
[33]. This may be due to prolactin being involved in both lactogenesis and
mammogenesis in cattle, but does not participate in galactopoiesis [34]. The impact on
milk production may be due to the vasoconstrictive action of ergot alkaloids on
reproductive vessels rather than the suppression of prolactin concentrations [35,36].
Additionally, cows were all on an endophyte-free fescue during lactation, thus, may have
recovered from the negative impacts of fescue toxicity prior to milk production.
4.3 Blood analysis
Prolactin concentrations decreased during mid-gestation and increased by late
gestation in cows grazing toxic endophyte-infected tall fescue. Similar results of reduced
prolactin concentrations were observed in postpartum beef cows [5], beef steers [9],
lactating ewes [33,37,38], and horses [39,40,41]. Ergot peptide alkaloids, produced by the
ingested endophyte, are contributing factors to fescue toxicity and have been observed to
decrease prolactin concentrations in livestock species [39,42]. Thus, prolactin serves as
the primary biomarker for evaluating the onset of fescue toxicities. Ergot peptide
alkaloids function as a dopamine agonist, whereas dopamine functions as an inhibitory
regulator for prolactin secretion [43].
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In the current study, leucocytes and HCM were increased in cows grazing toxic
endophyte-infected tall fescue compared to cows grazing non-toxic tall fescue during late
gestation. Whereas erythrocytes observed depressed levels from early to mid gestation
then increased by parturition in cows grazing non-toxic endophyte-infected tall fescue.
While hemoglobin, hematocrit, MCHC, and platelet count were unaffected by treatment.
Varying results have been observed in cattle for increasing, decreasing, or no difference
in leukocyte counts [8,9,44]. Experiments by Oliver [9] evaluated the blood components
of Angus steers grazing endophyte infected pastures and observed similar results:
increased erythrocyte count, no difference in hemoglobin or hematocrit, and decreased
mean corpuscular hemoglobin and mean corpuscular volume. In the same study, the
mean corpuscular hemoglobin concentration was decreased which contrasts from the
results of the current experiment [9].
Glucose concentrations of pre-suckled calves were decreased in calves born to
cows grazing toxic endophyte-infected tall fescue compared to calves born to cows
grazing non-toxic tall fescue. Similar observations have been reported in studies of late
gestation nutrient restriction in beef cattle, calves from nutrient restricted dams,
regardless of protein supplementation, observed reduced glucose concentrations
compared to control fed dams [45]. This may be due to the limited amount of nutrients
and resources received by the fetus closer to term due to restricted blood flow.
4.4 Urine analysis
Since ergovaline concentration was increased at day 210 and 240 of gestation in
cows grazing ergot alkaloids compared to cows on a control forage, the treated cows have
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been determined as receiving infected-tall fescue in order to induce the effects of fescue
toxicosis.
4.5 Placental measurements
Placental weight did not differ between treatments, while placental efficiency
tended to increased in cows grazing toxic endophyte-infected tall fescue compared to
cows grazing non-toxic tall fescue. Mares fed endophyte seed experienced heavier and
thicker placentas then those on control seed [46]. Additionally, in mares grazing
endophyte-infected fescue, placentas were observed to be a reddish color, thickened, and
heavier than those of mares grazing endophyte-free fescue [40]. Similar findings in sheep
and cow models determined that compromised pregnancies alter placental blood flow and
vascularity in late gestation [47]. In models of early gestation maternal undernutrition of
beef cows, placental vascularity did not differ by mid gestation, however, nutrient
restricted cows observed a placental programming effect in late gestation [48].
4.6 Offspring measurements
In the current study, birth weight was decreased in calves born to cows grazing
toxic endophyte-infected tall fescue compared to calves born to cows grazing non-toxic
tall fescue. However, an effect of sex was observed in which the birth weight of male
offspring was increased compared to female offspring. Similar results were observed in
[28], beef calves from cows fed endophyte-infected tall fescue observed decreased birth
weights by 5 kg and reduced average daily gain when raised on the same pasture. As well
as Bolt and Bond [49] where pregnant heifers grazing endophyte-infected tall fescue from
d 155 of gestation until parturition gave birth to lighter calves than heifers grazing
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endophyte-free tall fescue. However, Schmidt [50] did not observe any difference in birth
weight of calves from heifers grazing endophyte-infected or endophyte-free fescue.
In the current study, while body length, abdominal girth, hip height, and femur
length did not differ between treatments, BMI was decreased in calves born to cows
grazing toxic endophyte-infected tall fescue compared to calves born to cows grazing
non-toxic tall fescue. Interestingly, female offspring were also leaner than male
offspring. Moresca et al. [51] observed similar results of asymmetrical fetal development
in cows under conditions of protein restriction. Limited research has been performed
comparing the differences in body composition and growth of males and females.
However, in female rats, as the level of endophyte infected seed increased, average daily
feed intake and average daily weight gain [52].
In the current study, weaning weight was decreased in calves born to cows
grazing toxic endophyte-infected tall fescue compared to calves born to cows grazing
non-toxic tall fescue. Similar results were observed in adjusted weaning weights of
calves from postpartum beef cows fed infected fescue at 195.8 ± 4.5 kg [5]. Additionally,
during that time in the 1990s, livestock economic loss due to fescue resulted in
approximately $354 million due to reduced calf numbers and $255 million in reduced
weaning weights in the US [3]. More recently, Strickland [53] estimated that
approximately $1 billion are lost annually.
Similar results have been observed in calves from cows that experienced nutrient
restriction during late gestation. However, rather than a decrease in the amount of
nutrients readily available for the developing fetus, it may be due to a decrease in blood

155

flow due to the vasoconstrictive characteristics of ergot alkaloids. Ergovaline has been
observed to exhibit vasoactive effects in both reproductive and non-reproductive vessels
[10, 11, 12, 13, 14]. For example, in the bovine ruminal artery, ruminal vein, and
saphenous vein, ergovaline induced local vasoconstriction on vasculature [54]. In equine
medial palmer artery and vein, ergovaline was the most vasoactive alkaloid tested, but
did not alter activity in the uterine artery [35]. Ergovaline induced persistent
vasoconstriction on vasculature through serotonin receptors due to its similar ring
structure [11, 55, 56]. Serotonin activates S2- serotonergic receptors on vascular smooth
muscle to induce vasoconstriction directly [57]. However, Foote [58] has reported that
the constriction leads to a reduction in epithelial blood flow. Thus, the true mechanism in
which ergot alkaloids work is still being investigated. Additionally, as ergot alkaloids
induce vasoconstriction, they may activate nitric oxide, a known vasodilator. Nitric oxide
functions to regulate blood flow due to vasorelaxation of vascular smooth muscle cells
[59]. The disruption of blood flow in both reproductive and non-reproductive vessels due
to the consumption of ergovaline and other ergot alkaloids remains unclear.
Calves indirectly impacted by ergot alkaloids due to maternal consumption during
gestation are not the only concern for producers when evaluating fescue management
practices. In fescue grazing studies, steers would exhibit a decrement of 0.045 kg in
average daily gain for every 10% increase in ergovaline level [25], which may be due to
reduced feed intake [60]. However, when grazing endophyte-free tall fescue, steer weight
is increased by gains of 30 to over 100% [3]. Grazing studies in stocker cattle observed
decreased average daily gain and dry matter intake on endophyte-infected tall fescue,
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effects that were alleviated upon grazing endophyte-free tall fescue pastures [61].
Additionally, beef steers averaged a 70% or greater rate of gain and gain per hectare of
pasture compared to the endophyte-infected tall fescue grazers [61]. Recently, Mote [62]
evaluated Angus steers grazing toxic fescue pastures and determined the primary
consequences to endophyte consumption were tryptophan and lipid metabolism
disruption. However, the presence of the endophyte enhances persistence of the plant,
competitiveness, and prevalence of endophyte-infected tall fescue versus the endophytefree tall fescue [63, 64].
5 Conclusions
Exposure to E+ forage during late gestation results in decreased maternal semen
prolactin and BW during late gestation compared to cows consuming E- forage. Exposure
to E+ forage resulted in calves with reduced weight and BMI at birth and a tendency for
reduced BW at weaning compared to calves from E-dams. Exposure to E+ forage did not
affect locational performance of dams. Additionally, further work is needed to determine
the exact amount of ergot consumption that effects calf development in utero. This
amount is probably dependant on maternal BCS and possible maternal age. This could be
important to the cow calf industry since we know that dilution with other forages or
supplements may be one of the most important management options in managing fescue
toxicosis.
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Table 1. Chemical composition of forage consumed by cows grazing either a toxic endophyte tall fescue
(E+) or nontoxic endophyte tall fescue (E-) during gestation until parturition.
Treatm
ent
E+

E-

Day1

DM2

Organic matter,
%DM
0
38.2
89.6
16
38
92.3
32
38.9
91.7
48
45.2
91.7
64
39.4
89.3
80
31.1
89.8
0
29.1
89.3
16
27.2
89.5
32
35.6
88.5
48
30
89.2
64
35.2
88.5
80
34.1
90.5
1
Day relative to start of experiment
2
Dry matter (DM)
3
Neutral detergent fiber (NDF)

DM digestibility,
%DM
61
56.6
61.8
46
54.7
62.5
66.4
68
58.8
63.7
54.4
64.8
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Crude protein,
%DM
11
10.5
12.4
7
9.4
11.6
22.4
22.9
16.7
17.1
13.8
17.7

NDF3, %DM
59.4
63.9
52.7
70.3
61.7
56.3
51.6
52.3
55.2
53.7
61.7
53.6

Table 2. Body weight, body condition scores, body temperature, and respiratory frequency of multiparous
cows grazing either a toxic endophyte tall fescue (E+) or nontoxic endophyte tall fescue (E-) during
gestation.
Treatment

E+
210

E210

180
240
180
240
SEM
Trt
Item
20
20
20
20
20
20
Cow, n
Body weight,
511.6 532.5
550.4 510.9 505.8 502.75 18.34 0.180
b
kg
4
7
3a
4
0
8
Body
3.04
3.26
3.09
3.17
3.17
2.99
0.08
0.890
condition
6
scores1, 1 - 5
Body
37.67
38.51a 37.79
39.22b
0.11
0.000
temperature,
6
o
C
Respiratory
43.71 37.43
32.86 46.04 46.20
45.40
1.72
0.002
frequency,
7
beats/min
Cotyledon
312.5 365.5
387.4 300.1 377.1 393.15 6.71
0.627
diameter, mm
7
0
3
9
5
0
Data presented LSM ± SEM. a,b means differ by P value reported for that item
1
Body condition scoring system based on the findings of Wagner et al., 1988
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P-value
Day
0.219
4
0.028
7

Trt x
Day
0.030
4
0.290
4

<.000
1

0.012
9

0.115
0

0.171
8

<.000
1

0.351
2

Table 3. Milk analysis during lactation of multiparous cows that grazed either a toxic endophyte tall fescue
(E+) or nontoxic endophyte tall fescue (E-) during gestation.
Treatment
Item
Cow, n
Milk
yield,
kg/d
Fat, %
Protein,%
Lactose,
%
Total
solids, %

30

60

4
4.57

E-

120

200

30

60

4
7.22

4
4.55

4
4.37

6
5.80

2.6

2.94

2.99

3.47

3.00

3.42

3.47

4.75

4.97

11.79

11.94

E+

120

200

SEM

6
8.28

6
5.36

6
5.10

0.88

2.29

3.13

2.54

2.71

0.39

3.30

2.90

3.44

3.43

3.26

0.09

4.76

4.45

4.58

4.63

4.78

4.35

0.17

12.01

12.23

10.59

12.01

11.49

11.41

0.52

10.83 10.30 12.29 10.16 10.71 10.34 12.53 10.48
0.37
MUN1, %
Data presented LSM ± SEM. a,b means differ by P value reported for that item
1
Milk urea nitrogen (MUN)
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P-value
Trt

Day

0.290
8

0.000
3

0.371
1
0.709
1
0.419
3
0.256
0
0.673
7

0.188
1
<.000
1
0.037
8
0.289
4
<.000
1

Table 4. Blood analysis of multiparous cows grazing either a toxic endophyte tall fescue (E+) or nontoxic
endophyte tall fescue (E-) during gestation.
Treatment

Item
Cow, n
Leucocytes,
mm3
Erythrocytes,
mil/mm3
Hemoglobin,
g/dL

180

E210

240

20
8268.
36
6.67

20
7922.
87
6.06

20
7708.
76a
6.37

180

E+
210

240

SEM

20
8257.
90
6.74

20
7529.
25
6.34

20
8984.6
9b
6.08

362.1
2
0.15

P-value
Trt
Day

0.480
5
0.912
5
11.30 10.31
10.52 11.38 10.72
10.46
0.24
0.633
6
34.34 31.28
32.16 34.74 32.66
31.81
0.71
0.577
Hematocrit, %
0
51.45 51.40
50.66 51.70 51.56
52.30
0.66
0.425
VCM1, fl
8
16.92 16.97 16.49a 16.86 16.94 17.15b
0.23
0.505
HCM2, pg
8
32.82 32.92
32.74 32.77 32.70
32.75
0.13
0.443
MCHC3, g/L
6
26533 26530 21684 27664 21860 20124 28923 0.494
Platelets, mm3
0
6
1
9
1
6
9
Data presented LSM ± SEM. a,b means differ by P value reported for that item
1
Volume corpuscular mean (VCM)
2
Hemoglobin corpuscular mean (HCM)
3
Mean corpuscular hemoglobin concentration (MCHC)
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0.034
6
<.000
1
<.000
1
<.000
1
0.943
3
0.562
1
0.863
0
0.121
0

Trt x
Day
0.011
2
0.019
3
0.275
0
0.152
7
0.061
0
0.019
9
0.626
6
0.565
6

Table 5. Morphometric measurements of calves born to multiparous cows grazing either a toxic endophyte
tall fescue (E+) or nontoxic endophyte tall fescue (E-) at birth.
Treatment
EItem
Calf, n
Birth weight, kg
Head
circumference,
cm
Body length, cm
Abdominal girth,
cm

P-value

E+

Male
8
35.6 ± 1.3

Female
6
34.0 ± 1.0

Male
8
33.6 ± 1.3

Female
12
29.8 ± 1.0

Trt
0.0205

Sex
0.0387

48.9 ± 0.6

47.3 ± 0.7

48.9 ± 0.6

47.6 ± 0.5

0.7340

0.0150

72.0 ± 2.0

72.0 ± 2.3

74.5 ± 2.0

70.9 ± 1.6

0.7225

0.3717

73.3 ± 1.8

73.3 ± 2.1

75.1 ± 1.8

71.4 ± 1.5

0.9688

0.3212

64.8 ± 1.0
65.2 ±1.2
65.1 ± 1.0
62.9 ± 0.8
0.3714
0.3927
Hip height, cm
21.1 ± 0.6
20.5 ± 0.7
21.1 ± 0.6
21.1 ± 0.5
0.6552
0.6047
Femur length, cm
75.6 ± 1.6
77.7 ±1.8
72.3 ± 1.6
73.2 ± 1.3
0.0246
0.4187
Heart girth, cm
Cannon bone
circumference,
12.5 ± 0.3
12.4 ± 0.4
12.4 ± 0.3
11.4 ± 0.3
0.0878
0.0770
cm
0.49 ± 0.01 0.46 ± 0.02 0.47 ± 0.01 0.43 ± 0.01
0.0441
0.0200
BMI1, kg/cm2
Weaning weight,
218.7 ±
200.63 ±
183.9 ±
217.2± 14.8
0.0549
0.4820
kg
13.5
11.7
10.5
a,b
Data presented LSM ± SEM. means differ by P value reported for that item
1
Body mass index (BMI) calculated by birth BW (kg) / body length (cm)2
2
Adjusted 205-day weaning weight was computed using Beef Improvement Federation guidelines
without the age of dam or sex of calf adjustments
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Figure 1. Serum prolactin concentrations (ng/ml) of multiparous cows grazing either a
toxic endophyte tall fescue (E+) or nontoxic endophyte tall fescue (E-) during gestation.
An asterisk (*) signifies a significant difference at P ≤ 0.05.
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Figure 2. Urine Ergovaline concentrations of multiparous cows grazing either a toxic
endophyte tall fescue (E+) or nontoxic endophyte tall fescue (E-) during gestation. An
asterisk (*) signifies a significant difference at P ≤ 0.05.
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CHAPTER III
THE EFFECTS OF EARLY OR MID-GESTATIONAL NUTRIENT
RESTRICTION ON BOVINE FETAL PANCREATIC DEVELOPMENT
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ABSTRACT: Research on the effects of nutrient restriction in beef cows on fetal
pancreatic development is limited. To address this, multiparous Angus-cross cows (n =
22) were fed either control (CON; to gain 1 kg/wk) or nutrient restricted (NR; 0.55 %
NEm) diets based on NRC requirements. On d 30 of gestation, cows were blocked by
body condition and randomly assigned to one of three nutritional regimes: CON fed from
d30 to 190 (n = 8), or NR/C (n = 7) or C/NR (n = 7) fed either the CON or NR diet from
d 30 to 110 followed by CON or NR from d 110 to 190 of gestation. Cows were
harvested on d 190 of gestation and blood samples, fetal weights, and fetal tissue weights
and samples were collected. Pancreas samples were embedded in paraffin and sectioned
for standard immunohistochemistry procedures in order to quantify insulin positive β
cells and number of apoptotic β cells utilizing TUNEL staining. Data were analyzed via
ANOVA using the GLM procedure of SAS. At harvest, empty carcass weights were
decreased (P = 0.030) in fetuses from C/NR and NR/C fed dams compared to fetuses of
CON fed dams. Pancreas weight was decreased (P = 0.030) in fetuses of C/NR fed dams
compared to CON fetuses, however, fetuses of NR/C fed dams were not different (P >
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0.05) from fetuses of CON fed dams. Maternal and fetal serum insulin concentrations
were not different (P > 0.05) in NR/C fed compared to CON fed, however,
concentrations of insulin were decreased (P = 0.036) in C/NR fed compared to CON fed.
Beta cell mass was decreased (P = 0.009) in fetuses of NR/C and C/NR fed dams
compared to fetuses of CON fed dams. Percentage of apoptotic cells were increased (P <
0.0001) in fetuses of NR/C and C/NR fetuses than fetuses of CON fed dams. This
evidence suggests that nutrient restriction either during early or mid-gestation can
negatively impact fetal pancreatic development. However, mid gestational nutritional
insult is potentially recovered by re-acclimation to a diet that meets to requirements of the
dam, thus, reducing negative outcomes in fetal offspring.
Key words: fetal pancreas, β cells, nutrient restriction
1. Introduction
In cattle production, periods of nutrient restriction or over nutrition have been
evaluated to determine fetal development and performance to address various economic
or environmental stressors animals may encounter. Specifically, nutrient restriction may
negatively impact subsequent offspring if it occurs during critical periods of development
during gestation [1]. Insufficient maternal nutrition induces metabolic insults during
gestation that impair fetal development of endocrine organs, such as the pancreas, may be
a contributing factor to the occurrence of metabolic syndrome or diabetes in postnatal
animals. Pancreatic development is imperative to endocrine function and may be
impaired due to reduced fetal growth. Instances of reduced fetal growth due to maternal
undernutrition have been observed in sheep [2,3,4], pigs [5,6,7], horses [8], and cattle [9].
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In livestock species, the endocrine pancreas develops over a long period of fetal
and early postnatal life [10,11,12]. Prenatal induced changes influence postnatal
circulating concentrations during gestation, such as insulin [13]. Additionally,
disturbance of pancreatic growth and function may reduce insulin concentrations, and
may lead to intrauterine growth retardation. The objective of the current study was to
evaluate nutrient restriction in beef cows on fetal pancreatic development associated with
beta cell area and apoptosis.
2. Materials and Methods
2. 1 Animal Care and Treatments
Animal care and use were according to protocols approved by the Clemson
University Institutional Animal Care and Use Committee (#2013-038). All animals were
bred using a 7 d Co-Synch and CIDR artificial insemination protocol. Briefly,
primiparous Angus-cross cows (n = 22) received an EAZI-Breed CIDR implant and a
single100 µg intramuscular (IM) injection of GnRH (Zoetis Animal Health, New York,
NY, USA). CIDR’s were removed after 7 d and a 25 mg I.M. injection of PGF2α (Zoetis
Animal Health, New York, NY, USA) was delivered. Following PGF2α injection, estrus
was assessed at 0700 h and 1700 h and insemination occurred 12 h after observed estrus.
If no estrus was detected, cows were inseminated 60 h following PGF2α injection and
administered a second 100 µg IM injection of GnRH (Zoetis Animal Health, New York,
NY, USA). All cows were inseminated using bull-sexed semen from a single Angus sire.
At approximately 30 d post-AI, both groups underwent transrectal ultrasonography
(Aloka 500-V with 7.5-MHz probe, Corometrics Medical Systems, Wallingford, CT,
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USA) to determine pregnancy to artificial insemination, and those who conceived were
enrolled in the study (n = 16).
From d 0 to d 30, all cows were fed to meet or exceed NRC requirements until
conception was confirmed via transrectal ultrasonography [14]. Throughout the study, all
cows received a total mixed ration of 30 % soybean hulls, 20 % cottonseed hulls, 17.5 %
peanut hulls, 17 % corn screening, 12.5 % corn gluten feed, 1.5 % salt, 0.5 % calcium,
0.5 % trace mineral, and 0.5 % vitamin premix: 0.65 Mcal NEm/lb, 8.9 % CP. Control
(CON) diets were fed to exceed CP requirements and for cows to gain 1 kg/wk while
nutrient restricted (NR) diets were fed to meet 0.55 % of maintenance energy and CP
requirements based on body weight [14]. On d 30 of gestation, cows were blocked by
body condition and randomly assigned to one of three nutritional regimes: CON fed from
d30 to 190 (n = 8), or NR/C (n = 7) or C/NR (n = 7) fed either the CON or NR diet from
d 30 to 110 followed by CON or NR from d 110 to 190 of gestation. All cows were
housed identically on dry lot with ad libitum access to water and fed individually once
daily. Body weight was collected weekly and feed adjusted accordingly throughout the
duration of the experiment. Body condition scores (BCS) were collected every two
weeks.
Maternal blood samples were collected via jugular venipuncture 24 h prior to
transportation to a commercial abattoir at d 190 of gestation. At the time of slaughter, the
gravid uterus was removed and fetuses harvested. Fetal blood samples were collected via
venipuncture of the umbilical cord. Blood samples were processed as previously
described [15]. Briefly, samples were collected in 10 mL serum vacutainers (Becton,
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Dickinson and Company, Frankin Lakes, NJ, USA) and centrifuged at 2,000 x g for 20
min at 4 oC. The supernatant was aliquoted and stored at either -20 oC (maternal samples)
or -80 oC (fetal samples) long term.
Fetuses were harvested and weighed immediately, additionally, total pancreas
weight was collected. A 1 g section from the tail of the pancreas was dissected and
placed in an embedding cassette (Econolab, Chanley, Quebec) and submerged in 10 %
formalin for histological analysis. The entire remaining pancreas was cut up to be
pulverized and homogenized in liquid nitrogen, snap frozen in liquid nitrogen, and stored
at -80 oC for later analysis. Homogenization was to ensure a representative sample of the
pancreas rather than select cell types to provide reliable extrapolated data relative to the
entire pancreas.
2.2 Hormone and metabolite analysis
Serum samples were analyzed from fetuses (n = 22) of treated cows as well as the
associated dam as previously described [16]. Serum insulin concentrations were
determined using an RIA kit in duplicate (Siemens Medical Solutions Diagnostics, Los
Angeles, CA, USA). Intra-assay CV for insulin was 6.7 % and sensitivity was 0.10 ng/ml.
A 50 mg pancreas section was weighed out and insulin content extracted by incubating in
an intracellular buffer (70 % ethanol and 1 mol/L HCl) at -20 oC for 12 h and debris
removed via centrifugation. The insulin content of the supernatant was determined using
the previously mentioned RIA and normalized per gram and whole pancreas weight.
2.3 Immunohistochemistry
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As previously described [17], pancreatic tissue was embedded in paraffin and
sections were sliced into six 5 µm sections, maintaining a 50 µm distance between
sections. Sections were deparaffinized and rehydrated prior to heating in a 95 oC water
bath for antigen retrieval [17]. Briefly, nonspecific antigen sites were blocked via a 60
min incubation in 1.5 % normal goat serum (Vector Laboratories, Burlingame,CA, USA)
in phosphate-buffered saline with 0.05 % Tween 20 (Bio-Rad Laboratories, Inc,
Hercules, CA, USA) before sections were incubated with mouse anti-ovine insulin
(Abcam, CA, USA; 1:500) antibodies at 4 °C overnight, followed by fluorescent-labeled
secondary antibodies: rhodamine-labeled goat anti-mouse (Millipore, Billerica, MA,
USA; 1:500) for 60 min at 22 °C. Ten fields per section were visualized using a ZEISS
AxioCam MRm microscope (BioSciences, Jena, Germany) and captured digitally using a
Retiga EXiFast camera (Q Imaging, Burnaby, BC, Canada). Numbers of insulin-positive
cells were counted per field of view by 2 experienced individuals blinded to treatment
and the counts were averaged as previously described [17].
Following dewaxing, rehydrating, and antigen retrieval as described above,
terminal deoxynucleotidyl transferase-mediated dUTP nick translation end labeling
(TUNEL) was performed on 3 pancreatic sections per fetus with the In Situ Cell Death
Detection POD kit (Biotium, Hayward, CA, USA) per the manufacturer’s instructions
[17]. The sections were incubated with 50 µL of TUNEL reaction mixture or 50 µL of
label solution alone (negative control) for 60 min at 37°C. Sections were incubated with
guinea pig antiporcine insulin (Dako; 1:500) at 4 °C overnight and rhodamine- labeled
goat anti-guinea pig (Millipore; 1:500) at 22 °C for 60 min. Slides were mounted in
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Vectashield mounting medium (Vector Laboratories Inc., Burlingame, CA, USA) with
4=,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA, USA) as
previously described [17]. Ten fields per section were visualized as previously stated.
2.4 Statistical Analysis
Data was analyzed as a complete randomized design using the General Linear
Model (GLM) procedure of SAS (SAS software version 9.4, SAS Institute, Cary, NC,
USA). The post-hoc test to determine differences between individual treatment groups
was analyzed using PDIFF of SAS (SAS software version 9.4, SAS Institute, Cary, NC,
USA). The model statement included treatment. Statistical significance was declared at P
≤ 0.05 while a tendency was declared at 0.05 < P ≤ 0.10.
3. Results and Discussion
At harvest, empty carcass weights were decreased (P = 0.030) in fetuses from
C/NR and NR/C fed dams compared to fetuses of CON fed (Table 1). Previous findings
of this laboratory observed empty carcass weight at d 110 of gestation, where male
fetuses of nutrient restricted dams were reduced (0.47 ± 0.01 kg) compared to male fetus’
of control fed dams (0.54 ± 0.01 kg) [15]. Similar studies in beef calves evaluated the
effects of late gestation nutrient restriction [18]. In LeMaster et al. [18], calves from
nutrient restricted dams observed reduced birth weights compared to calves from control
dams (33.4 ± 1.2 and 37.2 ± 1.3 kg, respectively). In an ovine model of maternal
undernutrition, nutrient restricted Mongolian ewes from d 90 of gestation to parturition,
exhibited decreased fetal daily growth rate and lamb birth weight [19].
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Pancreas weight was decreased (P = 0.030) in fetuses from C/NR fed dams
compared to fetuses of CON fed dams (Table 1). Pancreas weight of fetuses from NR/C
fed dams was not different (P > 0.05) from fetuses of CON fed dams (Table 1). At d 90
of gestation in nutrient restricted ewes, fetal pancreas weight was decreased, but pancreas
weight did not differ at birth between treatments [19]. Conversely, previous impact of
maternal nutrient restriction on pancreatic growth reported no differences in bovine [9]
and ovine [4]. Additionally, previous reports of decreased fetal pancreas weight have
been reported in ewes fed obesogenic diets 60 d prior to conception [21]. Whereas
maternal nutrient restriction during pregnancy has been observed to reduce overall
growth in bovine [9], ovine [4, 20, 21], swine [22], and equine [23] fetuses.
Serum insulin concentrations in maternal and fetal samples at d 190 of gestation
are in table 2. Insulin concentrations were not different (P > 0.05) in NR/C fed dams
compared to CON fed dams, however, concentrations of insulin were decreased (P =
0.036) in C/NR fed dams compared to CON fed dams. Similarly, insulin concentrations
were not different (P > 0.05) in fetuses of NR/C fed dams compared to fetuses of CON
fed dams, but were decreased (P = 0.036) in fetuses of C/NR fed dams compared to
fetuses of CON fed dams. Insulin concentrations in fetal pancreas per wet sample were
decreased (P < 0.001) in NR/C and C/NR fed dams compared to CON fed dams. Insulin
concentrations of the whole fetal pancreas were increased (P < 0.01) in NR/C and C/NR
fed dams compared to CON fed dams. In LeMaster et al. [18], maternal plasma insulin
concentrations were decreased when nutrient restriction occurred during late gestation in
beef cows. Insulin secretion reduction may be associated with reduced transport of
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nutrients coming from maternal circulation to the developing fetus as fetal insulin
concentrations are produced by the fetal pancreas since insulin does not cross the
placenta. When placental and uterine blood flow was reduced in overfed pregnant ewes, a
concomitant decrease in fetal insulin concentration was observed [24].
Reduced insulin could also be relative to the younger dams (≤ 4 years) used in the
current study. Younger cows have previously been observed to be more susceptible to
nutrient restriction compared to older cows [18]. Immature and growing heifers do not
have the developed maternal ability to repartition nutrients to the developing fetus. Thus,
during periods of nutrient restriction, there is an increased likelihood of negative longterm effects on subsequent offspring. In observations by Bellows and Short [25], calves
experienced decreased birth weight more consistently from heifers that were more
responsive to nutrient restriction during the last third of gestation than cows. Overall,
mature females have been reported to tolerate nutrient restriction better than immature
females [24, 25].
Beta cell mass was decreased (P = 0.009) in fetuses of NR/C and C/NR fed dams
compared to fetuses of CON fed dams (Figure 1). Percentage of apoptotic cells were
increased (P < 0.0001) in fetuses of NR/C and C/NR fetuses than fetuses of CON fed
dams (Figure 2).
Fetuses from dams on the nutrient restricted diet at any point in gestation observed
decreased β cell mass and increased number of apoptotic cells, and particularly in animals
who experiences nutrient restriction closer to harvest. In nutrient restricted rats, the
offspring exhibited reduced beta cell mass at birth and by 21 days of age [26] a finding
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that occurred as well in offspring of protein restricted rats [27, 28]. Conversely, in
overfeeding models of maternal nutrition in sheep, fetal beta cell mass growth is
accelerated [17] or beta cell number is reduced [21]. Decreased beta cell mass has been
linked to increased incidence of apoptosis during development [29]. This may be due to
the fact that apoptosis participates in the remodeling of the pancreas during development
[30].
4. Conclusions
Decreased serum insulin concentrations were observed in fetuses that underwent
periods of nutrient restriction during gestation, potentially to maintain metabolism,
although carcass weight was forfeited. This evidence suggests that nutrient restriction
either during early or mid-gestation can negatively impact fetal pancreatic development.
However, mid gestational nutritional insult is potentially recovered by re-acclimation to a
diet that meets to requirements of the dam, thus, reducing negative outcomes in fetal
offspring.
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Table 1. Measurements of fetuses from multiparous cows fed either a control (CON),
nutrient restricted / control (NR/C), or control / nutrient restricted (C/NR) diet at d 190 of
gestation.
Treatment
P-Value
Item
CON
NR/C
C/NR
Trt
Calf, n
8
7
7
Empty carcass
8.5 ± 0.47a
7.2 ± 0.4b
7.2 ± 0.4b
0.036
weight, kg
Pancreas weight,
6.3 ± 0.4a
5.6 ± 0.4a
4.5 ± 0.4b
0.028
g
Pancreas
0.08 ± 0.004a
0.07 ± 0.005b
0.06 ± 0.005b
0.047
weight1, %
Data presented LSM ± SEM. a,b means differ by P value reported for that item
1
Pancreas weight as a percent of empty carcass weight at d 190 of gestation
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Table 2. Fetal and maternal serum and fetal pancreatic insulin concentrations from
multiparous cows fed either a control (CON), nutrient restricted / control (NR/C), or
control / nutrient restricted (C/NR) diet at d 190 of gestation.
Treatment
P-Value
Item
CON
NR/C
C/NR
Trt
n
8
7
7
Maternal
Serum insulin,
2.12 ± 0.3a
2.01 ± 0.3a
1.18 ± 0.3b
0.036
ng/mL
Fetal
Serum insulin,
0.37 ± 0.05a
0.31 ± 0.05a
0.19 ± 0.04b
0.040
ng/mL
Pancreatic
1370.8 ±
1245.0 ± 28.8b
1042.5 ± 28.8c
< 0.001
insulin1, ng/g
25.4a
Pancreatic
8624.3 ±
7021.0 ± 436.8b 4676.4 ± 436.8c
< 0.01
insulin2, ng/g
345.3a
Data presented LSM ± SEM. a,b means differ by P value reported for that item
1
Insulin concentration/g of wet pancreas
2
Insulin concentration of whole pancreas
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Figure 1. βeta cell mass of fetal pancreas from nutrient restricted induced cows during
gestation. Representative immunofluorescence images of fetal pancreatic tissue at d 190
of gestation. Sectioned pancreas tissues were stained for insulin-positive cells with
fluorescent labeled secondary antibodies. Data presented LSM ± SEM. a,b means by
significant difference at P ≤ 0.05.
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Figure 2. βeta cell apoptosis of fetal pancreas from nutrient restricted induced cows
during gestation. Representative immunofluorescence images of fetal pancreatic tissue at
d 190 of gestation. Sectioned pancreas tissues were stained by TUNEL reaction mixture.
Data presented LSM ± SEM. a,b means by significant difference at P ≤ 0.05.
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CHAPTER IV
EFFECT OF EXOGENOUS GLUCOCORTICOID INFUSION ON APPETITIC
CENTER DEVELOPMENT IN POSTNATAL DAIRY BULL CALVES
1

Abstract
The objective was to determine the effects of exogenous glucocorticoids on

circulating leptin concentrations and hypothalamic development in perinatal dairy bull
calves. Within 4h of parturition (day 0), Holstein bull calves were weighed , randomly
assigned to treatments, and intravenously infused with either a low cortisol (LC; n = 9,
3.5 ug/kg of body weight (BW)), high cortisol (HC; n = 9, 7.0 ug/kg of BW), or a sham
infusion control (CON; n = 9, similar volume of saline. A second infusion of its
respective treatment was given 24 hours postpartum at 1.5 ug/kg of BW for LC, 3.5 ug/kg
of BW for HC, and similar volume of saline for CON. All calves were housed similarly
and fed milk replacer three times daily. Blood collections were performed via jugular
venipuncture before infusion and daily from days 0-5 of age. At 5 days of age, calves
were euthanized. Cerebral-spinal fluid (CSF) from the third ventricle of the brain, and
adipose (omental, perirenal, and mesenteric) and hypothalamic tissue were collected.
Blood and CSF samples were analyzed for leptin concentrations via radioimmunoassay.
Adipose samples were analyzed via western blotting for leptin and glucocorticoid
receptor. Hypothalamus samples were analyzed via qRT-PCR for genes associated with
neuronal growth factors. Data were analyzed using appropriate modeling of SAS. Serum
leptin concentrations of HC and LC were decreased (P = 0.013) compared to CON.
Leptin concentrations in CSF of HC and LC were decreased (P = 0.005) compared to
CON. Protein expression of Ob was decreased (P < 0.044) in the perirenal and omental
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adipose tissue of LC treated calves compared to CON. Protein expression of GR did not
differ between treatments or adipose tissue depots (P > 0.05). The genes for Ob, ObR,
and GR were not different (P > 0.188) while BDNF, FGF1 and FGF2 expression were
decreased in HC and LC compared to CON samples (P < 0.006). In summary, exogenous
cortisol administered to perinatal dairy bull calves reduced leptin concentrations in serum
and CSF, decrease protein expression of leptin in perirenal and omental tissues, and
altered gene expression in hypothalamic tissue.
Key words: exogenous glucocorticoid, leptin, cerebral-spinal fluid, appetitic center,
dairy calves
2

Introduction
Hypothalamic regulation of appetite and food intake is based on circulating

nutrient concentrations. Hunger and satiety stimulate centers of the brain, such as the
arcuate nucleus (ARC), which contain neurons that traverse the blood-brain barrier and
come in contact with the blood stream. This allows the ARC to respond to signals such as
leptin (Martin-Gronert and Ozanne, 2005); an adipokine associated with suppression of
appetite and long term food intake. Additionally, neurons of the ARC express peptides
such as neuropeptide Y (NPY), agouti-related peptide (Agrp), and proopiomelanocortin
(POMC) as a means to regulate energy expenditure. Interestingly, neuronal circuitry in
the brain is still forming during the first few days of postnatal life in ruminants that play a
role in appetite regulation (Long et al., 2011; Tipton et al., 2018). Timing and extent of
development of neuronal connection is currently unknown in cattle.
Leptin has been suggested to promote development of appetite control centers of
the brain during early postnatal development (Yura et al., 2005; Bourat et al., 2006) while
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decreased leptin concentrations during this time have been associated with increased feed
intake in ruminants. Cattle exhibit an increase in circulating leptin from 1 to 4 days of age
(Long & Schafer, 2013) while a surge from days 5 to 9 of age has been observed in sheep
(Long et al., 2011). Previously, models of maternal nutrition during gestation have shown
altered leptin concentrations during early postnatal life and its impact on feed
consumption in adulthood. Long et al. (2011) observed that a leptin surge was not present
within the first 11 days of life in lambs born to obese ewes fed at 150% of NRC
requirements (NRC, 2000). However, the offspring born to obese ewes consumed more
feed during a 12 week ad libitum feeding trial and ate approximately 10% more feed
compared to offspring born to ewes fed to meet NRC requirements (Long et al., 2011).
Whereas in LeMaster et al. (2017), nutrient restricted cows for the last 100 days of
gestation designed to lose 1 body condition score (BCS) produced offspring with
decreased leptin and increased cortisol concentrations at birth. In which the female
offspring to nutrient restricted dams observed increased feed consumption during a 10
week ad libitum feeding trial (Tipton et al., 2018).
Rather than incorporate a nutritional stimulus or insult during gestation,
administration of a glucocorticoid at birth has been under examination since cortisol and
leptin exhibit an inverse relationship. Glucocorticoids have been reported to decrease
leptin concentrations and may serve as a tool to alter endocrine status and associated
brain development. Previously, Long and Schafer (2013) reported that cattle had
increased leptin from about 1 to 4 days of postnatal life while cortisol is elevated at birth
then decreases over the next 5 days of life. Administration of synthetic glucocorticoids,
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such as dexamethasone, during mid-gestation increased cortisol and decreased leptin
concentrations in grand offspring (Long et al., 2013). Additionally, ruminants with
increased cortisol the first 24 to 48 hours of life had decreased plasma leptin
concentrations throughout the early postnatal period (LeMaster et al., 2017; Long et al.,
2010b; Long & Schafer, 2013; Shasa et al., 2015). Recently, use of an exogenous
glucocorticoid infusion at birth in cattle has been observed to alter leptin concentrations
from days 1 to 17 of age in early postnatal beef calves (Lewis et al., 2019). However,
further investigation is required to determine if altered leptin concentrations impact
appetite control center development during early postnatal life.
The objective of the study was to determine the effects of exogenous cortisol
administration on 1) hypothalamic development as a result of altered circulating leptin
concentrations and 2) identify the source of leptin production in postnatal ruminant
animals.
3

Materials and Methods

3.1

Animal Care and Treatments
All procedures were approved by Clemson University’s Institutional Animal Care

and Use Committee (AUP #2017-05553).
At birth, bull calves (n = 27) born from multiparous Holstein Fresian cows were
obtained from Clemson University Lemaster Dairy Center (Clemson, SC, USA). Calves
were randomly assigned into one of three treatment groups. Within 4 hours of parturition,
calf body weight (BW) was determined via a hoof circumference measuring tape
(Calfscale Company, Ames, IA, USA). Blood samples were collected using 10 mL tubes
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containing EDTA (Sarstedt, Newton, NC, USA) via jugular venipuncture prior to
treatment infusion. Calves were then given an intravenous infusion of either hydrocortisol
sodium succinate (Solu-Cortef; Pfizer, NY, USA) or sterile saline depending upon
treatment group. Dosage of cortisol infusions were based on calf body weight (BW),
where calves received 3.5 μg/kg of BW of hydrocortisol sodium succinate (low cortisol;
LC), 7.0 μg/kg of BW of hydrocortisol sodium succinate (high cortisol; HC), or a similar
volume of sterile saline as the LC treated calves (control; CON). At 24 ± 4 hours of age, a
second blood sample was collected and each calf received a second intravenous infusion
of either LC at a dosage of 1.5 μg/kg of BW, HC at a dosage of 3.0 μg/kg of BW, or
CON at a similar volume of sterile saline for a LC dosage. This dose was calculated to
mimic the biological secretion of cortisol concentrations reported in LeMaster et al.
(2017). Calves were housed similarly and fed milk replacer (28% CP, 20% fat) three
times daily with ad libitum access to water.
3.2

Blood collection
Remaining plasma blood samples were collected daily at 0600 hours from days 2

to 5 of age and were immediately placed on ice. Within 1.5 hours of blood collection,
plasma samples were centrifuged at 1800 x g for 20 minutes at 4 C. Plasma was
decanted and stored at -20 C until analysis. Serum samples were collected on day 5 prior
to harvest. Serum samples were collected in Z/9mL serum collection tubes (Sarstedt,
Newton, NC, USA). The tubes were then incubated at room temperature for 1 hour and
then overnight at 4C. After overnight incubation, serum samples were centrifuged at
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1800 x g for 20 minutes at 4 C. Serum was decanted and stored long term at -20 C until
analysis.
3.3

Tissue collection
At 100 ± 4 hours (approximately 5 days of age), calves were euthanized utilizing

an overdose of sodium pentobarbital (Beuthanasia-D Special; Schering-Plough Animal
Health, Union, NJ, USA). Immediately following euthanasia, the brain was extracted to
collect hypothalamic and pituitary samples as well as extract cerebral-spinal fluid (CSF)
from the third ventricle of the brain for quantification of leptin content and western
blotting. To determine protein expression, all adipose tissue (AT) samples were snap
frozen in liquid nitrogen and collection was performed via previously published
procedures (Long et al., 2015). Briefly, adipose samples for perirenal, omental, and
mesenteric depots were collected. Omental AT was collected close to the dorsal rumen
and the celiac artery, perirenal AT from around the left kidney close to the hylus, and
mesenteric AT was collected between the cecum and the colon. Samples, following
freezing, were stored long term at -80 C until analysis.
3.4

Hormone analysis
Plasma leptin concentrations were determined by radioimmunoassay in duplicate

in multiple assays (Multispecies leptin RIA, Linco Research, St. Charles, MO, USA)
within a single assay and sensitivity of 0.5 ng/mL using a previously validated procedure
(Long & Schafer, 2013). The CSF concentrations were determined by radioimmunoassay
in duplicate in multiple assays (Multispecies leptin RIA, Linco Research, St. Charles,
MO, USA) within a single assay. Validation of CSF analysis was performed to mimic the
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procedure of Long and Schafer (2013). Briefly, the volume of CSF was doubled and 10
samples were analyzed to be corrected back to the linear range provided by the standard
curve. A 99.1% recovery of mass was observed with a sensitivity of 0.12 ng/mL.
3.5

Western blotting
Western blot analyses were conducted according to previously established

methods (Long et al., 2012). Briefly, protein was extracted from ~ 200 mg of pulverized
perirenal (PR), omental (OM), and mesenteric (MES) AT using ice-cold lysis buffer and
a mechanical homogenizer (Tissue Tearor, Biospec Productions Inc., Bartlesville, OK,
USA). Homogenates were sonicated and clarified by centrifugation then protein
concentration determined by Bradford protein assay (Bio-Rad Laboratories, Hercules,
CA, USA). The supernatant was mixed with 2.5 × SDS sample loading buffer for a 20 µL
total loading volume per well. Protein extractions were separated by 12% miniPROTEAN TGX precast gels (Bio-Rad Laboratories, Hercules, CA, USA) followed by
transfer to a 0.2 µm nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA,
USA) for immunoblotting analyses. All blots were washed three times and incubated in a
blocking solution of 5% bovine serum albumin (BSA) in tris-buffered saline (TBS)
containing 0.1% Tween20 solution (TBST). Blots were incubated in primary antibodies
(Ab) against leptin (Ob; ab16227; abcam, Cambridge, MA, USA) and glucocorticoid
receptors (GR; ab3578; abcam, Cambridge, MA, USA) diluted in blocking solution at a
1:1000 dilution. Blots were incubated overnight at 4oC , washed in blocking solution,
followed by a 1 hour incubation at room temperature using a secondary Ab, donkey antirabbit IgG (A16035; Invitrogen, Carlsbad, CA, USA), diluted in blocking solution at a
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1:1000 dilution. Blots were washed with TBST for 5 minutes and membrane stripping
was performed via two washes of glycine (400 nm, pH 2.5) for 15 minutes each at room
temperature, followed by two PBS washes and a TBST wash for 10 minutes each.
Chemiluminescent detection was performed using a ChemiDoc MP Gel Imaging system
(Bio-Rad Laboratories, Hercules, CA, USA). Each membrane (per adipose tissue depot)
was first used for the detection of target protein, then underwent glycine stripping and
were re-probed for the housekeeping gene. Following membrane stripping, blots were
incubated in primary antibody for glyceraldehyde 3 phosphate dehydrogenase (GAPDH;
14C10; Cell Signaling Technologies, Danvers, MA, USA) diluted in a mixture of 5%
non-fat dry milk and blocking solution at a 1:1000 dilution. Blots were incubated
overnight at 4oC, washed in a 5% non-fat dry milk and blocking solution, followed by a
final 1 hour incubation at room temperature using the secondary Ab and
immunodetection as previously mentioned. A representative image of the western
blotting method previously described using AT is represented in Supplemental Figure 1.
Protein was quantified via band density measurements of the western blot. Densitometry
data for leptin and GR protein expression was normalized to a GAPDH housekeeping
protein density as follows. Background subtraction was applied to each GAPDH, Ob, and
GR sample densities. Blot normalization factors were calculated for each blot (highest
GAPDH expression value on blot/ GAPDH signal of each individual sample). Adjusted
density of each sample for Ob and GR signal was then divided by the blot normalization
factor to obtain relative protein expression.
3.6

Real time RT-PCR
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Total RNA was extracted from liquid nitrogen powdered hypothalamic tissue
using Tri®Reagent (Invitrogen, Carlsbad, CA, USA) and cleanup was performed with
E.Z.N.A RNA clean-up kit (Omega-Biotek; Norcross, GA, USA). Extracted total RNA
purity and mass was assessed using a NanoDrop One spectrophotometer (Thermo Fisher
Scientific, Wilmington, DE, USA) and visible quantification of ribosomal RNA bands by
slab gel electrophoresis. Samples exhibiting 260 nm/280 nm ratios between 1.9 and 2.1
were deemed acceptable for downstream procedures. The cDNA was synthesized using
SuperScriptTM III first-strand synthesis for RT-PCR kit (Invitorgen, Carlsbad, CA, USA).
Real-time RT-PCR was conducted using a CFX96 Touch Real-Time PCR detection
system (Bio-Rad Laboratories, Hercules, CA, USA) in which beta actin (ACTB) and
GAPDH served as housekeeping genes. In hypothalamic samples, the genes of interest
associated with neuronal growth factors and dendritic growth were: leptin (Ob), leptin
receptor (ObR), glucocorticoid receptor (GR), brain-derived neurotrophic factor (BDNF),
fibroblast growth factor -1 (FGF1), and fibroblast growth factor -2 (FGF2). All primer
pairs and products generated were verified, and accession number, primer sequences, and
product sizes for all primer combinations are given in Table 1. For qRT-PCR, pooled
RNA (1 µg) was reverse transcribed as stated above. A standard curve based on the
original mass of the RNA in the RT reaction was generated (50, 25, 12.5, 6.35, and 3.125
ng per reaction), run in duplicate, and subjected to qRT-PCR by SsoAdvanced Universal
SYBR Green SuperMix kit (Bio-Rad Laboratories, Hercules, CA, USA) using a CFX96
Touch Real-Time PCR detection system (Bio-Rad Laboratories, Hercules, CA, USA).
Primer efficiency was calculated by regression analysis. Thermal cycling conditions for
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qRT-PCR are as follows: polymerase activation and DNA denaturation at 95 oC for 30
seconds, 40 PCR cycles for 95 oC for 10 seconds and annealing temperature specific to
primer for 30 seconds as reported in Table 1. Melting curves were generated at the end of
amplification, at 50 - 95 oC at 0.5 oC increment, to verify the presence of a single product.
Data normalization was performed using the average of the housekeeping genes ACTB
and GAPDH. The cycle thresholds (CT) for housekeeping genes and all target genes were
used for normalization by repeated pair-wise correlation and regression analysis (Pfaffl et
al., 2004). Normalized CT values (Δ CT = CT,gene − CT,Housekeeping) were calculated for each
sample and fold changes in gene expression for were calculated by using the X−ΔΔCT
method, where X is the primer efficiency for each gene of interest via previously
established methods (Pfaffl et al., 2002).
3.7

Statistical analysis
Calf birth weights were analyzed via ANOVA (SAS software version 9.4, SAS

Institute, Cary, NC, USA). The model statement included treatment. Blood analysis of
plasma leptin concentrations were analyzed via MIXED procedures of SAS (SAS
software version 9.4, SAS Institute, Cary, NC, USA). The model statement included:
day, treatment, and their respective interactions. Analysis of CSF leptin concentrations
were analyzed via GLM procedures of SAS (SAS software version 9.4, SAS Institute,
Cary, NC, USA). The model statement included treatment. Individual calves served as
the experimental unit for body weight and hormone analysis. The area under the curve
(AUC) was determined using GraphPad Prism for serum leptin concentrations from d 0
to 5 of age. Pearson correlation coefficients were derived using the CORR procedure of
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SAS (SAS software version 9.4, SAS Institute, Cary, NC, USA) to analyze the
relationships between serum leptin concentrations from d 0 to 5 of age and CSF leptin
concentrations. Protein expression of mesenteric, omental, and perirenal AT were
analyzed via GLM procedures of SAS (SAS software version 9.4, SAS Institute, Cary,
NC, USA). The model statement included treatment. For qRT-PCR, expression
differences were determined by subtracting CT of target genes from the CT of averaged
housekeeping genes (ACTB and GAPDH) and the differences were analyzed via GLM
procedures of SAS (SAS software version 9.4, SAS Institute, Cary, NC, USA). The
model statement included treatment. Statistical significance was declared at P ≤ 0.05
while a tendency was declared at P ≤ 0.10.
4.4

Results

4.1

Calf morphometric measurements and hormone analysis
Calf birth weight did not differ (P = 0.750) between CON (39.2 ± 1.5 kg), LC

(40.2 ± 1.5 kg), or HC (38.5 ± 1.5 kg) treated calves. Plasma leptin concentrations of HC
and LC were decreased (P = 0.013) compared to CON, and day 0 was decreased (P <
0.001) compared to all other days of age (Figure 1). Leptin concentrations in CSF were
decreased (P = 0.005) in HC and LC were compared to CON at day 5 of age (Figure 2).
The correlation coefficients of CSF and the d 5 serum leptin concentrations from
perinatal dairy bull calves are reported in Supplemental Table 1. A moderate positive
correlation (P = 0.002) was observed for CSF and day 5 serum leptin concentrations, The
correlation coefficients of CSF and the area under the curve (AUC) of leptin
concentrations from perinatal dairy bull calves are reported in Supplemental Table 2. A
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strong positive correlation (P < 0.001) was observed for CSF and the AUC of serum
leptin concentrations from 1 to 5 days of age.
4.2

Protein expression
Western blot analysis for Ob and GR in various AT depots is shown in Figure 3.

Protein expression of Ob was decreased (P < 0.044) in the PR and OM AT of LC treated
calves compared to HC and CON while MES did not differ between treatments (P =
0.267). Protein expression of GR tended (P = 0.067) to be decreased in PR tissue of HC
treated calves compared to CON and did not differ (P > 0.665) between treatments in
other AT depots.
4.3

Gene expression
Genes of interest associated with neuronal growth factors and dendritic growth in

hypothalamic samples were Ob, ObR, GR, BDNF, FGF1, and FGF2. Mean relative
normalized expression levels of mRNA for the genes of interest in hypothalamus samples
collected at 5 days of age in calves is reported in Table 3. Hypothalamic expression of
Ob, ObR, and GR were not different between treatments (P > 0.224). However,
expression of BDNF was decreased (P = 0.003) in LC compared to CON, FGF1 was
decreased (P = 0.0004) in HC and LC compared to CON, and FGF2 was decreased (P =
0.006) in LC compared to CON hypothalamus samples.
5

Discussion

5.1

Calf morphometric measurements and hormone analysis
In the current experiment, calves were randomized per treatment group and

similar BW across treatment. Lewis et al. (2019) performed administration of
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hydrocortisol sodium succinate at 3.5 μg/kg of BW within 4 hours of birth in Angus
calves from dams of similar body condition. Birth weight was not different between
treatments (averaged 38.3 ± 1.4 kg), cortisol treated calves had decreased leptin
concentrations from 1 to 13 days of age, and no difference in BW from 60 to 150 days of
age. Limited research has been performed on exogenous glucocorticoid administration
and postnatal leptin secretion in beef cattle. Previously, administration of a synthetic
glucocorticoid, dexamethasone, in perinatal dairy calves at 15 μg/kg of BW did not alter
leptin concentrations from 1 to 4 days of age (Blum et al., 2005). However, in the Blum
et al. (2005) study, calves were supplemented dexamethasone (DEX) in their colostrum
and may not have elicited an effect based on the amount of DEX that traversed the
gastrointestinal tract to the general circulation. In lambs, infusion of exogenous cortisol
at birth and 24 hours of life resulted in decreased leptin concentration in a dose dependent
manner (362 µg/mg; Ford et al., 2015). Transfer of leptin from the peripheral blood to
CSF occurs within the choroid plexus of the brain (within the third ventricle). The ARC
lies adjacent to the median eminence, which contains hypothalamic glia that lines the
third ventricle, and serves as the CSF barrier. Peripheral blood that has entered through
the pituitary portal system is filtered by the blood-CSF barrier. In the current study, both
peripheral blood and CSF concentrations of leptin were decreased by glucocorticoid
treatment, irrespective of dosage. Furthermore, a strong positive correlation was observed
for CSF leptin concentrations and the AUC of circulating leptin concentrations from 1 to
5 days of age.
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Adam and Findlay (2010) utilized an obese sheep model to determine if leptin
resistance was due to decreased blood-brain leptin transfer or hypothalamic insensitivity.
Briefly, sheep were sorted by leanness (obese versus lean) as well as administered leptin
(0.5 mg leptin / kg BW) via intracerebroventricular (ICV) cannulae to detect leptin
concentrations in blood and CSF. Obese animals did not differ in leptin sensitivity of the
brain, but impaired leptin transport across the blood-brain barrier was observed (BBB;
Adam & Findlay, 2010). Leptin resistance may be induced by lack of downstream
signaling of leptin binding to neuronal receptors as a means of inducing obesity
(associated with impaired leptin signaling) or decreased efficiency of BBB leptin
transporters (Szczesna & Zeiba, 2015). Disrupted signal transduction pathways may be
due to uncoupled leptin from ObR due to increased plasma leptin concentrations as
observed in obese patients (Ahima and Flier, 2000). Ishida-Takahasi et al. (2004)
performed a similar experiment in rodents in which animals received a dexamethasone
ICV infusion prior to a leptin ICV infusion. Observations of the study included the
antagonistic action of dexamethasone on leptin via impaired leptin-induced signaling
pathways JAK/STAT and MAPK signaling cascades (Ishida-Takahasi et al., 2004).
Overall, reduced leptin concentrations in circulation would lead to reduced leptin to
traverse the BBB (reduced CSF concentrations), suggesting that leptin concentrations in
the brain would be depressed and, thus, diminish the amount of influence it would have
on brain development during early postnatal life as well as potentially impaired signaling
pathways. However, more experimentation is required to fully understanding the blood-
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CSF transfer and the effects on downstream intracellular leptin signaling pathways in
hypothalamic development in cattle.
5.2

Protein expression
Both Ob and ObR have been previously detected in AT depots and hypothalamus

samples in dairy cattle (Chalikani, Glimm, & Kennelly, 2003), which supports the idea
that leptin may have multiple physiological functions in cattle. Conversely, Ji et al.
(2009) did not observe Ob expression in the brain of beef cattle. Bovine adipose tissue
treated with dexamethasone (100 nM) in vitro exhibited stimulated Ob expression
(Houseknecht et al., 2000). Conversely, ad libitum feeding in late gestation reduces Ob
expression in ovine adipose tissue (Bispham et al., 2003). Under normal conditions, Ob
and ObR expression in AT depots were characterized as having similar expression among
adipose depots in dairy cattle (Chalikani, Glimm, & Kennelly, 2003). In the current
study, Ob was decreased and GR tended to be decreased in PR adipose samples.
Compared to other AT depots in the current study, PR adipose may play a role in the
leptin signaling cascade. In which glucocorticoid administration binds to receptors found
on PR tissue, decreasing leptin production. This may be due to the fact that PR is the
largest depot present at the time of collection in the early postnatal calves. While OM is
functional during early postnatal life, due to its role in thermoregulation, it may not be
sensitive or mature enough to respond to the glucocorticoids. Conversely, while
subcutaneous tissue is also associated with thermoregulatory action, it is present in
limited quantities at the time of birth and may not support leptin production. Overall, this
supports the hypothesis that PR adipose is the source of leptin production in postnatal
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ruminants that contributes to increased leptin circulation previously observed by Long
and Schafer (2013).
5.3

Gene expression
As previously mentioned, the connection and development of neuronal circuitry

in the brain that play a role in appetite regulation are still forming during the first few
days of postnatal life in ruminant species. The greatest expression of ObR has been
observed in the central nervous system of monogastric species (Fruhbeck, 2001).
However, the current study utilized a single form of the leptin receptor rather than
separating into the short form (ObRa) or long form (ObRb). This is due to the fact that
while only the long form has been observed to be fully functional and contribute to the
effectiveness of leptin signaling (Tartaglia, 1997), the short form of the receptor has been
observed to contribute to leptin transport (Hileman et al., 2002) and catecholamine
synthesis (Yanagihara et al., 2000). Additionally, expression of the Ob gene has been
observed to serve as a more relevant index associated with body fat content compared to
ObRb expression in cattle (Ren et al., 2002). In the current study, expression of Ob did
not differ due to treatment meaning that local hypothalamic expression was not altered,
which may be due to the fact that Ob and ObR are already highly expressed in the brain
(Tartaglia, 1997). These genes may not be affected by treatment differences due to the
body trying to maintain homeostasis as leptin is associated with metabolic regulation and
energy expenditure. Similar profiles arehave been observed in human and animal obesity
models in which decreased leptin expression is a result of increased adipose Ob mRNA
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and serum leptin levels (Maffei et al., 1995; Frederich et al., 1995; Considine et al., 1996;
Hamilton et al., 1995; Lonnqvist et al., 1995).
Similar to the response observed for Ob and ObR, GR expression in the
hypothalamus did not differ in the current study. In the literature, most administration
models for glucocorticoids in livestock species are performed during gestation. As
glucocorticoids are primarily associated with the maturation of specific fetal tissues
during late gestation and the findings of Liggins (1969) in which synthetic glucocorticoid
administration improved mortality and morbidity of premature sheep offspring relative to
lung maturation. Ovine and rodent models of maternal synthetic glucocorticoid
administration (dexamethasone and betamethasone, respectively) during gestation altered
GR mRNA expression throughout adulthood of subsequent offspring (Levitt et al., 1996;
Sloboda et al., 2008). Known models of maternal undernutrition in sheep reported altered
pituitary and adrenal GR, hypothalamic corticotropic releasing hormone, and
adrenocorticotropin hormone mRNA abundance (McMillon and Robinson, 2005;
Fowden et al., 2005).While known ovine and rodent models of maternal synthetic
glucocorticoid administration (dexamethasone and betamethasone, respectively) during
gestation reported altered GR mRNA abundance throughout adulthood of subsequent
offspring (Levitt et al., 1996; Sloboda et al., 2008). However, unaltered glucocorticoid
abundance in the brain may be beneficial for the health of the animal as permanently
altered GR abundance may negatively impair and the hypothalamo-pituitary-adrenal-axis
(HPAA) and associated stress response. The HPAA is susceptible to stress-induced by

209

the maternal environment which impairs responsiveness in adulthood (Bloomfield et al.,
2003; Fisher et al., 2010).
In the current study, hypothalamic gene expression of BDNF, FGF1, and FGF2
were decreased in cortisol treated calves compared to control calves. Brain derived
neurotrophic factor (BDNF), is a protein that promotes differentiation (Binder &
Scharfman, 2004), maturation (Acheson et al., 1995), maintenance of neurons (Huang &
Reichardt, 2001), and stimulates neurogenesis during development (Zigova et al., 1998;
Benraiss et al., 2001). Exogenous supplementation of BDNF in tissue cultures increased
dendritic length as well as modulated specific branching and growth patterns, but only
when neurons were active enough to respond to the action of BDNF (Bus et al., 2011;
Pillai et al., 2012; Hofer & Barde, 1998). While fibroblast growth factors (FGF) stimulate
and differentiate various endothelial cells, such as mesoderm- and neuroectoderm-derived
cells, as well as promote cell migration. Both acidic (FGF1/FGFa; Gospodarowicz,1975)
and basic (FGF2/FGFb; Gospodarowicz, 1974) forms of FGF play a role in endothelial
cell development. Acidic FGF has only been detected in the brain and retina (Lobb &
Fett, 1984; Baird et al., 1985; Bohlen et al., 1984; Thomas et al., 1985), whereas basic
FGF has been found in the central nervous system and peripheral tissues.
Both BDNF and FGFs are associated with development of neuronal circuitry that
impact appetite regulation. For example, formation of ARC projections (Martin-Gronert
and Ozanne, 2005) is concomitant to elevated circulating leptin concentrations (Yura et
al., 2005) in mice. Centers of the brain, such as the ARC, contain neurons that traverse
the blood-brain barrier and come in contact with the blood stream. The ARC responds to
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leptin (Martin-Gronert and Ozanne, 2005) and expressed NPY, Agrp, and POMC as a
means to regulate energy expenditure. Maternal nutrient restriction in rats inhibits the
formation of ARC projections (Delahaye et al., 2008), potentially due to a repressed
leptin surge. Conversely, the leptin surge is amplified and prolonged in offspring of
obese rats (Kirk et al., 2009) while a premature surge can increase the density of ARC to
paraventricular nucleus (PVN) projections (Lee and Blackshaw, 2014).
It has previously been speculated that glucocorticoids interact with BDNF to
affect central nervous system function (Numakawa et al., 2013). Rodents that underwent
chronic restrain test did not show altered BDNF or BDNF receptor expression, however,
BDNF-induced glutamate release was decreased (Chiba et al., 2012). Reduced interaction
with the BDNF receptor, tropomyosin receptor kinase B (TrkB) was observed following
glucocorticoid exposure to cortical neurons of rodents (Kumamaru et al., 2011).
Numakawa et al. (2009) determined that GR association to TrkB plays a role in BDNFstimulated signaling. Interestingly, Longenecker et al. (1982) reported that growths of
primary bovine endothelial cells were not influenced by glucocorticoids in the absence of
FGF. Moreover, bovine smooth muscle cells were inhibited by glucocorticoids; however,
glucocorticoid inhibition was prevented when FGF was added to the culture
(Longenecker at al., 1982). Additionally, the activity of FGF on DNA synthesis was
inhibited in adrenal cell lines when treated with glucocorticoids (Gospodarowicz et al.,
1975). As the literature is lacking, more experimentation is required to elucidate the
mechanism of glucocorticoids on neuronal growth factors in the ruminant brain and their
effects on early postnatal growth and development.
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Exogenous cortisol administered to perinatal dairy bull calves reduced leptin
concentrations in serum and CSF, decreased protein expression of leptin in perirenal and
omental AT, and altered gene expression in hypothalamic tissue. The administration of
glucocorticoids decreased circulating leptin concentrations, which then reduced
expression of genes associated with neuronal development of appetite control centers in
the hypothalamus. This information leads to the speculation that reduced appetite center
development in the hypothalamus could lead to increased feed intake later in life due to
diminished neuronal regulation of appetite and satiety. The authors’ believe this to be the
first study of exogenous glucocorticoid administration in cattle to observe altered brain
development during early postnatal life. Further investigation is necessary to determine if
glucocorticoid administration can be utilized as a tool to improve feed intake of cattle
later on in life due to hypothalamic programming at birth.
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Table 4.1. Primers used for RT-PCR of genes of interest associated with dendritic and
synaptic development in hypothalamus samples collected at 5 days of age from calves
intravenously infused with either a low cortisol (LC; n = 9, 3.5 ug/kg of BW), high
cortisol (HC; n = 9, 7.0 ug/kg of BW), or a sham infusion control (CON; n = 9, similar
volume of saline).
Gene

Primer1 Sequence (5’ – 3’)

Leptin
F
TTCCCTCTACTCCACCGAGG
Leptin
R
GGACTTTGGGAAGAGAGGCC
Ob2
F
CTGCTCCCCCAGAAAGACAG
Ob
R
GCTGAGCTGACATTGGAGGT
GR3
F
CAACTCACACCTACGCTGGT
GR
R
TTGCCTTTGCCCATTTCACG
4
BDNF
F
TACCTGGATGCCGCAAACAT
BDNF
R
CGACATGTCCACTGCAGTCT
5
FGF1
F
AGGGATTCCAATGGCAAGGG
FGF1
R
TCCTGCTGCTGAATGACCAG
6
FGF2
F
CACGACTGAGCGACTTCACT
FGF2
R
GACCCCATAGACAGCAGCTC
7
ACTB
F
CTCTTCCAGCCTTCCTTCCT
ACTB
R
GGGCAGTGATCTCTTTCTGC
8
GAPDH
F
GGGGTCATCATCTCTGCACCT
GAPDH
R
GGTCATAAGTCCCTCCACGA
1
F, forward; R, reverse
2
Leptin Receptor (Ob)
3
Glucocorticoid receptor (GR)
4
Brain-derived neurotrophic factor (BDNF)
5
Fibroblast growth factor-1 (FGF1)
6
Fibroblast growth factor-2 (FGF2)
7
Beta-actin (ACTB)
8
Glyceraldehyde 3 phosphate dehydrogenase (GAPDH)
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Length
(bp)
123

Annealing temp
(oC)
60
65

163

60

134

60

166

60

103

55

178

55

176

55

Table 4.2. Mean relative normalized expression levels of mRNA for the genes of interest
in hypothalamus samples collected at 5 days of age from calves intravenously infused
with either a low cortisol (LC; n = 9, 3.5 ug/kg of BW), high cortisol (HC; n = 9, 7.0
ug/kg of BW), or a sham infusion control (CON; n = 9, similar volume of saline).
Treatment
P-Value
CON
HC
LC
SE
Trt
n
9
9
9
Leptin
11.99
5.32
9.85
3.18
0.333
Ob1
1.43
1.58
2.12
0.47
0.188
2
GR
1.74
1.51
2.89
0.31
0.224
BDNF3
1.67
1.43
3.50
0.41
0.003
4
FGF1
0.87
2.34
4.79
0.73
0.0004
FGF25
4.48
2.50
12.49
1.91
0.006
a,b
Means differ P < 0.05; Data are given as a mean ΔCT normalized to housekeeping gene
expression. Higher values indicate lower gene expression.
1
Leptin receptor (Ob)
2
Glucocorticoid receptor (GR)
3
Brain-derived neurotrophic factor (BDNF)
4
Fibroblast growth factor-1 (FGF1)
5
Fibroblast growth factor-2 (FGF2)
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Table 4.3. Correlation matrix showing Pearson’s r for CSF and d 5 serum leptin
concentrations of samples collected at 5 days of age from calves intravenously infused
with either a low cortisol (LC; n = 9, 3.5 ug/kg of BW), high cortisol (HC; n = 9, 7.0
ug/kg of BW), or a sham infusion control (CON; n = 9, similar volume of saline).
P- value
Item
CSF
d 5 serum
CSF
1.000
0.559*
d 5 serum
0.559*
1.000
*Indicates a P < 0.003
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Table 4.4 Correlation matrix showing Pearson’s r for CSF and AUC1 for leptin
concentrations of samples collected at 5 days of age from calves intravenously infused
with either a low cortisol (LC; n = 9, 3.5 ug/kg of BW), high cortisol (HC; n = 9, 7.0
ug/kg of BW), or a sham infusion control (CON; n = 9, similar volume of saline).
P-value
Item
CSF
AUC
CSF
1.000
0.679**
AUC
0.679**
1.000
1
Area Under the Curve (AUC)
**Indicates a P < 0.001
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Figure 4.1. Representative western blotting image to demonstrate primary antibody
specific to leptin and glucocorticoid receptor (GR) in adipose tissue. Leptin was detected
at approximately 16 kDa in all tissues, GR was detected at approximately 86 kDa, and
GAPDH was detected at approximately 37 kDa.
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Figure 4.2. Leptin radioimmunoassay results of serum samples collected from 0 to 5
days of age from calves intravenously infused with either a low cortisol (LC; n = 9, 3.5
ug/kg of BW), high cortisol (HC; n = 9, 7.0 ug/kg of BW), or a sham infusion control
(CON; n = 9, similar volume of saline). (*) indicates P < 0.05
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Figure 4.3. Leptin radioimmunoassay results of cerebral-spinal fluid (CSF) samples
collected at 5 days of age from calves intravenously infused with either a low cortisol
(LC; n = 9, 3.5 ug/kg of BW), high cortisol (HC; n = 9, 7.0 ug/kg of BW), or a sham
infusion control (CON; n = 9, similar volume of saline). (a,b) indicates means differ P <
0.05
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Figure 4.4. Western blotting analysis of adipose tissue samples collected at 5 days of
age from calves intravenously infused with either a low cortisol (LC; n = 9, 3.5 ug/kg of
BW), high cortisol (HC; n = 9, 7.0 ug/kg of BW), or a sham infusion control (CON; n =
9, similar volume of saline). Protein quantifies via band densitometry of the western blot
and densities normalized to glyceraldehyde 3 phosphate dehydrogenase (GAPDH)
content within each sample. *Means ± SEM differ (P < 0.05) **Means ± SEM tend to
differ (P < 0.10)
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CHAPTER V
EFFECT OF EXOGENOUS GLUCOCORTICOID INFUSION ON LEPTIN
CONCENTRATIONS AND VOLUNTARY FOOD INTAKE IN POSTNATAL
BEEF CALVES
1

Abstract
The objective of this studt was to determine the effects of exogenous cortisol

administration on leptin concentrations and feed intake of postnatal beef calves. Angus
(AN) and AN crossbred cows (n = 62) of similar age, parity and body condition score
(BCS) were bred using a 7 day Co-Synch and CIDR artificial insemination (AI) protocol
and bred to commercial semen from two AN sires. Transrectal ultrasonography was
performed at 30 days of gestation to confirm pregnancy to AI. Non-pregnant animals
were exposed to natural service to one of two AN bulls. Following natural calving within
four hours of parturition (day 0), calves (n = 62) were weighed and randomly assigned to
treatments. Each calf was intravenously infused with either a low cortisol (LC; n = 22,
3.5 ug/kg body weight (BW)), high cortisol (HC; n = 20, 7.0 ug/kg BW), or sham
infusion control (CON; n = 20, similar volume of saline), then a second infusion of its
respective treatment 24 hours postpartum at 1.5 ug/kg BW, 3.5 ug/kg BW, and similar
volume of saline, respectively. Blood was collected via jugular venipuncture before
infusion and daily from days 0-17 of age to be analyzed for leptin concentrations using a
validated radioimmunoassay. Animal BW was collected every 14 days from day 0 until
the end of the study. Heifers (n = 30; 367 ± 4 days of age) and steers (n = 32; 385 ± 4
days of age) entered a Growsafe system to measure feed intake (FI) and were allowed a 2
week adjustment period to a commercial ration of each respective diet. Heifer BCS was
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collected at the beginning and end of the trial. Heifers were fed for 70 days and steers
until they obtained a 12th rib back fat (BF) thickness of 1.15cm. Data was analyzed via
ANOVA or repeated measures using appropriate models of SAS. Serum leptin
concentrations exhibited a treatment by day interaction (P = 0.003), in which HC and LC
were decreased compared to CON from days 2-17 of age. Calf birth BW and adjusted
205 day BW did not differ (P > 0.056) between treatments. Heifer BW gain, BCS
change, and number of feed events were increased (P = 0.001) in LC compared to HC
and CON. Steers did not differ between treatments (P > 0.080) in BW, BW gain, or BF
thickness. However, LC steers had greater daily FI (P = 0.047), tended to have greater
final BW (P = 0.080), and required fewer days on feed to achieve comparable finish
compared to HC and CON steers. In summary, exogenous cortisol administered to calves
at parturition reduced leptin concentrations and improved FI of beef steers during a
feeding trial.
Key words: exogenous glucocorticoid, leptin, feed intake, GrowSafe, postnatal calves
2

Introduction
Profitability in beef cattle production may be influenced by voluntary feed intake

and the neuronal circuitry that regulate it. Leptin is associated with suppression of
appetite and long term food intake and promotes development of appetite control centers
of the brain during early postnatal development (Yura et al., 2005). Formation of
neuronal circuitry occurs during the perinatal period (Bouret et al., 2006), which is
concomitant to when cattle exhibit increased leptin at about 1 to 4 days of postnatal life
(Long & Schafer, 2013). Disruption of leptin feedback regulation may alter body weight
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and the regulation of energy maintenance which may lead to the onset of obesity.
Maternal nutrient restriction during gestation has been associated with altered leptin
concentrations during early postnatal life as well as its impact on feed consumption and
body composition of subsequent offspring in adulthood. Increased leptin concentrations
were absent within the first 11 days of life in lambs born to obese ewes Long et al.
(2010a) fed at 150% of NRC Requirements (NRC, 2000). The offspring born to obese
ewes consumed more feed during a 12 week ad libitum feeding trial and ate
approximately 10% more feed compared to offspring born to control fed ewes (Long et
al., 2010b). LeMaster et al. (2017) observed that nutrient restricted cows (last 100 days of
gestation designed to lose 1 body condition score; BCS) produced offspring that had
decreased leptin and increased cortisol concentrations at birth. Similar to the obese sheep
study, female offspring born to late gestation nutrient restricted dams consumed more
feed during a 10 week ad libitum feeding trial had increased body weight gain (as a % of
initial body weight) compared to offspring born to control fed cows (Tipton et al., 2018).
Other models have incorporated administration of glucocorticoids due to an
inverse relationship of cortisol and leptin. Increased circulating leptin concentrations
from 1 to 4 days of postnatal life were observed in beef calves (Long & Schafer, 2013).
Elevated cortisol levels were observed at birth then decreased over the next 5 days of life
(Long & Schafer, 2013). Increased cortisol concentrations during the first 24-48 hours of
life is concomitant to decreased plasma leptin concentrations during the early postnatal
period in ruminants (LeMaster et al., 2017; Long et al., 2010b; Long & Schafer, 2013;
Shasa et al., 2015). Blood profiles have also been examined in sheep administered

233

synthetic glucocorticoids (dexamethasone) in which treatment increased cortisol and
decreased leptin concentrations in sheep (Long et al., 2012a). Female offspring at 1 year
of age had increased appetite, weight gain, and adiposity when put on a feeding challenge
(Long et al., 2012b). As glucocorticoids have been reported to decrease leptin
concentrations, administration at birth may serve as a tool to improve voluntary feed
intake in adulthood. Exogenous glucocorticoid administration at birth depressed plasma
leptin concentrations from days 1 to 17 of age in postnatal beef calves (Lewis et al.,
2019). Recently, administration of an exogenous glucocorticoid during the first four
hours was observed to alter appetite control center development in perinatal dairy bull
calves (McCarty et al., 2021). The objective of the study was to determine the effects of
exogenous cortisol administration on leptin concentrations relative altered voluntary feed
intake in postnatal beef calves.
3

Materials and Methods

3.1

Animal Care and Treatments
All procedures were approved by Clemson University’s Institutional Animal Care

and Use Committee (AUP #2017-05553).
Angus and Angus crossbred cows (n = 90) of similar age, parity and body
condition score (BCS) were selected for this study. Cow age ranged from 3 to 8 years old
and BCS ranged from 5 to 7.5. All animals were bred using a 7 day Co-Synch and CIDR
artificial insemination (AI) protocol. Briefly, Angus (AN) and AN-cross cows (n = 90)
received an EAZI-Breed CIDR implant and a single100 µg intramuscular (IM) injection
of GnRH (Zoetis Animal Health, New York, NY, USA). CIDR’s were removed after 7
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days and a 25 mg I.M. injection of PGF2α (Zoetis Animal Health, New York, NY, USA)
was delivered. Following PGF2α injection, estrus was assessed at 0700 hours and 1700
hours and insemination occurred 12 hours after observed estrus. If no estrus was detected,
cows were inseminated 60 hours following PGF2α injection and administered a second
100 µg IM injection of GnRH (Zoetis Animal Health, New York, NY, USA). All cows
were inseminated using conventional semen from two AN sires. Approximately 14 days
later, cows are exposed to two AN sires for natural service (NS). At approximately 55
days post-AI, all cows underwent transrectal ultrasonography (Aloka 500-V with 7.5MHz probe, Corometrics Medical Systems, Wallingford, CT, USA) to determine
pregnancy to AI or NS. All cows allotted for the study were allowed to calve naturally.
At birth, calves (n = 32 males; n = 30 females) were allotted into treatment groups
based on sex. Within 4 hours of parturition, calf body weight (BW) was determined via a
hoof circumference measuring tape (Calfscale Company, Ames, IA, USA). Blood
samples were collected using 6 mL blood collection syringes containing EDTA
(Starstedt, Newton, NC, USA) via jugular vein prior to treatment infusion. Calves were
then given an intravenous infusion of either hydrocortisol sodium succinate (Solu-Cortef;
Pfizer, NY, USA) or sterile saline depending upon treatment group. Dosage of cortisol
infusions were based on calf BW, where calves received 3.5 μg/kg of BW of
hydrocortisol sodium succinate (low cortisol; LC), 7.0 μg/kg of BW of hydrocortisol
sodium succinate (high cortisol; HC), or a similar volume of sterile saline as the LC
treated calves (control; CON). At 24 ± 4 hours of age, a second blood sample was
collected and each calf received a second intravenous infusion of either LC at a dosage of
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1.5 μg/kg of BW, HC at a dosage of 3.0 μg/kg of BW, or CON at a similar volume of
sterile saline for a LC dosage. This dose was calculated to mimic the biological secretion
of cortisol concentrations reported in LeMaster et al. (2017).
3.2

Calf management
All male calves (n = 32) were castrated at 17 days of age following blood

collection and implanted with Ralgro (Merck; Readington Township, NJ, USA) then
received a second implant at (173.3 ± 19.0 d of age) in the opposite ear. Calf BW (heifer
and steer calves) was collected biweekly using a scale mounted beneath a squeeze chute
and adjusted to days 30, 60, 90, 120, 150 and 180 BW using standard Beef Improvement
Federation guidelines (2010) without using the age of dam adjustments. All calves were
vaccinated at 150.2 ± 20.4 and 208.2 ± 20.4 days of age via manufacturer’s instructions:
Bovi-Shield GOLD (FP 5 modified live virus; Zoetis, Kalamazoo, MI, USA) and
Clostridium Chauvoei-Septicum-Novyi_Sordelli-Perfingens Types C & D Bacterin
Toxoid (Ultrabac 7; Zoetis, Kalamazoo, MI, USA). During this time, all calves were also
administered Noromectin (Ivermectin; Norbrook Lab limited; Newry Co. Down,
Northern Ireland) as per manufacturer’s instructions. All calves were weaned via abrupt
separation from their dams at approximately 7 months of age (217.2 ± 20.4 days of age)
and placed into a single feedlot pen per sex. During weaning, calves were offered a
commercial complete feed at 13.0% crude protein (CP; CPC Commodities, Cowpens,
SC, USA). Following weaning, calf BW was collected biweekly as previously mentioned
and adjusted to days 205, 235, 265, 295, 325, and 355 BW using standard Beef
Improvement Federation guidelines (2010) without age of dam adjustment.
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Heifers (n = 30) at 367 ± 4 days of age were sorted randomly into one of two pens
(15.2 m x 258.47 m). Over a period of two weeks, all animals were adjusted to a
commercial total mixed ration (0.4 Mcal NEm/kg, 0.2 Mcal NEg/kg and 14.7% CP; all on
DM basis) previously described by Tipton et al. (2018). Feed intake was monitored for a
10-week period utilizing an automated feeding behavior data acquisition system
(GROWSAFE Systems, Airdrie, Alberta, Canada) with three nodes per pen. Feed intake
(FI) was continuously measured based on the weight difference of the feed bunk
(accuracy 0.01 kg) at the beginning and end of each feeding event for each individual
animal as determined by unique electronic ear tag worn by each heifer. A feeding event
was defined as the electronic identification tag of the animal being read at the bunk of a
single scale without an absence in reading of that tag for more than 300 seconds (5
minutes). Additionally, a single feeding event constitutes that the animal was not
interrupted by a different animal feeding at the same scale. This reflects continuous
feeding of the animal at the same scale or bunk in a feedlot setting. Nodes were filled at
0600 and again at 1800 hours daily. Initial BW was calculated as the average of BW
collected over two consecutive days (day 0 and 1 relative to the start of the feeding trial).
Biweekly BW and blood samples were taken for a period of 10 wk at 0600 hr. During the
10 week feeding period, BCS was collected at the beginning and end of the feeding trial.
Final BW was calculated as the average of BW collected over two consecutive days (days
69 and 70 relative to the start of the feeding trial).
Similarly, steers (n = 32) at 385 ± 4 days of age were sorted randomly into one of
two pens (15.2 m x 258.47 m). Over a period of two weeks, all animals were adjusted to a
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total mixed ration in which composition and nutrient analysis of the ration are given in
Table 1. Feed intake was monitored utilizing an automated feeding behavior data
acquisition system (GROWSAFE Systems, Airdrie, Alberta, Canada) with three nodes
per pen. Steers were re-implanted with Revalor-S (Merck; Readington Township, NJ,
USA) at day 0 of the feeding trial to mimic commonly accepted management practices.
Initial BW was calculated as the average of BW collected over two consecutive days (day
0 and 1 relative to the start of the feeding trial). Biweekly BW and blood samples were
taken at 0600 hours for the duration of the feeding trial. Steers were maintained on the
feeding trial (approximately 110 to 140 days) until steers averaged a 12th rib back fat
thickness of 1.15 cm. Back fat thickness was collected on days 70, 98, 112, 126, and 140.
Back fat thickness was evaluated via ultrasonography (Aloka 500-V with 5-MHz linear
probe, Corometrics Medical Systems, Wallingford, CT, USA) on the 12th rib on the right
thoracic side of the animal. Once steers achieved minimum back fat thickness, they were
sent to a local abattoir and carcass characteristics collected (i.e. yield grade (YG),
marbling score (MS)). Final BW was calculated as the average of BW collected over two
consecutive days: the day they ended the trial and were transported to the abattoir and hot
carcass weight (HCW) collected. At the time of final BW collection, final hip height was
collected for steers. Length of the trial was recorded for each animal (day of trial) and
average daily gain (ADG) calculated.
3.3

Blood collection
Blood samples were collected daily at 0600 h from d 2-5 of age, then every other

day from d 7 to 17 of age. Once animals entered the feeding trial, blood samples were

238

collected biweekly at 0600 h from d 0 (relative to the start of the trial) to the end of the
trial (d 70 for heifers and d 110 to 140 for steers). Plasma samples were collected in 10
mL tubes containing Ethylenediaminetetraacetic acid (EDTA; Sarstedt, Newton, NC,
USA) and immediately placed on ice. Within 1.5 h of blood collection, plasma samples
were centrifuged at 1800 x g for 20 min at 4 C. Plasma was decanted and stored at -20
C until analysis. Serum samples were collected in Z/9mL serum collection tubes
(Sarstedt, Newton, NC, USA). The tubes were then incubated at room temperature for 1 h
and then overnight at 4C. After overnight incubation, serum samples were centrifuged at
1800 x g at 4C for 20 min. Serum was decanted and stored long term at -20C until
analysis.
3.4

Biochemical assays
Serum leptin concentrations were determined by radioimmunoassay in duplicate

in multiple assays (Multispecies leptin RIA, Linco Research, St. Charles, MO, USA) with
a sensitivity of 0.5 ng/mL using a previously validated procedure (Long & Schafer,
2013). Plasma glucose concentration was measured colorimetrically in triplicate (Liquid
Glucose Hexokinase, Reagent, Pointe Scientific, Canton, MI, USA) via a previously
validated procedure (Long & Schafer, 2013).
3.5

Statistical analysis
Calf birth weights and biweekly BW measurements were analyzed via repeated

measures of ANOVA (SAS software version 9.4, SAS Institute, Cary, NC, USA). The
model statement included: sex, day, treatment, sire, and their respective interactions.
Blood analysis of serum leptin concentration were analyzed via repeated measures of
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ANOVA (SAS software version 9.4, SAS Institute, Cary, NC, USA). The model
statement included: day, treatment, sire, and their respective interactions. Individual
calves served as the experimental unit for body weight and hormone analysis. Blood
analysis of plasma glucose concentration was analyzed via repeated measures of
ANOVA (SAS software version 9.4, SAS Institute, Cary, NC, USA). The model
statement included: sex, pen, day, treatment, sire, and their respective interactions. All
GrowSafe data was analyzed via repeated measures of ANOVA (SAS software version
9.4, SAS Institute, Cary, NC, USA). The model statement included: sex, pen, day,
treatment, sire, and their respective interactions. Sire was initially included in the
previous models, found to be insignificant (P > 0.05) and removed from the model.
Statistical significance was declared at P ≤ 0.05 while a tendency was declared at P ≤
0.10.
4

Results

4.1

Calf morphometric measurements
Calf birth weight did not differ (P = 0.556) between CON (38.7 ± 1.2 kg), LC

(37.4 ± 1.2 kg), or HC (39.1 ± 1.2 kg) treated calves. Male calves were heavier (40.1 ±
1.0 kg) then female calves (36.7 ± 1.0 kg) at birth. Adjusted d 205 weaning weight did
not differ (P = 0.790) between CON (239.9 ± 6.0 kg), LC (239.1 ± 5.9 kg), or HC (234.5
± 5.8 kg) treated calves and did not differ due to sex (P = 0.948). However, sire tended (P
= 0.071) to influence weaning weight as calves born to the natural service sires were
heavier (244.1 ± 5.7 kg) then calves born to the sires used for AI (231.2 ± 4.0 kg).
4.2

Leptin analysis
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There was a treatment by day interaction for serum leptin concentrations (P =
0.003) in which treatments did not differ at day 0 and 1 then HC and LC were decreased
(P < 0.0001) compared to CON from days 2 to 17 of age (Figure 1).
4.3

Heifer feeding performance
Heifer performance during the 10 week GrowSafe feeding trial is reported in

Table 2. Initial and final BW did not differ (P > 0.204) between treatments; however, BW
gain was greatest (P = 0.0001) in LC compared to HC and CON. Initial BW tended to be
influenced by sire (P = 0.055) in which heifers from AI sires were heavier (424.1 ± 8.1
kg) than heifers from natural service sires (399.6 ± 10.7 kg) at the beginning of the
feeding trial. Sire tended (P = 0.075) to influence BW gain as heifers born to the natural
service sires gained more weight (88.5 ± 3.8 kg) then heifers from the sires used for AI
(80.4 ± 2.9 kg). Initial BCS tended to be decreased (P = 0.086) in LC and HC compared
to CON heifers. Final BCS and BCS change were increased (P = 0.044 and P = 0.034,
respectively) in LC compared to HC and CON heifers.
Heifer feeding behavior during the 10 week GrowSafe feeding trial is reported in
Table 3. The total number of feed events during the feeding trial was greater (P = 0.016)
in LC heifers compared to HC and CON heifers. Total feed consumed during the trial
tended to be greater (P = 0.093) in LC and HC compared to CON heifers. However,
average feed intake during feeding events did not differ (P = 0.606) between treatments.
As previously mentioned, a feeding event was defined as the electronic identification tag
of the animal being read at the bunk of a single scale without an absence in reading of
that tag for more than 300 sec (5 min). Additionally, a single feeding event constitutes
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that the animal was not interrupted by a different animal feeding at the same scale. This
reflects continuous feeding of the animal at the same scale or bunk in a feedlot setting.
4.4

Steer feeding performance
Steer performance during the GrowSafe feeding trial is reported in Table 4. Initial

BW did not differ (P = 0.296) between treatments and final BW tended to be greatest (P
= 0.080) in LC compared to HC and CON steers. Initial BW was influenced by sire (P =
0.010) in which steers from AI sires were heavier (446.6 ± 7.5 kg) than steers from
natural service sires (406.8 ± 12.0 kg) at the beginning of the feeding trial. Similarly,
final BW was influenced by sire (P = 0.032) in which steers from AI sires were heavier
(632.3 ± 7.5 kg) than steers from natural service sires (599.8 ± 12.1 kg) at the end of the
feeding trial. Days on feed, or the duration of the feeding trial for steers until they
achieved a BF thickness of 1.15cm, did not differ (P = 0.281) between treatments.
However, it is interesting to note that while statistically there are no treatment
differences, numerically the LC steers require fewer days on feed compared to HC and
CON steers. Lastly, BF thickness (P = 0.160) and hip height (P = 0.134) did not differ
between treatments.
Steer feeding behavior collected during the GrowSafe feeding trial is reported in
Table 5. Total feed consumed during the trial did not differ (P = 0.252) between
treatments. Additionally, average feed intake during feeding events did not differ (P =
0.228) between treatments. However, daily feed intake was greatest (P = 0.039) in LC
compared to HC and CON steers. Steer carcass characteristics during the GrowSafe
feeding trial is reported in Table 6. Steer HCW was greater (P = 0.019) in LC compared
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to HC and CON steers while YG (P = 0.640), MS (P = 0.371), and feed consumed per
HCW (P = 0.472) did not differ between treatments.
4.5

Glucose concentrations during the feeding trials
Plasma glucose concentrations in heifers did not differ due to treatment (P =

0.991) and decreased over time (P = 0.014: Figure 2). Plasma glucose concentrations in
steers was greater (P = 0.038) in LC compared to HC and CON steers and changed over
time (P = 0.044; Figure 3).
5

Discussion

5.1

Calf morphometric measurements
Lewis et al. (2019) performed administration of hydrocortisol sodium succinate at

3.5 μg/kg of BW within 4 hours of birth in Angus calves from dams of similar body
condition. Similar to the current study, birth weight was not different between treatments
(averaged 38.3 ± 1.4 kg) and no difference in BW was observed from 60 to 150 days of
age in beef calves.
5.2

Leptin analysis
Rather than incorporate a nutritional stimulus or insult during gestation,

administration of a glucocorticoid has been under examination in recent years. This is due
to the fact that cortisol and leptin exhibit an inverse relationship (Daniels, 1972), thus,
glucocorticoid administration may play a role in the regulation of leptin secretion.
Limited research has been performed on exogenous glucocorticoid administration and
postnatal leptin secretion in beef cattle. Previously, administration of a synthetic
glucocorticoid, dexamethasone, in perinatal dairy calves at 15 μg/kg of BW did not alter
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leptin concentrations from 1 to 4 days of age (Blum et al., 2005). Similar to the current
study, cortisol treated calves observed decreased leptin concentrations from 1 to 13 days
of age (Lewis et al., 2019) and 1 to 5 days of age (McCarty et al., 2021) when treated
with hydrocortisol sodium succinate. Reduced leptin concentrations in circulation would
lead to decreased leptin available to traverse the blood brain barrier, as leptin plays role in
appetite control center development of the brain during early postnatal life. Decreased
leptin in the circulation is positively correlated with leptin cerebral spinal fluid (CSF)
concentrations (McCarty et al., 2021). Because of this, decreased leptin CSF
concentrations are associated with altered hypothalamic gene expression which may
promote voluntary feed intake.
5.3

Growth performance
Previous models of maternal nutrition during gestation have reported altered

leptin concentrations during early postnatal life and their impact on feed consumption of
subsequent offspring in adulthood. In obese models, Long et al. (2010a) observed an
absence of the leptin surge traditionally present within the first 11 days of life in lambs
born to obese ewes fed at 150% of NRC Requirements (NRC, 2000). When the F1 lambs
reached adulthood and underwent an ad libitum feeding trial, lambs born to obese ewes
had increased appetite, adiposity, and insulin resistance compared to lambs born to
control fed ewes (Long et al., 2010b). In restriction models, offspring born to ewes that
were nutrient restricted from mid to late gestation had increased gain per unit feed when
fed a high quality ad libitum diet (George et al., 2012). Mid to late gestation nutrient
restriction is associated with decreased weight at birth (Greenwood et al., 1998) and
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lambs of low birth weight have increased voluntary feed intake during early postnatal life
(Greenwood et al., 1998).
This is further supported by data from LeMaster et al. (2017) as Heifers born to
dam’s nutrient restricted during the last 100 days of gestation observed greater feed
consumption compared to heifers born to dams that were control-fed or control-fed with a
protein supplement (LeMaster et al., 2017). Female offspring to nutrient restricted dams
consumed more feed during a 10 week ad libitum feeding trial, observed increased body
weight gain (as a % of initial body weight), and improved BCS compared to offspring
born to control fed cows (Tipton et al., 2018). While heifers in the current study
demonstrated altered feed consumption behavior due to treatment and improved BCS, it
did not alter final BW. This suggests that the heifers may have had increased adipose
deposition; however, those parameters were not evaluated within the current study.
Foote et al. (2016) reported a positive correlation between dry matter intake and
leptin concentrations in steers subjected to an 84 day feeding trial. Similar to the current
study, data from a meta-analysis of feedlot steers reported that steers with increased
leptin concentrations also had greater dry matter intake but no difference in feed
conversion (Nkrumah et al., 2007). During an ad libitum feeding trial, lambs born to
obese ewes exhibited increased appetite, and adiposity compared to lambs born to control
fed ewes (Long et al., 2010b). This is due to the decreased neuronal regulation of the
feeling of satiety which encourages the deposit of more adipose tissue when animals are
exposed to elevated nutritional plane in adulthood (Long et al., 2011). However, in the
current study there was no significant difference in BW and BF between treatments. This

245

may be due to the fact that while cortisol treated steers required numerically fewer days
on feed and had greater daily feed intake, they consumed the same amount of feed as
control treated steers by the end of the feeding trial. The author’s acknowledge that LC
treated steers tended to have greater final BW following the feeding trial whereas the HC
treated steers were not different from the control steers. This may be indicative that the
dose of leptin for the LC group may not have been enough in order to take effect while
the dose for the HC group may have overwhelmed the receptors and internalized them to
elicit no effect.
Interestingly, it appears as though glucocorticoid administration in the current
study exhibits a sexual dimorphic affect in which body composition was impacted to a
greater extent in heifers compared to steers. While steers of the glucocorticoid treated
group did not exhibit improved composition, this does bring about the potential for using
cortisol as a management tool relative to the amount of time an animal is in the feed lot to
achieve the same level of finish as traditional market animals.
5.4

Glucose analysis
Glucose concentrations of the current study differ from data reported by Tipton et

al. (2018) in which heifers born to nutrient restricted dams had greater glucose
concentrations during a 10 wk ad libitum feeding trial. Additionally, glucose
concentrations reported in the current study (average 80 to 100 mg/dL; are less than
concentrations reported in the literature (average 200 to 300 mg/dL; Tipton et al., 2018).
However, during that study, heifers were consuming greater quantities of feed a day
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(approximately 200-300 g of feed) compared to the heifers of the current study. This
difference in consumption may explain the discrepency in circulating glucose levels.
6

Conclusion
The beef cattle industry strives to improve profitability by reducing input costs in

addition to increasing the value of the animal at market. Feed cost is the leading
contributors to costs of producing a market animal which may be influenced by voluntary
feed intake. Feed conversion, or units of gain/animal tissues, is first dependent upon the
amount of feed consumed by the animal (Tess and Kolstad, 2000; Herd and Bishop,
2000). Feed efficiency, units of weight gain divided by the amount of feed required to do
so, will improve animal performance so long as it is not confounded by compromised
physiology, growth, and development. Increasing the amount of feed consumed by the
animal should increase weight gain. However, unless voluntary feed intake is increased,
provision of feed may be a wasted effort. Greater daily energy intake and reduced
number of days on feed may reduce the overall amount of maintenance energy required
to develop the animal to achieve a marketable weight by achieving a comparable finish
sooner. Because of this increased weight gain relative to their maintenance requirement
per day (Tedeschi et al., 2006), feed efficiency will be improved. It has previously been
demonstrated that leptin concentrations may be altered in livestock species using
exogenous glucocorticoids at birth (Lewis et al., 2017; McCarty et al., 2021) and may
alter voluntary feed intake. In the current study, serum leptin concentrations were
decreased in low dosage cortisol treated calves from days 2 to 17 of age. In summary,
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exogenous cortisol administered to calves at parturition reduced leptin concentrations,
improved heifer BCS, and improved feed intake of beef steers during an ad libitum
feeding trial. To the authors’ knowledge, this is the first study to determine the effects of
glucocorticoid administration at birth on voluntary feed intake of mature animals fed a
typical feedlot ration.
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Table 5.1. Ingredient composition of diets (DM basis) fed to steers during the feedlot
period.
Item
Ingredient, % of diet
Corn, ground
1291.32
Corn gluten
200.00
Soyhull Pe
175.00
Soybean Meal
100.00
Cotton Meal, 41%
100.00
Molasses
50.00
Animal fat
30.00
Salt
25.00
Calcium carbonate
20.00
Dynamate1
3.10
Magnesium oxide
2.20
2
TriMin revise
2.00
Vitamin A, D, E
1.00
3
Bovatecc 91
0.38
1
Nutrient, % (DM Basis)
DM, %
87.1
NEm, Mcal/kg
2.0
NEg, Mcal/kg
1.4
ADF, %
18.8
NDF, %
30.2
CP, %
15.3
1
All values are from laboratory analysis and are presented on a 100% DM basis (except
DM)
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Table 5.2. Performance of heifers intravenously infused with either a low cortisol (LC;
3.5 ug/kg of BW), high cortisol (HC; 7.0 ug/kg of BW), or a sham infusion control
(CON; similar volume of saline) at birth then introduced to an automated feeding
behavior data acquisition system at 385 ± 4 d of age for 10 wk.
CON

Treatment
HC
10
404.8 ± 11.7
479.4 ± 13.1
74.5 ± 4.2

LC

P-Value
Trt

n
10
10
1
Initial BW , kg
425.9 ± 11.6
404.7 ± 10.0
0.270
2
Final BW , kg
508.5 ± 12.9
501.0 ± 11.1
0.204
BW gain during trial,
82.6 ± 4.2
96.2 ± 3.6
0.001
kg
Initial BCS3
6.4 ± 0.1
6.1± 0.1
6.1 ± 0.1
0.086
Final BCS
6.9 ± 0.2
6.7 ± 0.2
7.3 ± 0.2
0.044
BCS ∆ during trial
0.5 ± 0.2
0.6 ± 0.2
1.2 ± 0.2
0.034
Data presented LSM ± SEM.
1
Initial body weight (BW) was calculated as the average of BW collected over two
consecutive days (d 0 and 1 relative to the start of the feeding trial).
2
Final BW was calculated as the average of BW collected over two consecutive days (d
69 and 70 relative to the start of the feeding trial).
3
Wagner et al., 1988
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Table 5.3. Feeding behavior of heifers intravenously infused with either a low cortisol
(LC; 3.5 ug/kg of BW), high cortisol (HC; 7.0 ug/kg of BW), or a sham infusion control
(CON; similar volume of saline) at birth then introduced to an automated feeding
behavior data acquisition system at 385 ± 4 d of age for 10 wk.
Treatment
CON
n
Total feed events1

10
2890.6 ±
187.1
817.0 ± 47.9
291.6 ± 23.0

HC

LC

10
3051.4 ±
191.1
877.5 ± 48.9
299.9 ± 23.5

10
3594.8 ±
161.8
955.8 ± 41.4
271.3 ± 19.9

PValue
Trt
0.016

Total feed consumed2, kg
0.093
3
Average FI during feed
0.606
events, g
Data presented LSM ± SEM
1
Total feed events is the total number of feed events that occurred during the 10 wk
feeding trial
2
Total feed consumed is the total amount of feed consumed on average per animal during
the 10 wk feeding trial
3
Average feed intake (FI) during a feed events
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Table 5.4. Performance of steers intravenously infused with either a low cortisol (LC;
3.5 ug/kg of BW), high cortisol (HC; 7.0 ug/kg of BW), or a sham infusion control
(CON; similar volume of saline) at birth then introduced to an automated feeding
behavior data acquisition system at 385 ± 4 d of age.
CON

Treatment
HC
10
430.1 ± 11.7
614.6 ± 11.7
122.0 ± 3.5
1.18 ± 0.04
128.3 ± 1.4

P-Value
LC

Trt

n
10
12
1
Initial BW , kg
412.7 ± 11.9
437.1 ± 10.9 0.296
2
Final BW , kg
598.4 ± 11.9
635.2 ± 11.0 0.080
3
D on feed , d
126.1 ± 3.5
118.5 ± 3.3
0.281
BF thickness4, cm
1.08 ± 0.04
1.17 ± 0.04
0.160
Final hip height, cm 126.9 ± 1.4
130.8 ± 1.4
0.134
Data presented LSM ± SEM
1
Initial BW was calculated as the average of BW collected over two consecutive days (d
0 and 1 relative to the start of the feeding trial)
2
Final BW was calculated as the average of BW collected over two consecutive days (d
69 and 70 relative to the start of the feeding trial)
3
Days on feed is the number of days the animal was on the feeding trial until declared to
have a back fat thickness of 1.1 cm
4
Backfat (BF) thickness as measured via ultrasonography on the 12th rib on the right
thoracic side of the animal at the final time point of the feeding trial prior to
transportation to a local abattoir
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Table 5.5. Feeding behavior of steers intravenously infused with either a low cortisol
(LC; 3.5 ug/kg of BW), high cortisol (HC; 7.0 ug/kg of BW), or a sham infusion control
(CON; similar volume of saline) at birth then introduced to an automated feeding
behavior data acquisition system at 385 ± 4 d of age.
P-Value

Treatment
CON
n
Total feed consumed,
kg
Average FI1 during
feed events, kg
DFI2, kg

HC

LC

Trt

10
10
1312.2 ± 38.6 1269.0 ± 41.5

12
1371.1 ± 41.5

0.252

11.1 ± 0.4

10.5 ± 0.4

11.5 ± 0.4

0.228

10.6 ± 0.3

10.6 ± 0.4

11.7 ± 0.4

0.039

Data presented LSM ± SEM
1
Average feed intake (FI) during a feed events
2
Daily feed intake (DFI)
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Table 5.6. Carcass performance of steers intravenously infused with either a low cortisol
(LC; 3.5 ug/kg of BW), high cortisol (HC; 7.0 ug/kg of BW), or a sham infusion control
(CON; similar volume of saline) at birth then introduced to an automated feeding
behavior data acquisition system at 385 ± 4 d of age.
Treatment
CON

HC

n
10
10
1
HCW , kg
343.1 ± 6.6
348.1 ± 7.1
Yield grade, 1-5
3.4 ± 0.2
3.1 ± 0.3
Marbling score2, 0-500
48.4 ± 3.3
45.2 ± 3.6
Feed consumed/HCW,
3838.6 ±
3654.0 ±
g/kg
109.1
117.5
Data presented LSM ± SEM
1
Hot carcass weight (HCW)
2
Marbling score: 300 = Slight 00; 400 = Small 00
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LC
12
371.3 ± 7.1
3.1 ± 0.3
52.6 ± 3.6
3690.0 ±
117.5

PValue
Trt
0.019
0.640
0.371
0.472

Figure 5.1. Leptin concentrations of serum samples collected from d 0 to 17 of the
feeding trial from all calves intravenously infused with either a low cortisol (LC; n = 9,
3.5 ug/kg of BW), high cortisol (HC; n = 9, 7.0 ug/kg of BW), or a sham infusion control
(CON; n = 9, similar volume of saline) at birth. (*) indicates P < 0.05
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Figure 5.2. Glucose concentrations of plasma samples collected from d 0 to 70 of the
feeding trial from heifers intravenously infused with either a low cortisol (LC; n = 9, 3.5
ug/kg of BW), high cortisol (HC; n = 9, 7.0 ug/kg of BW), or a sham infusion control
(CON; n = 9, similar volume of saline) at birth. (*) indicates P < 0.05
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Figure 5.3. Glucose concentrations of plasma samples collected from d 0 to 140 of the
feeding trial from steers intravenously infused with either a low cortisol (LC; n = 9, 3.5
ug/kg of BW), high cortisol (HC; n = 9, 7.0 ug/kg of BW), or a sham infusion control
(CON; n = 9, similar volume of saline) at birth. (*) indicates P < 0.05
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CHAPTER VI
GENERAL DISCUSSION
Maternal condition during gestation alters fetal growth and development during
critical periods of development which may impact early postnatal life. McCarty et al.
(2020a) examined the effects of endophyte–infected tall fescue during late gestation on
maternal and offspring performance. Exposure to endophyte–infected forage during late
gestation results in decreased maternal semen prolactin and body weight during late
gestation compared to cows consuming non-infected forage. Exposure to endophyte–
infected forage resulted in calves with reduced weight and body mass index at birth and a
tendency for reduced body weight at weaning compared to calves from non-infected
dams.
In cattle production, periods of nutrient restriction or over nutrition have been
evaluated to determine fetal development and performance to address various economic
or environmental stressors animals may encounter. Specifically, nutrient restriction may
negatively impact subsequent offspring if it occurs during critical periods of development
during gestation. McCarty et al. (2020b) examined the effects of nutrient restriction in
beef cows on fetal pancreatic development. Decreased serum insulin concentrations were
observed in fetuses that underwent periods of nutrient restriction during gestation,
potentially to maintain metabolism, although carcass weight was forfeited. This evidence
suggests that nutrient restriction either during early or mid-gestation can negatively
impact fetal pancreatic development. However, mid gestational nutritional insult is
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potentially recovered by re-acclimation to a diet that meets to requirements of the dam,
thus, reducing negative outcomes in fetal offspring.
Finally, profitability in beef cattle production may be influenced by voluntary
feed intake and the neuronal circuitry that regulate it. Leptin promotes development of
appetite control centers of the brain during early postnatal development (Yura et al.,
2005). Cattle exhibit a surge of leptin from about 1 to 4 days of postnatal life (Long and
Schafer, 2013). Conversely, decreased leptin concentrations during this time have been
associated with increased feed intake in ruminants. Glucocorticoids have been reported to
decrease leptin concentrations and may serve as a tool to alter endocrine status and
associated brain development. Previous reports have observed altered leptin
concentrations due to glucocorticoid infusion at birth in beef cattle (LeMaster et al.,
2017). In the current study, administration of an exogenous glucocorticoid (hydrocortisol
sodium succinate) at birth decreased circulating leptin and cerebrospinal fluid (CSF)
concentrations in dairy bull calves. Overall, reduced leptin concentrations in circulation
would lead to reduced leptin to traverse the blood brain barrier; as observed by reduced
CSF concentrations at day 5 of age. Meaning that leptin concentrations in the brain would
be depressed and, thus, diminish the amount of influence it would have on brain
development during early postnatal life as well as potentially impaired signaling
pathways. Nonetheless, more experimentation is required for understanding the bloodCSF transfer and the effects on downstream intracellular leptin signaling pathways in
cattle.
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Glucocorticoid administration decreased leptin (Ob) and tended to decrease
glucocorticoid receptor (GR) protein expression in perirenal adipose tissue at 5 days of
age. Compared to other adipose tissue depots (such as omental and mesenteric), perirenal
adipose may play a role in the leptin signaling cascade. In which glucocorticoid
administration binds to glucocorticoid receptors found on perirenal tissue, decreases
leptin production, and results in reduced leptin in circulation. Based on the findings of the
current study, we believe that perirenal serves as the predominant adipose depot that is
responsible for circulating leptin during the early postnatal period and surge present in
cattle the first two to four days of life. Decreased leptin production would lead to reduced
expression of genes associated with neuronal development of appetite control centers in
the hypothalamus. In the current study, expression of leptin (Ob), leptin receptor (ObR),
and glucocorticoid receptor (GR) in the hypothalamus did not differ due to treatment.
However, expression of brain derived neurotrophic factor (BDNF), and fibroblast growth
factor 1 and 2 (FGF1 and FGF2, respectively) were decreased in cortisol treated calves
compared to control treated calves.
The authors hypothesize that reduced appetite center development in the
hypothalamus would lead to increased voluntary feed intake later in life due to
diminished neuronal regulation of appetite and satiety. Data from the previous
experiment reported that cortisol treated calves observed decreased circulating leptin
concentrations from days 2 to 17 of age. Cortisol treated heifers then underwent a 70 day
feeding trial and observed body weight gain, body condition gain, and increased number
of feeding events. While glucocorticoid treated steers that underwent a feeding trial for
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upwards of 140 days observed greater daily feed intake and hot carcass weight in cortisol
treated compared to control steers. Additionally, dairy bull calves from the current study
observed similar circulating leptin concentrations as beef calves (Lewis et al., 2019)
during early postnatal life. Thus, dairy bull calves serve as a reliable model for early
postnatal research in beef cattle.
In summary, exogenous cortisol administered to perinatal dairy bull calves
reduced leptin concentrations in serum and CSF, decreased protein expression of leptin in
perirenal adipose tissue, and altered gene expression in hypothalamic tissue. When the
experiment was performed in beef cattle, similar depression of circulating leptin was
observed and feed intake of beef steers increased in cortisol treated animals compared to
control. In summary, exogenous cortisol administered to calves at birth reduced leptin
concentrations and altered appetitic control center development of the brain in perinatal
dairy bull calves and improved FI of beef steers during a feeding trial. Thus, exogenous
glucocorticoid administration served as a useful tool for altering feeding behavior in
adulthood.
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